university institute of pharmaceutical sciences

92
Evaluative Report of the Department 1. Name of the Department: University Institute of Pharmaceutical Sciences 2. Year of establishment 1944 3. Is the Department part of a School/Faculty of the university? Yes 4. Names of programmes offered (UG, PG, M.Phil., Ph.D., Integrated Masters; Integrated Ph.D., D.Sc., D.Litt., etc.) B. Pharm, M. Pharm. & Ph.D. 5. Interdisciplinary programmes and departments involved : Nil 6. Courses in collaboration with other universities, industries, foreign institutions, etc.: Nil 7. Details of programmes discontinued, if any, with reasons: Nil 8. Examination System: Annual/Semester/Trimester/Choice Based Credit System: Credit Based Semester 9. Participation of the department in the courses offered by other departments: Nil 10. Number of teaching posts sanctioned, filled and actual (Professors/Associate Professors/Asst. Professors/others) Sanctioned Filled Actual (including (CAS & MPS) Professor 5 1 14 Associate Prof. 8 4 1 Asstt. Prof 23 14 7 Others - - -

Upload: doannguyet

Post on 01-Jan-2017

270 views

Category:

Documents


9 download

TRANSCRIPT

Page 1: University Institute of Pharmaceutical Sciences

Evaluative Report of the Department

1. Name of the Department: University Institute of Pharmaceutical Sciences

2. Year of establishment 1944

3. Is the Department part of a School/Faculty of the university? Yes

4. Names of programmes offered (UG, PG, M.Phil., Ph.D., Integrated Masters; Integrated

Ph.D., D.Sc., D.Litt., etc.)

B. Pharm, M. Pharm. & Ph.D.

5. Interdisciplinary programmes and departments involved : Nil

6. Courses in collaboration with other universities, industries, foreign institutions, etc.: Nil

7. Details of programmes discontinued, if any, with reasons: Nil

8. Examination System: Annual/Semester/Trimester/Choice Based Credit System: Credit

Based Semester

9. Participation of the department in the courses offered by other departments: Nil

10. Number of teaching posts sanctioned, filled and actual (Professors/Associate Professors/Asst. Professors/others)

Sanctioned Filled Actual (including

(CAS & MPS)

Professor 5 1 14

Associate Prof. 8 4 1

Asstt. Prof 23 14 7

Others - - -

Page 2: University Institute of Pharmaceutical Sciences

11. Faculty profile with name, qualification, designation, area of specialization, experience

and research under guidance

Name Qualification Designati

on

Specialization No. of

Years

of

Experi

enceAs

on

2014

No. of

Ph.D./

M.Phil.

students

guided

for the

last 4

years

Prof V.R. Sinha

Chairperson

M.Pharm.,Ph.

D. Professor Pharmaceutics 21 5 3

Prof. Karan

Vasisht

M.Pharm.,Ph.

D. Professor Pharmacognosy 33 2 1

Prof. O.P. Katare M.Pharm.,Ph.

D. Professor Pharmaceutics 27 4 4

Prof. B.S. Bhoop

M.Pharm.

Ph.D. Dip. in

Stat.

Professor Pharmaceutics 33 2 2

Prof.

RenuChadha M.Sc.,Ph.D. Professor

Pharmaceutical

Chemistry 26 3 3

Dr.Kanwaljit

Chopra

M.Pharm.,Ph.

D. Professor Pharmacology 25 5 6

Dr Anupam

Sharma

M.Pharm.Ph.

D. Professor Pharmacognosy 30 1 1

Dr Indu Pal Kaur M.Pharm.,Ph.

D. Professor Pharmaceutics 19 2 3

Dr Manoj Kumar M.Pharm.,Ph.

D. Professor

Pharmaceutical

Chemistry 24 2 3

Dr.Shishu M.Pharm.,Ph.

D Professor Pharmaceutics 18 1 1

Dr. Anil Kumar M.Pharm.,Ph.

D. Professor Pharmacology 15 3 5

Dr RanjuBansal M.Pharm.,Ph.

D. Professor

Pharmaceutical

Chemistry 17 3 3

Page 3: University Institute of Pharmaceutical Sciences

Dr

PoonamPiplani

M.Pharm.,Ph.

D. Professor

Pharmaceutical

Chemistry 17 - -

Dr Maninder

Karan

M.Pharm.

Ph.D Professor Pharmacognosy 18 2 2

Ms Alka Bali M.Pharm. Associate

Professor

Pharmaceutical

Chemistry 20 - -

Dr AnuragKuhad M.Pharm.,Ph.

D.

Assistant

Professor Pharmacology 9 - -

Dr Ashwani

Kumar

M.Pharm.

Ph.D

Assistant

Professor Pharmacognosy 8 - -

Dr Jai Malik M.Pharm.,Ph.

D

Assistant

Professor Pharmacognosy 9 -

Dr Jai Malik M.Pharm.,Ph.

D

Assistant

Professor Pharmacognosy 9 -

Dr

NeelimaDhingra

M.Pharm.,Ph.

D.

Assistant

Professor

Pharmaceutical

Chemistry 6 -

Dr

VanditaKakkar

M.Pharm.,Ph.

D.

Assistant

Professor Pharmaceutics 3 -

Dr AmitaSarwal M.Pharm.,Ph.

D.

Assistant

Professor Pharmaceutics 7 -

Dr

SangeetaPilkhwal

Sah

M.Pharm.,Ph.

D.

Assistant

Professor Pharmacology 7 -

12. List of senior Visiting Fellows, Adjunct Faculty, Emeritus Professors

Visiting Fellows:

Dr.Mohinder Singh Bathala

Dr. M. Ravikumar

Dr. M.S. Singh

Mr. M.S. Tanwar

Dr.UmeshBanakar

Dr.Arvind Singh

Dr. Louis S. Prem Kumar

Dr. G.V. Madhava Sharma

Dr.NavitaMallalieu

Page 4: University Institute of Pharmaceutical Sciences

Adjunct faculty:

Sr. No. Name Of Guest Faculty

1 Mukesh Kumar

2 ManojTiwari (Kumar)

3 SangeetaArora

4 RichaPuri

5 R. Jindal

6 Karanjot K. Brar

7 Sanjeev K Sharma

8 AnupamaSharama

9 Tankeshwar

10 Archana

11 S.K.Singla

12 ShilpaBhasin

13 G P Mehta

14 Meenu Paul

15 G.L. Singal

16 ShilpaBhasin

17 AnupamaSaini

18 Tejvir Singh

19 KalpanaMahajan

20 R.K.Chhabra

21 Rohit

Emeritus Professors

Dr.Harkishan Singh

Dr. S.K. Kulkarni

Page 5: University Institute of Pharmaceutical Sciences

13. Percentage of classes taken by temporary faculty – programme-wise information: 20-

30%

14. Programme-wise Student Teacher Ratio: B. Pharm: 7:1

M. Pharm: 2:1

15. Number of academic support staff (technical) and administrative staff: sanctioned, filled

and actual:

Sanctioned Filled Actual

21 18+2* 22

40 21+2* 18

*Daily wages staff

16. Research thrust areas as recognized by major funding agencies

Drug Discovery & Development

Drug / Lead Molecules from Natural & Synthetic Sources

Computer-aided Drug Designing; QSAR

Pharmacological Evaluation of Lead Molecules & NCEs

In vivo Pharmacokinetic – Pharmacodynamic

In-vivo Correlation

Crystal Engineering of drug molecules

Novel Drug Delivery Systems (NDDS)

Modified (control, sustained & extended) Release DDS

Pharmaceutical Biotechnology and Nanotechnology

Scale-up & Validation

Vesicular, Colloidal &Micellar Drug Delivery Systems

Herbal Drugs Technology

Standardisation of Plant Drugs & Development of Monographs

Development of Herbal Formulations

SOPs of Polyherbal Formulations

Basic & clinical Pharmacological Research

Development of New Animal Models

Mechanistic evaluation of phytoconstituents

Neuropsychopharmacological Research

Metabolic research – diabetes, diabetes, diabetic complications &obesity

Pharmacovigilance

Page 6: University Institute of Pharmaceutical Sciences

17. Number of faculty with ongoing projects from a) national b) international funding

agencies and c) Total grants received. Give the names of the funding agencies, project

title and grants received project-wise.

Details of research grant received from different agencies last four years(2009-

2013)

Name and

Designation of

Faculty

Title of the project and duration Amoun

t

sanctio

ned

Funding Agency

Professor Karan

Vasisht

Central Scheme for „Development

of Standard Operating Procedures

(SOPs) of Manufacturing Process

of Compound Ayurvedic-Siddha-

Unani Formulations and their

Pharmacopoeial Standards‟

2004 to till date

Rs 30

lac

Department of

AYUSH, Ministry

of Health &

Family Welfare,

Govt of India,

Delhi.

Professor O.P.

Katare

Development and scale-up of

some novel liposomal products

2005 to till date

Rs. 5.1

lacs

Life care

Innovations Pvt.

Ltd., Gurgaon

Design, Development and

Evaluation of Some Novel

Formulations of some drug

candidates

2008 to till date

Rs.

36.0

lacs

IPCA Labs. Ltd,

Mumbai

Professor V.R.

Sinha

Development and characterization

of ARV (antiretroviral) Therapy

(ART) based prolonged release

drug delivery systems for

treatment of AIDS

2007-2011

Rs. 9.30

lacs

CSIR

Development of colon targeted Rs.

8,91,800/-

UGC

Page 7: University Institute of Pharmaceutical Sciences

drug delivery systems for local

pathologies

2012-2015

Professor B.S.

Bhoop

Design Development and

Optimization of Oral Drug

Delivery Systems with Enhanced

Bioavailability Potential

2009-2011

Rs. 20.00

lacs

AICTE

Screening and Formulation

Development of Novel

Phytochemical Drugs for various

CNS Disorders

2010-2011

Rs. 4.00

lacs

Industry

(AvancePhytothera

pies Pvt Ltd.)

Formulation Development of

Novel Bioenhanced Oral Drug

Delivery Systems of Antiretroviral

Drugs using Optimized Polymer

Blends

2011 to till date

Rs. 11.68

lacs

CSIR

“Nanoparticles of Flavone

Derivatives for Brain Targeting: A

Possible Remedy for Alzheimer‟s

Disease”

2007-2011

Rs. 7.46

lacs

ICMR

Professor

RenuChadha

Preparation and characterization of

various polymorphic forms of

selected drugs and study of their

complexes with cyclodextrins

using calorimetry and other

techniques

2007-2010

Rs.

22.00

lacs

DST

Page 8: University Institute of Pharmaceutical Sciences

Preparation and characterization of

Inclusion complexes with

cyclodextrins of some

Antihyperlipidemic drug.

2010 to till date

Rs10.0

0 lacs

DST-W-OSE

Studies on the preparation of

crystals and pharmaceutical

Cocrystals of selected

hypoglycaemic agents and their

characterization by

thermoanalytical and

spectroscopic techniques

2011 onwards

Rs7.00

lacs

CSIR

Preparation and characterization of

crystal polymorphs of selected

drugs with anti aging effect-

Thermoanalytical and

Spectroscopic aspects

2012-2015

Rs.

6.27

lacs

UGC

Professor

Kanwaljit

Chopra

Evaluation of anti-diabetic activity

of plant extracts

2007 to till date

Rs.2.18

lacs

Ayush Herbs Inc.

USA

Development of novel therapeutic

modalities for diabetic neuropathy

2008 to till date

Rs.7.60

lacs

CCRAS, New

Delhi

Development of Therapeutic

Rescue for Memory Deficits &

Alzheimer‟s Disease Associated

with Insulin Resistance Syndrome

2011-2013

Rs.

8.50

lacs

UGC

Evaluation of anti-diabetic activity

of FENFURO

Rs.2.30

lacs

Chemical

Resources

Page 9: University Institute of Pharmaceutical Sciences

2009 to till date

Evaluation of anti-diabetic activity

of GONIFLEX

2012 to till date

Rs.6.50

lacs

Dr.Dozo Lab.

Mohali

Professor Indu

Pal Kaur

Development of drug loaded solid

Lipid nanoparticles for treating

cereleral tuberculosis

2008-2011 to till date

Rs.

1.10

crores

DBT

Development of Cureumin as a

Neurohermetic therapeutic

2008-2012

Rs.

7.52

lacs

CSIR

“Nanotechnological Interventions

in Cerebral Tuberculosis

Treatment”

2008 -2013

Rs 6.40

lacs

ICMR

Genotoxicity studies on impurities

of active pharmaceutical

ingredients

2008 onwards

Rs 77,

000 per

compo

und to

be

tested.

JUBILANT

ORGANOSYS

Ltd, Noida

“Development of Curcumin as a

Neurohormetic Therapeutic”

2008-2011

Rs 6.40

lacs

CSIR

“Development of Suitable nano-

ocular formulations for superficial

and vitreal fungal infections”

2011 onwards

Rs.

46.55

lacs

DST

Page 10: University Institute of Pharmaceutical Sciences

“Exploitation and fabrication of

suitable nanosystem for the relief

of neuropathic pain using siRNA

as a tool of treatment”

2011 onwards

Rs 8.37

lacs

ICMR

Professor Manoj

Kumar

Design, synthesis and study of

NovalSteriodal 5 Alpha Reductase

Inhibitors for the Management Of

BPH

2010-2013

Rs. 10.62

lacs

UGC

Discovery of novel protein

tyrosine phosphatise IB inhibitors

for metabolic disorders through

Biotechnological approach

2010-2013

Rs.

23.76

lacs

DRDO

Professor Shishu Novel Collodal Carrier Based

Dermal Delivery Systems of

Griseofulvin to Treat Topical

Fungal Infections

2008-2011

Rs.

11.31

lacs

CSIR

Development of topical

formulation itraconzole role using

noval colloidal drug carrier

system.

2009-2012

6.00 lacs UGC

Professor Anil

Kumar

Investigation on therapeutic

strategies and mechanism involved

stress and related disorders

2009-2011

18.00 lacs CSIR

Novel Therapeutic Strategies of

neuropathic pain and related

10.29 lacs ICMR

Page 11: University Institute of Pharmaceutical Sciences

disorders

2012 onwards

Pharmacological investigations on

Herbal Drug Curcumin in chronic

stress related disorders

2011 onwards

10.00 lacs ICMR

Development of newer therapeutic

strategies targets mitochondrial,

Neuro inflammatory and apoptotic

Mechanism in Huntington disease.

2011onwards

9.26 lacs UGC

Professor

RanjuBansal

Development of azole derived

steroidal hybrids as potent

aromatase inhibitors for the

management of breast cancer

2008-2011

Rs.

30.00

Lacs

DST

Design and synthesis of novel

pyridazinone based COX-2

selective hybrid molecules as

potent analgesic and anti-

inflammatory agents

2010-2013

Rs.

10.00

lacs

UGC

Chemoenzymatic synthesis and

antihypertensive activity of a new

series of

enantiopuredihydropyridines

2010-2012

Rs.

1.75lac

s

UGC

Synthesis and study of new

xanthine derivatives as potent and

selective adenosine receptor

Rs.

7.0lacs

ICMR

Page 12: University Institute of Pharmaceutical Sciences

antagonists for asthma therapy

2008-2011

Professor

PoonamPiplani

Rational Design and synthesis of

acetylcholinesterase inhibitors for

cognition disorders

2012-2015

Rs.

9.38

lacs

UGC

Rational Design of

acetylcholinesterase inhibitors for

cognition disorders

2013-2016

Rs.

16.00

lacs

CSIR

Dr.AnuragKuhad Development of Phytochemicals

as Potential Therapeutic Moieties

for Chronic Respiratory Diseases:

Targeting Matrix

Metalloproteinases

2013-2016

Rs.

18.29

lacs

DST

Development of Phytochemicals as

Therapeutic Rescue for

Antipsychotic-induced Metabolic

Syndrome

2013-2015

Rs.

6.00

lacs

UGC

Dr.Ashwani

Kumar

Phytochemical studies on

Selinumvaginatum

2013-2015

Rs.

6.00

lacs

UGC

Dr.NeelimaDhing

ra

Synthesis and Characterization of

17-Oxo-17a-aza-D-Homo-5-

androsten-3β-yl esters” amounting

Rs 5,40,000 for a period of 2 years

has been sanctioned under UGC

–BSR scheme 2013

2013-2015

Rs.

6.00

lacs

UGC

Page 13: University Institute of Pharmaceutical Sciences

Dr. Jai Malik Development and standardization

of a polyherbal memory enhancing

formulation with modern drug

delivery system

2013-2016

Rs. 22.5

lacs

DST

To evaluate & establish the

neuroprotective role of

CelastrusPaniculatus against 3-

Nitropropionic acid induced

neurotoxicity – A model for

Huntington‟s Disease

2013-2015

Rs.

6.00

lacs

UGC

Dr.VanditaKakka

r

Evaluation of curcumin loaded

solid lipid nanoparticles for

ameliorating depression

2013-2015

Rs.

6.00

lacs

UGC

Dr.AmitaSarwal Development and Evaluation of

Vaginal Delivery System of

Acyclovir for the prevention of

viral diseases

2013-2015

Rs.

6.00

lacs

UGC

Dr.SangeetaPilkh

walSah

Targetting inflammation in the

Pathogenesis of Insulin Resistance

& type II Diabetes Mellitus

2013-2015

Rs.

6.00

lacs

UGC

Page 14: University Institute of Pharmaceutical Sciences

18. Inter-institutional collaborative projects and associated grants received

a) National collaborationb) International collaboration

Collaborations National & International

Prof. O.P.

Katare

Life care Innovations

Pvt. Ltd., Gurgaon

Development and scale-up of

some novel liposomal

products

Rs. 5.1

lacs

200

5 to

till

date

IPCA Labs. Ltd,

Mumbai

Design, Development and

Evaluation of Some Novel

Formulations of some drug

candidates

Rs. 36.0

lacs

200

8 to

till

date

Prof. B.S.

Bhoop

Industry

(AvancePhytotherapiesP

vt Ltd.)

Screening and Formulation

Development of Novel

Phytochemical Drugs for

various CNS Disorders

Rs. 4.00

lacs

201

0 to

till

date

Florida ENDM Univ

Tallahassee, USA

Dermatalogical&Dermacokent

ics formulations of Nano-

technology

201

2 to

till

date

Dr.Kanwalj

it Chopra

Ayush Herbs Inc.

USA

Evaluation of anti-diabetic

activity of plant extracts

Rs.2.18

lacs

200

7 to

till

date

Chemical Resources Evaluation of anti-diabetic

activity of FENFURO

Rs.2.30

lacs

200

9 to

till

date

Dr.Dozo Lab. Mohali Evaluation of anti-diabetic

activity of GONIFLEX

Rs.6.50

lacs

201

2 to

till

date

Page 15: University Institute of Pharmaceutical Sciences

Dr.Indu

Pal Kaur

JUBILANT

ORGANOSYS Ltd,

Noida

Genotoxicity studies on

impurities of active

pharmaceutical ingredients

Rs 77,

000 per

compoun

d to be

tested.

Till date

5

molecule

s were

evaluated

and Rs.

3.85/-

were

received

200

8 to

till

date

19. Departmental projects funded by DST-FIST; UGC-SAP/CAS, DPE; DBT, ICSSR,

AICTE, etc.; total grants received.

UGC Networking 2009: Rs. 5 Crores

DST PURSE 2009: Rs. 25.50Lacs

DST PURSE 2010: Rs. 1.50 Lacs

UGC CAS 2013: Rs. 87.50 Lacs

UGC Networking 2013: Rs. 1 Crore

20. Research facility / centre with

• state recognition: UIPS with National Recognition, PCI & AICTE

• national recognition: CIL/RSIC/USIC with National & International recognition • international recognition 21. Special research laboratories sponsored by / created by industry or corporate bodies

DST-FIST Laboratory

22. Publications:

∗ Number of papers published in peer reviewed journals (national / international) ∗ Books with ISBN with d∗ Monographs:

Singh H. (author) Sir Ram Nath Chopra Work, Vision and Legacy, (2010)

published by VallabhPrakashan, Delhi

RanjuBansal, RakeshYadav and Gulshan Kumar “Asthma - Molecular Basis and

Treatment Approaches” (2011) LAP LAMBERT Academic Publishing GmbH

& Co. KG, DudweilerLandstraße 99 D - 66123 Saarbrücken.

Kanwaljit Chopra &AnuragKuhad, DIABETIC NEUROPATHY AND

ENCEPHALOPATHY (2011)LAP LAMBERT Academic Publishing.

Kanwaljit Chopra, NEUROBIOLOGY OF DEPRESSION & ALZHEIMER‟S

DISEASE (2011), LAP LAMBERT Academic Publishing

Page 16: University Institute of Pharmaceutical Sciences

Benign Prostatic Hyperplasia : an Overview (Various treatment option for

enlarged prostate) NeelimaDhingra and T R Bhardwaj

R. C. Sobti, A. Kaushik, Bhupinder Singh and S.K. Tripathi,Emerging

Paradigms in Nanotechnology, Pearson Education Publishers, Chennai, ISBN

978-81-317-8991-9, Hard bound, 1st Edition, 958 Pages, Price Rs. 950, 2012.

Singh H. (author) Witness to an Era (An autobiography of Dr. Harkishan Singh)

published by VallabhPrakashan, Delhi

∗ Chapters in Books

Book Chapters

Chopra K., Kuhad A., &Tiwari V. Vitamin E and Neuroinflammation “Vitamins in

the Prevention of Human Diseases” (Editor

Hermann/Obeid)

Indu P. Kaur, AnuragKuhad,

AmitaGarg&Kanwaljit Chopra

Chapter title: Probiotics: Potential

Pharmaceutical Applications, in: Susan S. Cho

(Eds), HANDBOOK OF PREBIOTICS AND

PROBIOTICS INGREDIENTS, HEALTH

BENEFITS AND FOOD AND FEED

APPLICATIONS, CRC Press, Boca Raton,

FL, USA(2010)

Indu P. Kaur, AnuragKuhad,

&Kanwaljit Chopra

Chapter title: Antioxidant and Anticancer

Activity of Tea Catechins And Their potential

For Development As Therapeutics, in: Rajesh

Arora (Eds), HERBAL DRUGS: A CANCER

CHEMOPREVENTIVE AND

THERAPEUTIC PERSPECTIVE.Jaypee

Brothers Medical Publishers Pvt. Ltd., New

Delhi, India(2010)

Indu P. Kaur, ShilpaKakkar, and

Harinder Singh

Chapter title: Repackaging of Anti-glaucoma

Medicines: New Therapeutic Vistas, Nova

Science Publishers, New York Inc., New York

Kaur, I.P., Kakkar, S. and Singh, H.

Chapter title: REPACKAGING OF ANTI-

GLAUCOMA MEDICINES: NEW

THERAPEUTIC VISTAS, Nova Science

Publishers, New York Inc., New York (2011).

Kaur, I.P., Geetha, T. and Kakkar, V.

Chapter title: Sesamol loaded solid lipid

nanoparticles for the control and cure of skin

cancers. Advanced Anticancer Approaches with

Multifuntional Lipid Nanocarriers published by

i Smithers-Creative Publishing Solutions,

England (2011).

Page 17: University Institute of Pharmaceutical Sciences

Kaur, I.P., and Kakkar, V. Chapter title: Bioavailability Enhancement and

Brain Targeting of Curcumin: A Potential

Antitumour Agent. Advanced Anticancer

Approaches with Multifuntional Lipid

Nanocarriers published by i Smithers-Creative

Publishing Solutions, England (2011).

Bhupinder Singh, S. Beg, S.

Bandyopadhyay and O.P. Katare

Chapter title: Lipid-based Self-emulsifying

Formulations with Enhanced Bioavailability

Potential, In: Advancement in Carrier based

Drug Delivery, Sanjay K. Jain (Editor),

Biohealthcare publishing Limited (Oxford),

Oxford OX28 4BN UK, Vol. 8, Chapter No. 6,

2013, pp. 455-468.

Bhupinder Singh, B. Garg, Y. Paul

and R. Kaur Pharmacokinetic and Biopharmaceutical

Considerations in Novel Drug Delivery, In:

Advancement in Carrier based Drug Delivery,

Sanjay K. Jain (Editor), Biohealthcare

publishing Limited (Oxford), Oxford OX28

4BN UK, Vol. 8, Chapter No. 10, 2013, pp.

515-539.

Indu Pal Kaur and Gaurav Sharma siRNA: A new approach to target neuropathic

pain, Biodrugs, 26:401-12, 2012

Praveen Rishi, AmanPreet

Singh, SumehaArora, NehaGarg, Ind

uPal Kaur

Revisiting eukaryotic anti-infective

biotherapeutics. Critical Reviews in

Microbiology.DOI : 10.3109/ 1040841X. 2012.

749210, 2012.

Bhupinder Singh, S. Beg, S.

Bandyopadhyay and O.P. Katare

Chapter title: Lipid-based Self-emulsifying

Formulations with Enhanced Bioavailability

Potential, In: Advancement in Carrier based

Drug Delivery, Sanjay K. Jain (Editor),

Biohealthcare publishing Limited (Oxford),

Oxford OX28 4BN UK, Vol. 8, Chapter No. 6,

2013, pp. 455-468.

Bhupinder Singh, B. Garg, Y. Paul

and R. Kaur Pharmacokinetic and Biopharmaceutical

Considerations in Novel Drug Delivery, In:

Advancement in Carrier based Drug Delivery,

Sanjay K. Jain (Editor), Biohealthcare

publishing Limited (Oxford), Oxford OX28

4BN UK, Vol. 8, Chapter No. 10, 2013, pp.

515-539.

Page 18: University Institute of Pharmaceutical Sciences

Edited Books

Details of publishers

∗ Number listed in International Database (For e.g. Web of Science, Scopus,

Humanities International Complete, Dare Database - International Social

Sciences Directory, EBSCO host, etc.): 425

∗ Citation Index – range / average: 5-8136 (Average)

∗SNIP

∗ SJR

∗ Impact Factor – range / average (0-40)

∗ h-index (2-45)

LIST OF PUBLICATIONS

UNIVERSITY INSTITUTE OF PHARMACEUTICAL SCIENCES, PANJAB

UNIVERSITY

2009

1. Vasisht, K., Karan, M., Sharma, P. D. (2009). Monograph on Selinum vaginatum

(Bhutakesi) fruit. The Ayurvedic Pharmacopoeia of India, Part I, Vol. VI, Ministry

of Health & Family Welfare, Department of AYUSH, Government of India, p. 12-

13.

2. Vasisht, K., Karan, M., Sharma, P. D. (2009). Monograph on Heliotropium

indicum (Hathisundi) whole plant. The Ayurvedic Pharmacopoeia of India, Part I,

Vol. VI, Ministry of Health & Family Welfare, Department of AYUSH,

Government of India, p. 66-67.

3. Vasisht, K., Karan, M., Sharma, P. D. (2009). Monograph on Celosia argentea

(Sivavarak) seed. The Ayurvedic Pharmacopoeia of India, Part I, Vol. VI, Ministry

of Health & Family Welfare, Department of AYUSH, Government of India, p.

148-149.

4. Vasisht, K., Karan, M., Sharma, P. D. (2009). Monograph on Gentiana kurroo

(Tryamana) rhizome. The Ayurvedic Pharmacopoeia of India, Part I, Vol. VI,

Ministry of Health & Family Welfare, Department of AYUSH, Government of

India, p. 175-176.

5. Vasisht, K., Karan, M., Sharma, P. D. (2009). Monograph on Aloe barbadensis

(Aluva) dried leaf juice. The Ayurvedic Pharmacopoeia of India, Part I, Vol. VI,

Ministry of Health & Family Welfare, Department of AYUSH, Government of

India.

6. Karan, M., Kumar, V., Suneja, V., Vasisht, K. (2009). Commercial herbal anti-

inflammatory formulations – A survey. Pharmacos, Vol. 36, 14-25.

7. Karan, M., Malik, J., Vasisht, K. (2009). US-FDA drug approval and clinical trial

results of 2009. Pharmacos, Vol. 36, 43-49.

Page 19: University Institute of Pharmaceutical Sciences

8. Singh, B., Bandopadhyay, S., Kapil, R., Singh, R., Katare, O. P. Self-Emulsifying

Drug Delivery Systems (SEDDS): Formulation Development, Characterization,

and Applications. Critical Reviews in Therapeutic Drug Carrier Systems, 26(5):

427–521, 2009.

9. Jain, B., Singh, B., Katare, O. P. and Vyas, S. P., Development and

Characterization of Minoxidil-Loaded Liposomal System for Delivery to

Pilosebaceous Units, Journal of Liposome Research.

http://www.informapharmascience.com/doi/abs/10.1080/0898 210090316144.

Posted online 21 August 2009.

10. Bhatia, A., Raza, K., Singh, B. and Katare, O. P. Phospholipid-based Formulation

with Improved Attributes of Coal Tar. Journal of Cosmetic Dermatology, 8: 291–

297, 2009 [Impact Factor: 1.049].

11. Bhatia, A., Bhushan, S., Singh, B. and Katare, O. P. Studies on Tamoxifen

Encapsulated in Lipid-Vesicles: Effect on the Growth of Human Breast Cancer

MCF- 7 Cells. Journal of Liposome Research, 19(3): 169-172, 2009.

12. Singh, B., Kapil, R. and Katare O. P. Pharmaceutical e-Learning: Precepts,

Retrospect and Prospects, Journal of Young Pharmacists, 2009, 1(2), 99-109.

13. Singh, B., Bandopadhyay, S., Kapil, R. and Katare O. P. Novel Nanostructured

Lipidic Drug Delivery Systems, The Pharma Review, 2009, 7 (42), 118-122.

14. Singh, B., Dhiman, A., Ahuja, N. and Katare, O. P. Dendrimers as

Nanobiopolymers: Fundamental Concepts, Pharma Buzz, 4(08), 2009, 30-35.

15. Singh, B., Kapil, R., Bandopadhyay, S., and Katare, O. P. Dendrimers as

Nanobiopolymers: Drug Delivery Applications, Pharma Buzz, 4(09), 2009, 34-43.

16. VR Sinha, RV Kumar & G Singh Ketorolac tromethamine formulations: an

overview Expert Opinion on Drug Delivery 2009; 6(9): 961-975.

17. Sinha V R, Kumar R V, Bhinge J R. Influence of Polymeric Blend of Carbomer-

Gum on the Targeted Delivery of 5-FU. Polymer-Plastics Technology and

Engineering, 48, 1287 – 1294 (2009).

18. Sinha VR, Kumar R V, Bhinge J R. A stability-indicating RP-HPLC assay method

for 5-fluorouracil. Indian J Pharm Sci 71, 630-7, (2009).

19. Sinha V R; Kumria R; Bhinge J R. Stress degradation studies on duloxetine

hydrochloride and development of an RP-HPLC method for its determination in

capsule formulation. Journal of chromatographic science 2009; 47(7):589-93.

20. Sinha V R, Agrawal M K, Agarwal A, Singh G, Ghai D. Extrusion-spheronization:

process variables and characterization. Critical reviews in therapeutic drug carrier

systems 2009; 26(3):275-331.

Page 20: University Institute of Pharmaceutical Sciences

21. V. R. Sinha, R. V. Kumar, J. R. Bhinge Influence of Polymeric Blend of

Carbomer-Gum on the Targeted Delivery of 5-FU Polymer-Plastics Technology

and Engineering, 48 (12) 2009, 1287 – 1294.

22. Sinha VR, Kumar RV, Bhinge JR. A stability-indicating RP-HPLC assay method

for 5-fluorouracil. Indian J Pharm Sci 2009; 71:630-7.

23. Bhupinder Singh, S. Bandopadhyay, R. Kapil, R. Singh, O. P. Katare, Self-

Emulsifying Drug Delivery Systems (SEDDS) for Drug Bioavailability

Enhancement: Formulation Development, Characterization and Applications,

Critical Reviews in Therapeutic Drug Carrier Systems, 2009, 26(5), 427-521.

24. A. Bhatia, Bhupinder Singh, S. Bhushan, and O. P. Katare, Studies on Tamoxifen

Encapsulated in Lipid-Vesicles: Effect on the Growth of Human Breast Cancer

MCF-7 Cells. Journal of Liposome Research, 2009, 19(3), 169-172.

25. Y. Paul, A. S. Dhake and Bhupinder Singh. In Silico Quantitative Structure

Pharmacokinetic Relationship Modeling on Quinolones: Time of Peak Plasma

Concentration, International Journal of Chemical Sciences, 2009, 7(3), 1613-1623.

26. R. Kapil, S. Dhawan and Bhupinder Singh, Development and Validation of a

Spectrofluorimetric Method for the Estimation of Rivastigmine in Formulations,

Indian Journal of Pharmaceutical Sciences, 2009, 71(5), 585-589.

27. Y. Paul, A. S. Dhake and Bhupinder Singh, In Silico Quantitative Structure

Pharmacokinetic Relationship Modeling of Quinolones: Apparent Volume of

Distribution, Asian Journal of Pharmaceutics, 2009, 3(3), 202-07.

28. A. Bhatia, Bhupinder Singh. K. Raza and O. P. Katare, Phospholipid-based

Formulation with Improved Attributes of Coal Tar, Journal of Cosmetic

Dermatology,2009, 8 (4), 282-288.

29. Bhupinder Singh, S. Pahuja, R. Kapil and N. Ahuja, Formulation Development of

Oral Controlled Release Tablets of Hydralazine: Optimization of Drug Release and

Bioadhesive Characteristics, Acta Pharmaceutica, 59, 2009, 1–13.

30. Bhupinder Singh, R. Kapil and O. P. Katare, Pharmaceutical e-Learning: Precepts,

Retrospect and Prospects, Journal of Young Pharmacists, 2009, 1(2), 99-109.

31. Y. Paul, M. Parle, A. S. Dhake and Bhupinder Singh. In Silico Quantitative

Structure Pharmacokinetic Relationships for Elimination Half-Life of

Fluoroquinolones, Asian Journal of Chemistry, 21(7), 2009, 5483-5487.

32. Bhupinder Singh, S. Bandopadhyay, R. Kapil and O. P. Katare, Novel

Nanostructured Lipidic Drug Delivery Systems, The Pharma Review, 2009, 7 (42),

118-122.

33. Y. Paul, A. S. Dhake and Bhupinder Singh, Quantitative Structure-

Pharmacokinetic Relationship Modeling on Quinolone Drugs: Serum Protein

Binding, Asian Journal of Chemistry, 21(6), 2009, 4728-4732.

Page 21: University Institute of Pharmaceutical Sciences

34. Bhupinder Singh, A. Dhiman, N. Ahuja and O. P. Katare, Dendrimers as

Nanobiopolymers: Fundamental Concepts, Pharma Buzz, 4(8), 2009, 30-35.

35. Bhupinder Singh, R. Kapil, S. Bandopadhyay and O. P. Katare, Dendrimers as

Nanobiopolymers: Drug Delivery Applications, Pharma Buzz, 4(09), 2009, 34-43.

36. Bhupinder Singh, March towards Pharma Excellence (Lett.), Pharma Buz, 4(7),

2009, 6.

37. R. C. Sobti and Bhupinder Singh, Science Education and Attraction of Talent for

Excellence in Research, Invited Theme Article, Proc. 96th

Indian Science

Congress, North-Eastern Hill University, Shillong, pp. 11-17, January 3-7, 2009.

38. Bhupinder Singh, S. Bandopadhyay, R. Kapil and N. Ahuja, Systematic

Optimization of Drug Delivery Systems: An Insight, The Pharma Review, 2009,

7(37), 146-186.

39. Renu Chadha, Anupam Saini, Sushma Gupta, Poonam Arora and Esha Sharma.

Cocrystals of Domperidone with Saccharin and Paracetamol. Pharmacose, 36,

2009, 38-42.

40. Renu Chadha, Poonam Arora, Rupinder Kaur, Anupam Saini, Madan Lal Singla

and Dharamvir Singh Jain, Characterization of solvatomorphs of methotrexate

using thermoanalytical and other techniques, Acta pharm. 59, 2009, 245-257.

41. Vijay K. Kapoor, Janhvi Dureja and Renu Chadha, Synthetic drugs with anti-

ageing effects, Drug Discovery Today, 14, 2009, 899-904.

42. Vijay K. Kapoor, Janhvi Dureja and Renu Chadha, Herbals in the control of

ageing, Drug Discovery Today, 14, 2009, 992-998.

43. Kuhad A, Chopra K. Natural products and traditional medicines: Old keys for

newer pathologies. Drugs of the Future 2009, 34(7).

44. Bishnoi M, Chopra K, Kulkarni SK. Co-administration of nitric oxide (NO) donors

prevents haloperidol-induced orofacial dyskinesia, oxidative damage and change in

striatal dopamine levels. Pharmacol Biochem Behav. 2009 Jan;91(3):423-9.PMID:

18789960. (IF-2.751, 2.703).

45. Gupta A, Vij G, Sharma S, Tirkey N, Rishi P, Chopra K. Curcumin, a polyphenolic

antioxidant, attenuates chronic fatigue syndrome in murine water immersion stress

model. Immunobiology. 2009;214(1):33-9. PMID: 19159825. (IF- 3.461).

46. Kuhad A, Chopra K. Attenuation of diabetic nephropathy by tocotrienol:

Involvement of NFkB signaling pathway. Life Sci. 2009 Feb 27;84(9-10):296-301.

PMID: 19162042. (IF-2.616).

Page 22: University Institute of Pharmaceutical Sciences

47. Gupta A, Sharma S, Kaur I, Chopra K. Renoprotective effects of sesamol in ferric

nitrilotriacetate-induced oxidative renal injury in rats. Basic Clin Pharmacol

Toxicol. 2009 Apr;104(4):316-21. Epub 2009 Feb 27. PMID: 19281599. (IF-

2.073)

48. Kulkarni SK, Bishnoi M, Chopra K. In vivo microdialysis studies of striatal level

of neurotransmitters after haloperidol and chlorpromazine administration. Indian J

Exp Biol. 2009 Feb;47(2):91-7. PMID: 19374163. (IF- 0.55).

49. Kuhad A, Bishnoi M, Chopra K. Anti-nociceptive effect of duloxetine in mouse

model of diabetic neuropathic pain. Indian J Exp Biol. 2009 Mar;47(3):193-7.

PMID: 19405385. (IF- 0.55).

50. Nandal S, Dhir A, Kuhad A, Sharma S, Chopra K. Curcumin potentiates the anti-

inflammatory activity of cyclooxygenase inhibitors in the cotton pellet granuloma

pouch model. Methods Find Exp Clin Pharmacol. 2009 Mar;31(2):89-93. PMID:

19455263. (IF-0.81).

51. Kaur IP, Kuhad A, Garg A, Chopra K. Probiotics: delineation of prophylactic and

therapeutic benefits. J Med Food. 2009 Apr;12(2):219-35. PMID: 19459724. (IF-

1.34).

52. Tiwari V, Kuhad A, Bishnoi M, Chopra K. Chronic treatment with tocotrienol, an

isoform of vitamin E, prevents intracerebroventricular streptozotocin-induced

cognitive impairment and oxidative-nitrosative stress in rats. Pharmacol Biochem

Behav. 2009 Aug;93(2):183-9. PMID: 19464315. (IF-2.751, 2.703).

53. Tiwari V, Kuhad A, Chopra K. Suppression of neuro-inflammatory signaling

cascade by tocotrienol can prevent chronic alcohol-induced cognitive dysfunction

in rats. Behav Brain Res. 2009 May 21. PMID: 19464322. (IF- 3.171, 3.214).

54. Kuhad A, Bishnoi M, Tiwari V, Chopra K. Tocotrienol attenuates diabetes-

associated cognitive deficits in rats. Alzheimer's and Dementia, 2009; 5(4,1),P44.

55. Vij G, Gupta A, Chopra K. Modulation of antigen-induced chronic fatigue in

mouse model of water immersion stress by naringin, a polyphenolic antioxidant.

Fundam Clin Pharmacol. 2009 Jun;23(3):331-7. PMID: 19469804. (IF-2.109).

56. Tiwari V, Kuhad A, Chopra K. Tocotrienol ameliorates behavioral and

biochemical alterations in the rat model of alcoholic neuropathy. Pain. 2009 Jun

19. PMID: 19541419. (IF- 6.030).

57. Kuhad A, Sachdeva AK, Chopra K. Attenuation of renoinflammatory cascade in

experimental model of diabetic nephropathy by sesamol. J Agric Food Chem. 2009

Jul 22;57(14):6123-8. PMID: 19601660. (IF- 2.53).

58. Kuhad A, Chopra K. Tocotrienol attenuates oxidative-nitrosative stress and

inflammatory cascade in experimental model of diabetic neuropathy.

Neuropharmacology 2009 57(4):456-62. PMID: 19555701. (IF- 3.383, 3.737).

Page 23: University Institute of Pharmaceutical Sciences

59. Kamboj SS, Chopra K, Sandhir R. Hyperglycemia-induced alterations in

synaptosomal membrane fluidity and activity of membrane bound enzymes:

beneficial effect of N-acetylcysteine supplementation. Neuroscience. 2009 Aug

18;162(2):349-58..PMID: 19426784. (IF- 3.292).

60. Sachdeva AK, Kuhad A, Tiwari V, Chopra K. Epigallocatechin gallate ameliorates

chronic fatigue syndrome in mice: Behavioral and biochemical evidence .

Behavioural Brain Research, Volume 205, Issue 2, 28 December 2009, Pages 414-

420. PMID: 19643148. (IF- 3.171, 3.214).

61. Chopra K, Kuhad A, Tiwari V. Rheumatoid Arthritis: A Pathobiological

Perspective. Pharmacos 2009; 36:26-31.

62. Gupta A, Chopra K. Effect of tocotrienols on iron-induced renal dysfunction and

oxidative stress in rats. Drug Chem Toxicol. 2009; 32(4):319-25. PMID:

19793023. (IF- 1.25).

63. Richa Shri, Manjeet Singh and Anupam Sharma (2009). Bioactivity directed

separation of an anxiolytic fraction from Aethusa cynapium Linn. Pharmacongosy

Research 1(6): 336-341.

64. Dutt, V., Thakur, S. Dhar, V.J. and Sharma, A. (2009). Antianxiety activity of

homoeopathic formulation of Gelsemium sempervirens. Pharmacognosy Research

5 (accepted)

65. Balbir, S., Tilak Raj, Ishar, M.P.S., Sateesh, S. and Sharma, A. In vivo

antimalarial evaluation of Ocimum sanctum Linn. and Ocimum basilicum Linn.

Canadian Journal of Pure and Applied Sciences (accepted).

66. Dutt, V., Dhar, V.J. and Sharma, A. (2009). Gelsemium sempervirens: Evaluation

of its antidepressant activity in forced swimming test. International Journal of

Chemical Sciences 7, 592-598.

67. Amit Gupta, Sameer Sharma, Indu Pal Kaur and Kanwaljit Chopra (2009).

Renoprotective Effects of Sesamol in Ferric Nitrilotriacetate-Induced Oxidative

Renal Injury in Rats, Basic and Clinical Pharmacology and Toxicology, 104, 316-

21.

68. Shishu and Indu Pal Kaur (2009), Inhibition of cooked food induced mutagenesis

by dietary constituents: comparison of two natural isothiocyanates, Food

chemistry, 112, 977-981.

69. Indu Pal Kaur, Anurag Kuhad, Amita Garg and Kanwaljit Chopra (2009),

Probiotics: Delination of prophylactic and therapeutic benefits, Journal of

Medicinal Food, 12(2), 219-235.

70. Thiraviam Geetha, Bhandari Rohit and Kaur Indu Pal (2009), Sesamol: An

efficient antioxidant with potential therapeutic benefits. Medicinal Chemistry, 5(4),

367-371.

Page 24: University Institute of Pharmaceutical Sciences

71. Indu Pal Kaur, Shruti Lal, Cheena Rana, Shilpa Kakkar and Harinder Singh

(2009), Ocular Preservatives: Associated Risks and Newer Options. Cutaneous and

Ocular Toxicology, 28(3), 93-103.

72. Shashi Bhushan, Fayaz Malik, Ajay Kumar, Harpreet Kaur Isher, Indu Pal Kaur,

Subhash Chandra Taneja, and Jaswant Singh (2009), ActivationQ1 of

p53/p21/PUMA Alliance and Disruption of PI-3/Akt in Multimodal Targeting of

Apoptotic Signaling Cascades in Cervical Cancer Cells by a Pentacyclic

Triterpenediol From Boswellia serrata. Molecular Carcinogenesis 9999, 1-17.

73. Indu Pal Kaur, Harinder Singh, Manoj Kumar and Rohit Bhandari (2009),

Tubercular Meningitis: Need to Reformulate Antitubercular Drugs. Pharmacos. 36,

32-37.

74. Suresh Thareja, Saurabh Aggarwal, Tilak Raj Bhardwaj and Manoj Kumar, “Self

Organizing Molecular Field Analysis on a series of Human 5α-Reductase

Inhibitors: Unsaturated 3-Carboxysteroid,” Eur. J. Med. Chem. 44 (2009) 4920-

4925.

75. Saurabh Aggarwal, Suresh Thareja, Preeti Arora, Priyanka Malla, Tilak Raj

Bhardwaj and Manoj Kumar, “Synthesis of Novel 17-Oxo-17a-Aza-D-Homo-3, 5-

Seco-Steroids as Potential 5α-Reductase Inhibitors,” J. Iran. Chem. Res. 2 (2009)

211-219.

76. Ashish K. Rehni, Inderbir Singh, Pradeep Kumar, Hassan Y. Aboul-Enein and

Manoj Kumar, Carbon nanotubes: synthesis, properties and pharmaceutical

applications. Fuller. Nanotub. Carbon Nanostruct. 17 (2009) 361-377

77. Shishu and Maheshwari M. Dendrimers: The novel pharmaceutical drug carriers.

Int Journal of Pharm Sci and Nanotechnology Vol. 2, Issue 2, Page 493-502, 2009.

78. Shishu and Kaur I.P. Inhibition of cooked food induced mutagenesis by dietary

constituents: comparison of two natural isothiocyanates. Food Chemistry, 112,

977-981, (2009).

79. Shishu, Varun Rishi Kapoor and Kamalpreet. Taste masking and formulation of

ofloxacin rapid disintegrating tablets and oral suspension. Indian Journal of

Pharmaceutical Education and Research, 43 (2), 150-155, (2009).

80. Shishu, Kamalpreet and Varun Rishi Kapoor. Development of taste masked fast

disintegrating tablets of tinidazole. Asian Journal of Pharmaceutical Sciences, 4

(1), 39-45, (2009).

81. Shishu, Sunita Rajan and Kamalpreet. Development of novel microemulsion-based

topical formulations of acyclovir for the treatment of cutaneous herpetic infections.

AAPS Pharm. Sci. Tech., 10 (2), 559-565 (2009).

Page 25: University Institute of Pharmaceutical Sciences

82. Anil Kumar, Garg R Neuroprotective Effects of antidepressants against Chronic

Fatigue Syndrome- Induced Behavioral Changes and Biochemical Alterations.

Fundamental and Clinical Pharmacology 2009, 23, 89-95.

83. Anil Kumar and Richa Goyal, Atish Kumar. GABAergic mechanism in the

protective effect of allopregnenolone against immobilization stress. Eur J

Pharmacol 2009, 602, 343-347

84. Puneet Kumar and Anil Kumar. Neuroprotective effect of cyclosporine and FK506

against 3-nitropropionic acid induced cognitive dysfunction and glutathione redox

in rat: Possible role of nitric oxide. Neuroscience Res, 2009,63:302-314.

85. Puneet Kumar and Anil Kumar. Possible neuroprotective effect of Withania

somnifera Root Extract Against 3-Nitropropionic Acid-Induced Behavioral,

Biochemical, and Mitochondrial Dysfunction in an Animal Model of Huntington‟s

Disease. Journal of Medicinal Food 2009, 12 (3) 2009, 591–600

86. Puneet Kumar and Anil Kumar. Sesamol Attenuate 3-Nitropropionic Acid-Induced

Huntington like behavioral, biochemical and cellular alterations in Rats. Journal of

Asian Natural Products Research 2009, 11(5):439-450.

87. Atish Kumar and Anil Kumar. Effect of N-Acetyl Cysteine against Aluminium-

Induced Cognitive Dysfunction and Oxidative Damage in Rats. Basic Clin

Pharmacol Toxicol. 2009, 105, 98-104.

88. Puneet Kumar and Anil Kumar. Protective effect of rivastigmine against 3-

nitropropionic acid-induced Huntington's disease like symptoms: possible

behavioural, biochemical and cellular alterations. European Journal of

Pharmacology 2009 Aug 1;615(1-3):91-101.

89. Anil Kumar and Ruchika Garg Possible role of trazodone and imipramine in sleep

deprivation-induced anxiety-like behavior and oxidative damage in mice. Method

findings and Clinical Pharmacology 2009, 31(6), 383-387.

90. Harikesh Kalonia, Puneet Kumar, Bimla Nehru, Anil Kumar. Effect of caffeic acid

(lipo-oxygenase inhibitor) and rofecoxib (cyclo-oxygenase-2 inhibitor) against

quinolinic acid induced behavioral alterations and glutathione redox status.

Neuroscience Bulletin 2009, 25(6), 343-352.

91. Anil Kumar, Samrita Dogra, and Atish Prakash Effect of carvedilol on behavioral,

mitochondrial dysfunction and oxidative damage against D-galactose induced

senescence in mice. Naunyn-Schmiedeberg's Archives of Pharmacology 2009,

380,431-441.

92. Puneet Kumar and Anil Kumar. Protective effect of hesperidin and naringin

against 3-nitropropionic acid induced Huntington's like symptoms in rats: possible

role of nitric oxide. Beha Brain Res 2009,206, 38-46.

93. Anil Kumar, Ruchika Garg, Vaibhav Gaur and Puneet Kumar. Nitric oxide

mechanism in protective effect of imipramine and venlafaxine against acute

Page 26: University Institute of Pharmaceutical Sciences

immobilization stress induced behavioral and biochemical alteration in rats.

Neuroscience Letter 2009, 467, 72-75.

94. Atish Kumar Prakash and Anil Kumar. Effect of chronic treatment of carvedilol on

oxidative stress in intracerebroventricle streptozotocin-induced model of dementia

in rat. Journal of Pharmacy and Pharmacology 2009, 61, 1665-1672.

95. Puneet Kumar and Anil Kumar. Protective Effects of Epigallocatechin Gallate

Following 3-Nitropropionic Acid-Induced Brain Damage: Possible Nitric Oxide

Mechanisms. Psychopharmacology (Berl). 2009, 207(2), 257-70.

96. Sridhar Thota , Ranju Bansal „Synthesis of some new pyridazinone derivatives as

platelet aggregation inhibitors‟ Medicinal Chemistry Research 2009

DOI:10.1007/s00044-009-9232-6

97. Ranju Bansal, Gulshan Kumar, Deepika Gandhi, Louise C. Young, Alan L. Harvey

„Synthesis of a series of 8-(substituted-phenyl)xanthines and a study on the effects

of substitution pattern of phenyl substituents on affinity for adenosine A1 and A2A

receptors‟ Eur. J. Med. Chem. 44 (2009) 2122–2127

doi:10.1016/j.ejmech.2008.10.017

98. Ranju Bansal, Dinesh Kumar, Rosalia Carron, Carmen de la Calle „Synthesis

and vasodilatory activity of some amide derivatives of 6-(4-

carboxymethyloxyphenyl)-4,5-dihydro-3(2H)-pyridazinone‟ Eur. J. Med. Chem.

44 (2009) 4441–4447.

99. Piplani, P.; Rani, A..; Sandhir, R.; Kulkarni, S.K. Synthesis and pharmacological

evaluation of some quinoline derivatives as potential antiamnesic agents. J Young

Pharmacists 2009, 1, 341-350.

100. Vasisht, K., Karan, M., Sharma, P. D. (2009). Monograph on Selinum vaginatum

(Bhutakesi) fruit. The Ayurvedic Pharmacopoeia of India, Part I, Vol. VI, Ministry

of Health & Family Welfare, Department of AYUSH, Government of India, p. 12-

13.

101. Vasisht, K., Karan, M., Sharma, P. D. (2009). Monograph on Heliotropium

indicum (Hathisundi) whole plant. The Ayurvedic Pharmacopoeia of India, Part I,

Vol. VI, Ministry of Health & Family Welfare, Department of AYUSH,

Government of India, p. 66-67.

102. Vasisht, K., Karan, M., Sharma, P. D. (2009). Monograph on Celosia argentea

(Sivavarak) seed. The Ayurvedic Pharmacopoeia of India, Part I, Vol. VI, Ministry

of Health & Family Welfare, Department of AYUSH, Government of India, p.

148-149.

103. Vasisht, K., Karan, M., Sharma, P. D. (2009). Monograph on Gentiana kurroo

(Tryamana) rhizome. The Ayurvedic Pharmacopoeia of India, Part I, Vol. VI,

Ministry of Health & Family Welfare, Department of AYUSH, Government of

India, p. 175-176.

Page 27: University Institute of Pharmaceutical Sciences

104. Vasisht, K., Karan, M., Sharma, P. D. (2009). Monograph on Aloe barbadensis

(Aluva) dried leaf juice. The Ayurvedic Pharmacopoeia of India, Part I, Vol. VI,

Ministry of Health & Family Welfare, Department of AYUSH, Government of

India.

105. Karan, M., Kumar, V., Suneja, V., Vasisht, K. (2009). Commercial herbal anti-

inflammatory formulations – A survey. Pharmacos, Vol. 36, 14-25.

106. Karan, M., Malik, J., Vasisht, K. (2009). US-FDA drug approval and clinical trial

results of 2009. Pharmacos, Vol. 36, 43-49.

107. Alka Bali, Sarika Malhotra, Himjyoti Dhir, Anil Kumar, and Ajay Sharma

„Synthesis and evaluation of 1-(quinoliloxypropyl)-4-aryl piperazines for atypical

antipsychotic effect‟ Bioorg. Med. Chem. Lett. 2009, 19, 3041–3044.

108. Alka Bali, Vandana Sharma, Vivek Sood & Ajay Sharma, „Hypoglycemic activity

of leaf extracts of Azadirachta indica‟, Indian Drugs, 2009, 46(1), 65-68.

2010

1. Vasisht, K., Karan, M. and Sharma, P. D. (2010). Monograph on SOPs of

manufacturing process of Saptanga Guggulu. The Ayurvedic Pharmacopoeia of

India, Part II (Formulations), Vol. 3, Ministry of Health & Family Welfare,

Department of AYUSH, Govt. of India, 44-46.

2. Vasisht, K., Karan, M. and Sharma, P. D. (2010). Monograph on SOPs of

manufacturing process of Varadi Guggulu. The Ayurvedic Pharmacopoeia of

India, Part II (Formulations), Vol. 3, Ministry of Health & Family Welfare,

Department of AYUSH, Govt. of India, 47-49.

3. Vasisht, K., Karan, M. and Sharma, P. D. (2010). Monograph on SOPs of

manufacturing process of Vidangadi Guggulu. The Ayurvedic Pharmacopoeia of

India, Part II (Formulations), Vol. 3, Ministry of Health & Family Welfare,

Department of AYUSH, Govt. of India, 50-52.

4. Vasisht, K., Karan, M., Sharma, P. D. (2010). Monograph on Angelica glauca

roots. In, N. Tandon and M. Sharma (Eds.). Quality Standards of Indian Medicinal

Plants, Vol. 8, Indian Council of Medical Research, New Delhi, p. 68-76.

5. Vasisht, K., Karan, M., Sharma, P. D. (2010). Monograph on Rauvolfia serpentina

roots. In, N. Tandon and M. Sharma (Eds.). Quality Standards of Indian Medicinal

Plants, Vol. 8, Indian Council of Medical Research, New Delhi, p. 272-282.

6. Dutt, S., Bhanwara, R.K., Vasisht, K., Karan, M. and Sharma, R.K. (2010).

Morphoanatomical studies on Malaxis acuminata D. Don-An endangered

medicinal orchid. Hippocratic Journal of Unani Medicine, 5(3), 149-161.

7. Karan, M., Sharda, D., Rubina, Jindal, D. K., Chadha, K., Gandhi, S. and Vasisht,

K. (2010). Patent opportunities in herbals. Pharmacos, Vol. 37, 49-52.

Page 28: University Institute of Pharmaceutical Sciences

8. Karan, M., Chadha, K., Jindal, D. K., Sharda, D., Rubina, Gandhi, S. and Vasisht,

K. (2010). Plant drug monographs in Pharmacopoeia of India-1955 to 2010.

Pharmacos, Vol. 37, 64-74.

9. Shukla A., Bhatia, A., Amarji, B., Singh, B., Katare, O. P., Vyas, S. P. Nano-

bilosomes as Potential Vaccine Delivery System for Effective Combined Oral

Immunization against Tetanus and Hepatitis B. Journal of Biotechnology, 150,

Suppl. 1, 98-99, November 2010.

10. Shukla, A., Katare, O. P., Singh, B. and Vyas, S. P., M-cell Targeted Delivery of

Recombinant Hepatitis B Surface Antigen Using Cholera Toxin B Subunit

Conjugated Bilosomes. International Journal of Pharmaceutics, 385(1): 47-52,

2010

11. Bhatia, A., Singh, B., Amarji, B. and Katare, O. P. Tamoxifen-Loaded Liposomal

Topical Formulation Arrests Hair Growth in Mice. British Journal of Dermatology,

2010, 163(2): 412-415.

12. Bhatia A., Singh, B., Bhushan S., and Katare, O. P. Tamoxifen Encapsulated

Vesicular Systems: Cytotoxicity Evaluation in Human Epidermal Keratinocyte

Cell Line. Drug Development and Industrial Pharmacy, 2010, 36(3), 350-354.

13. Katare O. P., Singh B., Raza K. and Dogra S. Novel Drug Delivery Systems in

Topical Treatment of Psoriasis: Rigours and Vigours, Indian Journal of

Dermatology, Venereology and Leprology (Official bimonthly peer-reviewed

publication of the Indian Association of Dermatologists, Venereologists and

Leprologists), 2010, 76 (6). 612-621.

14. Garg B. J., Saraswat A., Bhatia A. and Katare O. P. Topical Treatment in Vitiligo

and the Potential Uses of New Drug Delivery Systems, Indian Journal of

Dermatology, 76, 231-238 (2010).

15. Sinha, V R, Amita, Goel H. In Vivo Bioavailability and Therapeutic Assessment of

Host-Guest Inclusion Phenomena for the Hydrophobic Molecule Etodolac:

Pharmacodynamic and Pharmacokinetic Evaluation. Sci. Pharm. 78, 103–115

(2010).

16. V. R. Sinha, Amita, Renu Chadha, Honey Goel. Enhancing the dissolution of

hydrophobic guests using solid state inclusion complexation: characterization and

in vitro evaluation. Journal of Inclusion Phenomena and Macrocyclic Chemistry,

66 (3-4), 2010, 381-392.

17. V. R. Sinha, Amita, Renu Chadha, Honey Goel. Inter-Molecular physiochemical

Characterization for Etodolac-Hydroxypropyl cyclodextrin polymeric systems in

solid and liquid state .Central European Journal of Chemistry 8, 953-962 (2010).

18. V R Sinha, Vinay Jindal, Saurabh Srivastava, Honey Goel. Paradoxical effect of

coating on natural guar gum blended carbomer matrix systems for the neurological

depressive disorders. International Journal of Drug Delivery. 2010;2(2):113-124

Page 29: University Institute of Pharmaceutical Sciences

19. V. R. Sinha, Amita, H. Goel, S. Srivastava. Role of CDs in drug delivery systems:

Trends and implications. Pharmstudent (accepted, 2010).

20. Bamiro O.A., Odeku O.A., Sinha V.R. and Kumar V.R. Characterization and

evaluation of terminalia randii gum: as a binder Acta Pharmaceutica Scientia 52:

254-262 (2010)

21. V R Sinha, Ashu Aggarwal, Saurabh Srivastava, Honey Goel. Influence of

Operational Variables in Multi Particulate Delayed Release Systems for Colon

Targeted Drug Delivery of Celecoxib Using Extrusion-Spheronization. Asian J

Pharmaceutics 4(2):102-109 (2010).

22. Sinha V R, Kumar R V and Goel H, Nanodiamonds: Engineering therapeutic

system for the future, Innovations in Pharm. Tech. (Accepted)

23. Bhupinder Singh and R. Kapil, Developing Drug Delivery Systems via Modern

DoE Approaches, Chronicle Pharmabiz, 10(48), 30–32, 27 November 2010.

24. O. P. Katare,Bhupinder Singh, K. Raza and S. Dogra, Novel Drug Delivery

Systems in Topical Treatment of Psoriasis: Rigours and Vigours, Indian Journal of

Dermatology, Venereology and Leprology, 2010, 76 (6). 612-621.

25. Y. Paul, A. S. Dhake, M. Parle and Bhupinder Singh. In Silico Quantitative

Structure Pharmacokinetic Relationships for Quinolone Drugs: Biological Half-

Life, Asian Journal of Chemistry, 2010, 22(6), 4880-4890.

26. A. Shukla, A. Bhatia, B. Amarji, Bhupinder Singh, O.P. Katare, S.P. Vyas, Nano-

bilosomes as potential vaccine delivery system for effective combined oral

immunization against tetanus and hepatitis B, Journal of Biotechnology,150 Suppl.

1, 2010, 98-99.

27. Bhupinder Singh and R. Kapil, Developing “Optimized” Drug Delivery Systems

using Systematic “DoE” Approaches, Proc. 6th

International Symposium on

Innovations in Pharmaceutical Sciences and Technology, BV Patel Pharmaceutical

Education and Research Development (PERD) Centre, Ahmedabad, November 26-

28, 2010, pp. 116-129.

28. A. Bhatia, Bhupinder Singh, B. Amarji B., A. Shukla and O.P. Katare, Novel

Liposomal Gel of an Anti-inflammatory Agent: Randomized, Double-blind

Clinical Trial for Evaluation of the Efficacy and Safety in Patients with Signs and

Symptoms of Osteoarthritis of the Knees. The Journal of Clinical Pharmacology,

50, 1090, 2010

29. A. Bhatia, Bhupinder Singh, S. Bhushan, and O. P. Katare, Tamoxifen

Encapsulated Vesicular Systems: Cytotoxicity Evaluation in Human Epidermal

Keratinocyte Cell Line. Drug Development and Industrial Pharmacy, 2010, 36(3),

350-354.

30. R. Kapil, S. Dhawan and Bhupinder Singh, Brain Drug Delivery: Maladies and

Remedies, Pharma Buzz, 2010, 5(10), 12-21.

Page 30: University Institute of Pharmaceutical Sciences

31. Bhupinder Singh, A. Singla, Y. Paul and R. Sehgal, Clinical Research in India:

Retrospects and Prospects, The Pharma Review, 9(43), 37-46, 2010.

32. Bhupinder Singh, Compromising Research for Publishing Thirst: Maladies and

Remedies, Journal of Pharmaceutical Neg. Results, 2010, Inaugural Issue of

Journal, 2010, 1(1), 6-9.

33. Bhupinder Singh, A. Rani, N. Ahuja, Babita and R. Kapil, Formulation

Optimization of Hydrodynamically Balanced Oral Controlled Bioadhesive Tablets

of Tramadol Hydrochloride, Scientia Pharmaceutica, 2010, 78(2), 303–323.

34. A. Bhatia, Bhupinder Singh, B. Amarji and O.P. Katare, Tamoxifen-Loaded

Liposomal Topical Formulation Arrests Hair Growth in Mice, British Journal of

Dermatology, 2010, 163(2): 412-5.

35. Bhupinder Singh, A. Mohapatra, S. Bandyopadhyay and R. Kapil, Endeavoring

Biowaivers using BCS and IVIVC, The Pharma Review, 2010, 8(43), 87-93.

36. B. Jain, Bhupinder Singh, O.P. Katare and S. P. Vyas, Development and

Characterization of Minoxidil-Loaded Liposomal System for Delivery to

Pilosebaceous Units, Journal of Liposome Research, 2010, 20(2), 105-14.

37. A. Shukla, O. P. Katare, Bhupinder Singh, S. P. Vyas, M-cell targeted delivery of

recombinant hepatitis B surface antigen using cholera toxin B subunit conjugated

bilosomes, International Journal of Pharmaceutics, 2010, 29(1-2), 47-52.

38. R. Chadha, Sushma Gupta, Geeta Shukla. Characterization and In vivo antimalarial

activity of few morphological different forms of artemether. The Pharmacose 37,

2010, 44-48.

39. Vivek Ranjan Sinha, Amita, Renu Chadha, Honey Goel. Inter-molecular

physiochemical characterization for etodolac-hydroxypropyl-β-cyclodextrin

polymeric systems in solid and liquid state. Cent. Eur. J. Chem. 8(4), 2010, 953–

962.

40. Renu Chadha, Poonam Arora, Anupam Saini, and Dharamvir Singh Jain. Solvated

Crystalline Forms of Nevirapine: Thermoanalytical and Spectroscopic Studies.

AAPS Pharm Sci Tech. . 11 (3), 2010, 1328-1339.

41. Renu Chadha, Poonam Arora, Rekha Chhikara

and Swati Bhandari.

“Characterization and quantification of amorphous forms of Repaglinide” in The

Pharmacose 2010, 37, 19-24.

42. Renu Chadha, Poonam Arora, Rupinder Kaur, Anupam Saini and Dharamvir Singh

Jain.

Crystal modifications of 5-Flurouracil - preparation and haracterization in

Journal of pharmaceutical and education research. 2010, 1(2), 77-82.

43. R. Chadha, Sushma Gupta, Geeta Shukla, Dharamvir Singh Jain and Surjit Singh.

Characterization, Thermodynamic parameters and In vivo antimalarial activity of

Page 31: University Institute of Pharmaceutical Sciences

inclusion complexes of artemether. Journal of Drug Discovery and Therapeutics,

4(3): 2010, 190-201

44. R. Chadha, P. Arora, A. Saini, D.V.S. Jain. Inclusion parameters of pioglitazone

hydrochloride and glipizide with -cyclodextrin and its methyl derivative:

calorimetric and spectroscopic studies. International Journal of Biological and

Chemical Sciences, 4(2), 2010, 258-273.

45. V. R. Sinha, Amita, Renu Chadha, Honey Goel. Enhancing the dissolution of

hydrophobic guests using solid state inclusion complexation: Characterisation and

in vitro evaluation. Journal of Inclusion Phenomenon and Macrocyclic chemistry.

66, 2010, 381-392.

46. Renu Chadha, Anupam Saini, Sushma Gupta, Poonam Arora, Deepika Thakur,

Dharamvir Singh Jain, Encapsulation of rifampicin by natural and modified β-

cyclodextrins– Characterization and thermodynamic parameters. Journal of

Inclusion Phenomenon and Macrocyclic chemistry. 67, 2010, 109-116.

47. Sachdeva AK, Kuhad A, Tiwari V, Arora V, Chopra K. Protective Effect of

Epigallocatechin Gallate in Murine Water-Immersion Stress Model of Chronic

Fatigue Syndrome. Basic Clin Pharmacol Toxicol. 2010 Jun;106(6):490-6. PMID:

20088847. (IF- 2.308).

48. Chopra K, Tiwari V, Arora V, Kuhad A. Sesamol Suppresses Neuro-Inflammatory

Cascade in Experimental Model of Diabetic Neuropathy. J Pain. 2010

Oct;11(10):950-7. (IF-3.778, 4.219).

49. Tiwari V, Kuhad A, Chopra K. Downregulation Of oxido-inflammatory cascade In

alcoholic neuropathic pain by epigallocatechin-3-gallate. European Journal of Pain

Supplements, Volume 4, Issue 1, April 2010, Page 61.

50. Tiwari V, Kuhad A, Arora V, Chopra K. Neuroprotective effect of

epigallocatechin-3-gallate against chronic alcohol induced cognitive deficits in

rats: Possible role of oxidative stress and cytokine signaling. Alzheimer's and

Dementia July 2010; 6(4), 1:S580.

51. Gupta A, Vij G, Chopra K. Possible role of oxidative stress and immunological

activation in mouse model of chronic fatigue syndrome and its attenuation by olive

extract. J Neuroimmunol. 2010 Sep 14;226(1-2):3-7. PMID: 20537729. (IF-

2.841).

52. Tiwari V, Kuhad A, Chopra K. Epigallocatechin-3-gallate ameliorates alcohol-

induced cognitive dysfunctions and apoptotic neurodegeneration in the developing

rat brain. Int J Neuropsychopharmacol. 2010 Sep;13(8):1053-66. PMID:

20529413. (IF- 4.874).

53. Tiwari V, Kuhad A, Chopra K. Amelioration of functional, biochemical and

molecular deficits by epigallocatechin gallate in experimental model of alcoholic

Page 32: University Institute of Pharmaceutical Sciences

neuropathy. Eur J Pain. 2010 Aug 9. [Epub ahead of print]. PMID: 20699198. (IF-

3.612).

54. Sah SP, Mathela CS, Chopra K. Elucidation of possible mechanism of analgesic

action of Valeriana wallichii DC chemotype (patchouli alcohol) in experimental

animal models. Indian J Exp Biol. 2010 Mar;48(3):289-93. PubMed PMID:

21046983.

55. Kumar B, Kuhad A, Chopra K. Neuropsychopharmacological effect of sesamol in

unpredictable chronic mild stress model of depression: behavioral and biochemical

evidences. Psychopharmacology (Berl). 2011 Apr;214(4):819-28. Epub 2010 Nov

20. PubMed PMID: 21103863.

56. Bora, K.S. and Anupam Sharma (2010). In vitro antioxidant and free radical

scavenging potential of Medicago sativa Linn. Journal of Pharmacy Research,

2010; 3(6): 1206-1210.

57. Bora, K.S. and Anupam Sharma (2010). Evaluation of antioxidant and

cerebroprotective effect of Medicago sativa Linn. against ischemia and reperfusion

insult. Evidence-based Complementary and Alternative Medicine, 15th

march,

2010, 1-9.

58. Bora, K.S. and Anupam Sharma (2010). Neuroprotective effect of Artemisia

absinthium L. on focal ischemia and reperfusion-induced cerebral injury. Journal

of Ethnopharmacology, 2010; 129: 403-409.

59. Richa Shri, Manjeet Singh and Anupam Sharma (2010). Anxiolytic activity

screening studies on extracts of a few medicinal plants. In the book series:

Compendium of Bioactive Natural Products. Sudium Press LLC, USA (in press)

60. Richa Shri, Tiwari, A.K. and Anupam Sharma (2010). Pharmacognostic

investigations on Aethusa cynapium Linn. Indian Journal of Herbal Technology

(in press).

61. Balbir, S., Chopra, A. Ishar, M.P.S., Tilak Raj and Sharma, A. (2010).

Pharmacognostic and antifungal screening studies of Elaeocarpus ganitrus Roxb.

Indian Journal of Pharmaceutical Sciences 72(2): 261-265.

62. Dutt, V., Dhar, V.J. and Sharma, A. (2010). Antianxiety activity of Gelsemium

sempervirens (Linn.) Ait. Pharmaceutical Biology 48(10): 1091-1096.

63. Rumjhum Agrawal and Indu Pal Kaur (2010), Inhibitory effect of encapsulated

curcumin on UV-induced photoageing in mice. Rejuvenation Research, 13(3), DOI:

10.1089=rej.2009.0906.

64. Indu Pal Kaur, Deepika Aggarwal, Harinder Singh, Shilpa Kakkar (2010), Improved

ocular absorption kinetics of timolol maleate loaded into a bioadhesive niosomal

delivery system. Graefe's Archive for Clinical and Experimental Ophthalmology,

248(10), 1467-1472.

Page 33: University Institute of Pharmaceutical Sciences

65. Indu Pal Kaur, Cheena Rana, Gautam Bakshi (2010) Pharmaceutical Nanoelastic

Vesicular Systems. Indian Patent Office Journal, Application number

2390/DEL/2008, dated 17/10/08, Publication date 23/4/2010.

66. Vandita Kakkar, Sukhjeet Singh, Dinesh Singla, Indu Pal Kaur. Exploring Solid

Lipid Nanoparticles to Enhance the Oral Bioavailability of Curcumin. Molecular

Nutrition and Food Research, 2011, 55, 495-503.

67. Indu Pal Kaur, Shilpa Kakkar (2010), Topical delivery of antifungal agents. Expert

Opinion in Drug Delivery, 7 (11), 1303-27.

68. Vandita Kakkar, Sukhjit Singh, Dinesh Singla, Sudhir Sawhney, Anurag Singh

Chauhan, Gagandeep Singh, Indu Pal Kaur. Pharmacokinetic Applicability of a

Validated LC/MS/MS Method for Orally Adminstered Curcumin Loaded Solid

Lipid Nanoparticles. Journal of Chromatography B, 2010, 878, 3427-3431.

69. Neeraj Mehta, Saurabh Aggarwal, Suresh Thareja, Priyanka Malla, Megha Misra,

Tilak Raj Bhardwaj and Manoj Kumar, “Synthesis and in vitro Spleen Cell

Proliferation Activity of Novel Oxime Derivative of Ibuprofenamide,” Der Pharm.

Chem. 2(2010) 397-403.

70. Suresh Thareja, Saurabh Aggarwal, Tilak Raj Bhardwaj and Manoj Kumar, “Self

Organizing Molecular Field Analysis on a series of Human PTP 1B Inhibitors”

Lett. Drug Des. Disc. 6 (2010)395-401.

71. Neeraj Mehta, Saurabh Aggarwal, Suresh Thareja, Priyanka Malla, Megha Misra,

Tilak Raj Bhardwaj and Manoj Kumar, “Synthesis, Pharmacological and

Toxicological Evaluation of Amide Derivatives of Ibuprofen,” Int. J. Chem Tech

Res. 2 (2010) 233-238.

72. Suresh Thareja, Saurabh Aggarwal, Diksha Haskar, Tilak Raj Bhardwaj and Manoj

Kumar, “Saxagliptin: A New Drug for the Treatment of Type 2 Diabetes” Mini

Rev. Med Chem. 2010 10 (2010) 759-765.

73. Saurabh Aggarwal, Suresh Thareja, Tilak Raj Bhardwaj and Manoj Kumar,

“Ligand Based 3D-QSAR study on a series of steroidal human 5α-Reductase

Inhibitors” Lett. Drug Des. Disc. 7 (2010) 596-601.

74. Saurabh Aggarwal, Suresh Thareja, Abhilasha Verma, Tilak Raj Bhardwaj and

Manoj Kumar, “QSAR Studies on Human 5alpha-Reductase Inhibitors:

Unsaturated 3-Carboxysteroids,” Acta Pol. Pharm. Drug Res. (Accepted).

75. Suresh Thareja, Saurabh Aggarwal, Tilak Raj Bhardwaj and Manoj Kumar, “3D-

QSAR studies on arylidine thiazolidinedione as aldose reductase Inhibitors: A Self

Organizing Molecular Field Analysis Approach,” Med. Chem. 6 (2010) 30-36.

76. Saurabh Aggarwal, Suresh Thareja, Abhilasha Verma, Tilak Raj Bhardwaj and

Manoj Kumar, “An overview on 5α-reductase inhibitors,” Steroids 75 (2010) 109-

153.

Page 34: University Institute of Pharmaceutical Sciences

77. Saurabh Aggarwal, Suresh Thareja, Tilak Raj Bhardwaj and Manoj Kumar, “3D-

QSAR studies on unsaturated 4-azasteroids as human 5α-reductase inhibitors: A

self organizing molecular field analysis approach,” Eur. J. Med. Chem. 45 (2010)

476- 481.

78. Suresh Thareja, Ganesh R. Kokil, Saurabh Aggarwal, Tilak Raj Bhardwaj and

Manoj Kumar, “Sulphonamides as Inhibitors of Protein Tyrosine Phosphatase 1B

(PTP 1B): A 3D-QSAR Study Using SOMFA Approach,” Chem. Pharm. Bull. 58

(2010) 526-532.

79. Suresh Thareja, Saurabh Aggarwal, Tilak Raj Bhardwaj and Manoj Kumar, “Self

Organizing Molecular Field Analysis of 2, 4-Thiazolidinediones: A 3D-QSAR

Model for the Development of Human PTP 1B Inhibitors” Eur. J. Med. Chem. 45

(2010) 2537- 2546.

80. Saurabh Aggarwal, Suresh Thareja, Tilak Raj Bhardwaj and Manoj Kumar, “Self

Organizing Molecular Field Analysis on Pregnane derivatives as Human Steroidal

5α-Reductase Inhibitors,” Steroids 75 (2010) 411-418.

81. Neelima Dhingra, Tilak Raj Bhardwaj, Neeraj Mehta, Tapas Mukhopadhyay,

Ashok Kumar and Manoj Kumar, “Synthesis, antiproliferative, acute toxicity and

assessment of antiandrogenic activities of some newly synthesized steroidal

lactams,” Eur. J. Med. Chem. 45 (2010) 2229-2236.

82. Suresh Thareja, Saurabh Aggarwal, Tilak Raj Bhardwaj and Manoj Kumar,

“Protein Tyrosine Phosphatase 1B inhibitors: A Molecular Level Legitimate

Approach for the Management of Diabetes Mellitus” Med. Res. Rev. (2010) (DOI:

10.1002/med.20219).

83. David R. Lisgarten, Joanna S. Fell, John N. Lisgarten, Harkishan Singh, Manoj

Kumar, Tilak Raj Bhardwaj and Rex A. Palmer, “Crystal Structure, Absolute

Configuration, Conformational Analysis and Molecular Dynamics Study of the

Novel Steroidal Tetrazole Derivative: (25R)-3,12a-diaza-A,C-bishomo-

5aspirostano[3,4-d] [12a,12d] bistetrazole [HS-989]” J. Chem. Crystallogr. 40

(2010) 185–190.

84. Shishu, Kamalpreet and Varun Rishi Kapoor. Taste inhibition and development of

taste masked oral formulation of ornidazole. Indian J Pharm Sci. 72(2):211-215,

(2010).

85. Shishu and Manjul Maheshwari. Comparative bioavailability of curcumin,

turmeric and Biocurcumax™ in traditional vehicles using non-everted rat intestinal

sac model. Journal of Functional Foods, 2(1): 60-65, (2010).

86. Puneet Kumar and Anil Kumar. Protective effect of Sesamol against 3-

Nitropropionic Acid-Induced Cognitive Dysfunction and Altered Glutathione

Redox Balance in Rats. Basic Clin Pharmacol Toxicol 2010 Jul;107(1):577-82.

87. Vaibhav Gaur, Anil Kumar Possible involvement of L-arginine-nitric oxide

signaling pathway in protective effect of hesperidin against ischemic reperfusion

Page 35: University Institute of Pharmaceutical Sciences

cerebral injury induced memory dysfunction. Pharmacology Report

2010,62(4),635-48.

88. Anil Kumar, Beenta and Puneet Kumar. Protective effects of selective and non-

selective cyclooxygenase inhibitors in an animal model of chronic stress.

Neuroscience Bulletin 2010,26(1),17-27.

89. Harikesh Kalonia, Puneet Kumar, Anil Kumar, Bimla Nehru. Protective effect of

rofecoxib and nimesulide against intra-striatal quinolinic acid induced behavioral,

oxidative stress and mitochondrial dysfunctions in rats. Neurotoxicology 2010,

31,195-203.

90. Puneet Kumar, Harikesh kalonia, Anil Kumar. Cyclosporine Attenuates 3-

Nitropropionic Acid Induced Huntington‟s Like Symptoms in Rat: Possible Nitric

Oxide Mechanism. International Journal of Toxicology, 2010, 29, 318.

91. Puneet Kumar, Harikesh Kalonia, Anil Kumar. Nitric oxide mechanism in the

protective effect of antidepressants against 3-nitropropionic acid induced cognitive

deficit, glutathione and mitochondrial alterations in animal model of Huntington‟s

disease. Behavioral Pharmacology, 2010, 21 (3):217-230.

92. Anil Kumar, Ruchika Garg and Atish Prakash Effect of St. John's Wort

(Hypericum perforatum) treatment on restraint stress-induced behavioral and

biochemical alteration in mice. BMC Complementary and Alternative Medicine

2010, 10:18

93. Anil Kumar, Samrita Dogra, and Atish Prakash. Protective effect of naringin, a

citrus flavonoid, against colchicine induced cognitive dysfunction and oxidative

damage in rats Journal of Medicinal Food 2010 Aug;13(4):976-84.

94. Puneet Kumar, Harikesh Kalonia, Anil Kumar. Pioglitazone ameliorates

behavioral, biochemical and cellular alterations in quinolinic acid induced

neurotoxicity: possible role of peroxisome proliferator activated receptor-?

(PPAR?) in Huntington disease. Pharmacology Biochemistry and Behavior 2010,

96,115-124.

95. Anil Kumar, Aditi and Puneet Kumar. Potential role of pioglitazone, caffeic acid

and their combination against fatigue syndrome-induced behavioral, biochemical

and mitochondrial alterations in mice. Inflammopharmacology 2010, 18,241-251.

96. Vaibhav Gaur and Anil Kumar. Behavioral, biochemical and cellular correlates in

the protective effect of sertraline against transisent global ischemia induced

behavioral despair: possible involvement of nitric oxide cyclic guanosine

monophosphate study pathway. Brain Res Bulletin 2010, 82(1-2), 57-64.

97. Vaibhav Gaur, Anil Kumar. Protective effect of desipramine, venlafaxine and

trazodone against experimental animal model of transient global ischemia: Possible

involvement of NO–cGMP pathway. Brain Research 2010, 1353, 204-212.

Page 36: University Institute of Pharmaceutical Sciences

98. Amit Gupta, Anil Kumar and Kulkarni SK. Licofelone attenuates MPTP-induced

neuronal toxicity: behavioral, biochemical and cellular evidences.

Inflammopharmacology 2010 Oct; 18(5):223-32.

99. Ranju Bansal, Gaurav Narang, Christina Zimmer and Rolf W. Hartmann

„Synthesis of some imidazolyl-substituted 2-benzylidene indanone derivatives as

potent aromatase inhibitors for breast cancer therapy‟ Medicinal Chemistry

Research 2010 DOI: 10.1007/s00044-010-9368-4

100. Ranju Bansal, Sheetal Guleria, Christina Ries, Rolf W Hartmann, „Synthesis and

antineoplastic activity of O-alkylated derivatives of 7-hydroximinoandrost-5-ene

steroids‟ Arch Pharmazie 03/2010. DOI: 10.1002/ardp.200900258

101. Ranju Bansal, Gulshan Kumar, Deepika Gandhi, Rakesh Yadav, Louise C.

Young, Alan L. Harvey „Synthesis of 8-(cyclopentyloxy)phenyl substituted

xanthine derivatives as adenosine A2A ligands‟ Arzneimittel-Forschung /

DrugResearch 60(3) 2010, 131-136

102. Bhatt, L.K.; Bansal, J.; Piplani, P.; Bodhankar, S.L.; Veerajaneyulu, A.

Cardioprotective and β-adrenoceptor antagonistic activity of a newly synthesized

aryloxypropanolamine derivative PP-36. Journal of Experimental Pharmacology

2010, 2, 37-45.

103. Dubey, S.; Kaur, P.; Jindal, D.P.; Satyanarayan, Y.D.; Piplani. P. Synthesis and

qsar studies of 16-(3-methoxy-4-substituted benzylidene) androstene derivatives as

anticancer agents. Indian Jounal of Chemistry B 2010, 49B, 948-955.

104. Dube, A.; Chaudhary, S.; Bodhankar, S.L.; Piplani, P. Study of beta-

adrenoreceptor blocking and antihypertensive activity of a newly synthesized

aryloxypropanolamine derivative, PP-28 in laboratory animals.

Pharmacologyonline 2010, 1, 770-782.

105. Dube, A.; Chaudhary, S.; Tambe, S.; Bodhankar, S.L.; Piplani, P. Metabolic and

haemodynamic effects of PP-28 in fructose-fed wistar rats. Pharmacologyonline

2010, 3, 41-51.

106. Vasisht, K., Karan, M. and Sharma, P. D. (2010). Monograph on SOPs of

manufacturing process of Saptanga Guggulu. The Ayurvedic Pharmacopoeia of

India, Part II (Formulations), Vol. 3, Ministry of Health & Family Welfare,

Department of AYUSH, Govt. of India, 44-46.

107. Vasisht, K., Karan, M. and Sharma, P. D. (2010). Monograph on SOPs of

manufacturing process of Varadi Guggulu. The Ayurvedic Pharmacopoeia of

India, Part II (Formulations), Vol. 3, Ministry of Health & Family Welfare,

Department of AYUSH, Govt. of India, 47-49.

108. Vasisht, K., Karan, M. and Sharma, P. D. (2010). Monograph on SOPs of

manufacturing process of Vidangadi Guggulu. The Ayurvedic Pharmacopoeia of

India, Part II (Formulations), Vol. 3, Ministry of Health & Family Welfare,

Department of AYUSH, Govt. of India, 50-52.

Page 37: University Institute of Pharmaceutical Sciences

109. Vasisht, K., Karan, M., Sharma, P. D. (2010). Monograph on Angelica glauca

roots. In, N. Tandon and M. Sharma (Eds.). Quality Standards of Indian Medicinal

Plants, Vol. 8, Indian Council of Medical Research, New Delhi, p. 68-76.

110. Vasisht, K., Karan, M., Sharma, P. D. (2010). Monograph on Rauvolfia serpentina

roots. In, N. Tandon and M. Sharma (Eds.). Quality Standards of Indian Medicinal

Plants, Vol. 8, Indian Council of Medical Research, New Delhi, p. 272-282.

111. Dutt, S., Bhanwara, R.K., Vasisht, K., Karan, M. and Sharma, R.K. (2010).

Morphoanatomical studies on Malaxis acuminata D. Don-An endangered

medicinal orchid. Hippocratic Journal of Unani Medicine, 5(3), 149-161.

112. Karan, M., Sharda, D., Rubina, Jindal, D. K., Chadha, K., Gandhi, S. and Vasisht,

K. (2010). Patent opportunities in herbals. Pharmacos, Vol. 37, 49-52.

113. Karan, M., Chadha, K., Jindal, D. K., Sharda, D., Rubina, Gandhi, S. and Vasisht,

K. (2010). Plant drug monographs in Pharmacopoeia of India-1955 to 2010.

Pharmacos, Vol. 37, 64-74.

114. Lehra KS, Chawla AS, Karan M. (2010) Chemical investigations and anti-

inflammatory activity of Barleria prionitis. Indian J Nat Prod, 26(2), 3-7.

115. Alka Bali, Komal Sharma, Abhishek Bhalla, Suman Bala, Dinesh Reddy, Anant

Singh, Anil Kumar „Synthesis, evaluation and computational studies on a series of

acetophenone based 1-(aryloxypropyl)-4-(chloroaryl) piperazines as potential

atypical antipsychotics‟ Eur. J. Med. Chem. 2010, 45, 2656-2662.

116. Bali, Alka (2010, July 13). Drug discovery in schizophrenia: Multitude of

approaches. SciTopics. Retrieved July19, 2010, from http://www.scitopics.com.

117. Alka Bali „Two Dimensional Molecular Similarity: A Tool in Drug Design‟,

Pharmacos, 2010,37, 53-58.

118. Bali, Alka (2010, July 16). Dual Angiotensin II/Endothelin antagonists: A new

therapeutic approach. SciTopics. Retrieved July 19, 2010, from

http://www.scitopics.com

119. Bali, Alka (2010, October 15). Atypical antipsychotics: Serotonergic approaches

SciTopics. Retrieved October 15, 2010, from http://www.scitopics.com

2011

1. Malik, J., Karan, M. and Vasisht, K. (2011). Nootropic, anxiolyitc and CNS-

depressant studies on different plant sources of shankhpushpi. Pharmaceutical

Biology, 1-9.

2. Bhatia A., Singh B., Amarji B., Negi P., Shukla A. and Katare, O. P. Novel Stain-

free Lecithinized Coal Tar Formulation for Psoriasis. International Journal of

Page 38: University Institute of Pharmaceutical Sciences

Dermatology, 2011 Oct; 50 (10):1246-8. doi: 10.1111/j.1365-4632.2011.04913.x.

Epub 2011 Jun 15.

3. Raza, K., Negi, P., Takyar, S., Shukla, A., Amarji, B., Katare, O. P. Novel

Dithranol Phospholipid Microemulsion for Topical Application: Development,

Characterization and Percutaneous Absorption Studies. Journal of

Microencapsulation, 28(3): 190-199, 2011.

4. Raza, K., Singh, B., Mahajan, A., Negi, P., Bhatia, A., Katare, O.P. Design and

Evaluation of Flexible Membrane Vesicles (FMVs) for Enhanced Topical Delivery

of Capsaicin Journal of Drug Targeting, 19(4): 293–302, 2011. [Impact factor

2.885].

5. Shukla, A., Singh, B., Katare, O.P. Significant systemic and mucosal immune

response induced on oral delivery of diphtheria toxoid using nano-bilosomes.

British Journal of Pharmacology, 164 (2b): 820–827, 2011.

6. Bhupinder Singh, L. Khurana, S. Bandyopadyay, R. Kapil, and O. P. Katare,

Development of Optimized Self Nano-Emulsifying Drug Delivery Systems

(SNEDDS) of Carvedilol with Enhanced Bioavailability Potential, Drug Delivery,

18 (8), 599-612, 2011.

7. V.R. Sinha and Saurabh Srivastava. Development and Evaluation of Stavudine

Loaded Injectable Polymeric Particulate Systems. Current Drug Del. Jan 14(2011)

8. Sinha VR, Jindal V, Kumar RV, Bhinge JR and Goel H. Development and

validation of a simple stability indicating high performance liqud chromatographic

method for the determination of tolterodine tartarate . Acta Chromatographia

23(1): 133-143 (2011)

9. V. R. Sinha, A. Nanda, R. Chadha and H Goel, Molecular simulation of

hydroxypropyl-β-cyclodextrin with hydrophobic selective COX-II

chemopreventive agent using host-guest phenomena, Acta Poloniae Pharmaceutica

Drug Res. 68(4): 583-592 (2011).

10. V.R. Sinha, Azaki Ahmed Al-Azaki, R.V. Kumar. Novel Lannea Woodier gum

matrices for controlled release of drugs. Carbohydrate polymer 83(4): 1492-1498

(2011).

11. Bhupinder Singh, R. Kapil, M. Nandi and N. Ahuja, "Developing Oral Delivery

Systems using Formulation by Design (FbD), Part I: Vital Precepts", Expert

Opinion on Drug Delivery, 2011, 8(10), 1341-60.

12. Bhupinder Singh, L. Khurana, S. Bandyopadyay, R. Kapil, and O.P. Katare,

Development of Optimized Self Nano-Emulsifying Drug Delivery Systems

(SNEDDS) of Carvedilol with Enhanced Bioavailability Potential, Drug Delivery,

2011, 18 (8), 599-612,.

Page 39: University Institute of Pharmaceutical Sciences

13. S. Dhawan, R. Kapil, Bhupinder Singh, Formulation Development and Systematic

Optimization of Solid Lipid Nanoparticles of Quercetin for Improved Brain

Delivery, Journal of Pharmacy and Pharmacology, 2011, 63 (3), 342–351.

14. S. Sharma, A. Nanda, Bhupinder Singh, L. Singh, Progress in Stomach-Specific

Drug Delivery Systems: Features and Facts, International Journal of Current

Pharmaceutical Research, 3 (4), 48-52, 2011

15. Bhupinder Singh, Shantanu and Rishi Kapil, Systematic Optimization of Drug

Delivery Systems using Experimental Designs, The Pharm Student, 25th

Silver

Jubilee Volume, Special Issue on Drug Delivery Systems, 2011, 51-58.

16. A. Shukla, Bhupinder Singh and O.P. Katare, Significant systemic and mucosal

immune response induced on oral delivery of diphtheria-toxoid using nano-

bilosomes, British Journal of Pharmacology, 2011, 164, 820-827.

17. K. Raza, Bhupinder Singh, A. Mahajan, P. Negi, A. Bhatia, O P Katare, Evaluation

of Flexible Membrane Vesicles (FMVs) for Enhanced Topical Delivery of

Capsaicin, Journal of Drug Targeting, 2011, 9(4):293-302.

18. Bhupinder Singh, R. Bhatowa, C.B. Tripathi and R. Kapil, Developing Micro-

/Nano-particulate Drug Delivery Systems using “Design of Experiments

(DoE)”,International Journal of Pharmaceutical Investigation, 2011, 1(2), 15-22.

19. Bhupinder Singh and S. Bandyopadhyay, Enhancing Drug Oral Bioavailability

using Self-emulsifying Drug Delivery Systems (SEDDS), Chronicle Pharmabiz, 11

(15), 21-24, March 24, 2011.

20. Y Paul, S. Tyagi and Bhupinder Singh, Formulation Technologies for

Development of Oral Dispersible Tablets, The Pharma Review 9(49), 137-141,

2011.

21. S. Bandyopadhyay, G. Sharma, O.P. Katare and Bhupinder Singh,Hyperlipidemia:

Maladies and Remedies, Trendz in Medicine World, 3(4), 2011, 34-43.

22. Y. Paul, S. Tyagi and Bhupinder Singh, Formulation and Evaluation Oral

Dispersible Tablets of Zidovudine with Different Superdisintegrants, International

Journal of Drug Delivery Technology,, 2(2), 81-91, 2011.

23. Y. Paul, S. Kumar, Y. Girdhar and Bhupinder Singh, Development and Validation

of RP-HPLC Method for the Estimation of Gatifloxacin in Biological Matrices,

Indian Drugs, 2011, 48(1), 30-35.

24. Y. Paul, S. Tyagi and Bhupinder Singh, Formulation and Evaluation of Taste

Masked Dispersible Tablets of Zidovudine, International Journal of Pharma and

Bio Sciences, 2011, 2(2), 20-30.

25. Y. Paul, M. Kumar and Bhupinder Singh, Formulation and In Vitro Evaluation of

Gastroretentive Drug Delivery Systems of Cefixime Trihydrate, International

Page 40: University Institute of Pharmaceutical Sciences

Journal of Drug Development and Research (ISSN: 0975-9344), 3 (4), 148-161.

2011

26. Bhupinder Singh, S. Bandyopadyay, S. Beg and O. P. Katare, Handling Poorly

Bioavailable Drugs using Nanoemulsifying Drug Delivery Systems, The Pharma

Review (Kongposh Publications), 9(54), 91-98, 2011.

27. R. Kapil, S. Dhawan, S. Beg and Bhupinder Singh, Buccoadhesive Films for Once-

a-day Administration of Rivastigmine: Systematic Formulation Development and

Pharmacokinetic Evaluation, Drug Development and Industrial Pharmacy 2011,

Article published online, DOI: 10.3109/03639045.2012.665926

28. Y. Paul, M. Kumar and Bhupinder Singh, Formulation, Evaluation and Study of

Effect of Hydrophilic Polymers on Release Rate of Cefixime Floating Tablets,

International Journal of Pharma and Bio Sciences, 2(4), 2011, 472-488

29. L. Singh, A. Nanda, Bhupinder Singh and S. Sharma, Drug Delivery Technologies

for Upper Small Intestinal Window: A Review, Research Journal of Pharmacy and

Technology, 4(10): 1499-1505, 2011.

30. A. Bhatia, Bhupinder Singh, B. Amarji, P. Negi, A. Shukla and O.P. Katare, Novel

Stain-free Lecithinized Coal Tar Formulation for Psoriasis. International Journal of

Dermatology, 50(10), 1246-8, 2011

31. L. Singh, A. Nanda, B. Garg and Bhupinder Singh, Development of optimized

effervescent floating-bioadhesive matrix tablets of glipizide using central

composite design, Malaysian Journal of Pharmaceutical Sciences, Accepted for

Publication, Manuscript ID # MJPS-OA-08-11-0004

32. Renu Chadha, Anupam Saini, Poonam Arora, Dharamvir Singh Jain, Archi

Dasgupta and T N Guru Row. Multicomponent Solids of Lamotrigine with some

selected coformers and their characterization by thermoanalytical, spectroscopic

and X-ray diffraction methods. Crystal Engineering & Communications, 2011, 13,

6271-84.

33. Renu Chadha, Poonam Arora, Sushma Gupta, and D.V.S. Jain. “

Complexation of

nevirapine with β-cyclodextrins in the presence and absence of Tween 80:

characterization, thermodynamic parameters and permeability flux” Journal of

Thermal Analysis and Calorimetry, 2011, 105(3), 1049-1059.

34. Renu Chadha, Poonam Arora, Swati Bhandari, Dharamvir Singh Jain. “Effect of

hydrophilic polymer on complexing efficiency of cyclodextrins towards efavirenz

characterization and thermodynamic parameters” Journal of Inclusion Phenomena

and Macrocyclic Chemistry 2011, DOI 10.1007/s10847-011-9972-z.

35. Renu Chadha, Sushma Gupta, Geeta Shukla, DVS Jain and Surjit Singh.

“Characterization and in vivo efficacy of Inclusion complexes of Sulphadoxine

with <beta>-cyclodextrin: Calorimetric and spectroscopic studies" in Journal of

Inclusion Phenomena and Macrocyclic Chemistry, 2011, 71, 149-159.

Page 41: University Institute of Pharmaceutical Sciences

36. R. Chadha, Sushma Gupta, Geeta Shukla. Crystal habit, characterization and

pharmacological activity of various crystal forms of arteether. Acta Pharmaceutica

Sinica B 1(2), 2011, 129-135.

37. R. Chadha, Sushma Gupta, Geeta Shukla, DVS Jain, Rahguvir R S Pissurlenkar,

Evans C Coutinho. Interaction of artesunate with b-cyclodextrin: Characterization,

thermodynamic parameters, molecular modeling, effect of PEG on complexation

and antimalarial activity. Results in Pharma Sciences. 1, 2011, 38-48.

38. R. Chadha, Sushma Gupta, Natasha Pathak, Geeta Shukla, DVS Jain, Rahguvir R

S Pissurlenkar, Evans C Coutinho. Binary and ternary complexes of Arteether β-

CD characterization and In vivo studies. Pharmacology and pharmacy. 2, 2011,

212-225.

39. Chopra K, Misra S, Kuhad A. Current perspectives on pharmacotherapy of

Alzheimer's disease. Expert Opin Pharmacother. 2011 Feb;12(3):335-50. PubMed

PMID: 21222549.

40. Chopra K, Kumar B, Kuhad A. Pathobiological targets of depression. Expert Opin

Ther Targets. 2011 Apr;15(4):379-400. Epub 2011 Jan 23. PubMed PMID:

21254923.

41. Chopra K, Misra S, Kuhad A. Neurobiological aspects of Alzheimer's disease.

Expert Opin Ther Targets. 2011 May;15(5):535-55. Epub 2011 Feb 11. PubMed

PMID:21314231.

42. Sah SP, Mathela CS, Chopra K. Antidepressant effect of Valeriana wallichii

patchouli alcohol chemotype in mice: Behavioural and biochemical evidence. J

Ethnopharmacol. 2011 Apr 26;135(1):197-200. Epub 2011 Feb 24. PubMed

PMID: 21354297.

43. Tiwari V, Chopra K. Resveratrol prevents alcohol-induced cognitive deficits and

brain damage by blocking inflammatory signaling and cell death cascade in

neonatal rat brain. J Neurochem. 2011 May;117(4):678-90. doi: 10.1111/j.1471-

4159.2011.07236.x. Epub 2011 Mar 23. PubMed PMID: 21375533.

44. Tiwari V, Kuhad A, Chopra K. Emblica officinalis Corrects Functional,

Biochemical and Molecular Deficits in Experimental Diabetic Neuropathy by

Targeting the Oxido-nitrosative Stress Mediated Inflammatory Cascade. Phytother

Res. 2011 Mar 11. doi: 10.1002/ptr.3440. [Epub ahead of print] PubMed PMID:

21394805.

45. Misra S, Tiwari V, Kuhad A, Chopra K. Modulation of nitrergic pathway by

sesamol prevents cognitive deficits and associated biochemical alterations in

intracerebroventricular streptozotocin administered rats. Eur J Pharmacol. 2011

Jun 1;659(2-3):177-86. Epub 2011 Apr 2. PubMed PMID: 21463622.

Page 42: University Institute of Pharmaceutical Sciences

46. Sah SP, Tirkey N, Kuhad A, Chopra K. Effect of quercetin on lipopolysaccharide

induced-sickness behavior and oxidative stress in rats. Indian J Pharmacol. 2011

Apr;43(2):192-6. PubMed PMID: 21572657; PubMed Central PMCID:

PMC3081461.

47. Arora V, Kuhad A, Tiwari V, Chopra K. Curcumin ameliorates reserpine-induced

pain-depression dyad: Behavioural, biochemical, neurochemical and molecular

evidences. Psychoneuroendocrinology. 2011 May 23. [Epub ahead of print]

PubMed PMID: 21612876.

48. Bharrhan S, Koul A, Chopra K, Rishi P. Catechin suppresses an array of signalling

molecules and modulates alcohol-induced endotoxin mediated liver injury in a rat

model. PLoS One. 2011;6(6):e20635. Epub 2011 Jun 3. PubMed PMID:

21673994; PubMed Central PMCID: PMC3108820.

49. Misra S, Tiwari V, Kuhad A, Chopra K. Modulation of nitrergic pathway by

sesamol prevents cognitive deficits and associated biochemical alterations in

intracerebroventricular streptozotocin administered rats. Eur J Pharmacol. 2011

Jun 1;659(2-3):177-86. Epub 2011 Apr 2. PubMed PMID: 21463622.

50. Chopra K, Misra S, Kuhad A. Neurobiological aspects of Alzheimer's disease.

Expert Opin Ther Targets. 2011 May;15(5):535-55. Epub 2011 Feb 11. Review.

PubMed PMID: 21314231.

51. Chopra K, Kumar B, Kuhad A. Pathobiological targets of depression. Expert Opin

Ther Targets. 2011 Apr;15(4):379-400. Epub 2011 Jan 23. Review. PubMed

PMID: 21254923.

52. Kaura, G., Suttee, A., Arora, D. and Sharma, A. (2011). Study of in vitro

anthelmintic activity of Caesalpinia bonduc leaves. Canadian Journal of Pure and

Applied Sciences 5(2): 1505-1507.

53. Indu Pal Kaur, Harinder Singh, Shilpa Kakkar (2011), Newer Therapeutic Vistas

for Anti-Glaucoma Medicines. Critical ReviewsTM

in Therapeutic Drug Carrier

Systems, 28, 165-202.

54. Pramod Kumar, Indu Pal Kaur (2011) Development and evaluation of a

gastroretentive delivery system for improved antiulcer activity of ginger extract

(Zingiber officinale). Journal of Drug Targeting 19(9), 741-51.

55. Shilpa Kakkar, Indu Pal Kaur (2011), Spanlastic-a novel nanovesicular carrier for

targeting posterior eye segment. International Journal of Pharmaceutics, 413, 202-

210.

56. Vandita Kakkar, Anil Kumar Mishra, Krishna Chuttani, Kanwaljit Chopra and

Indu Pal Kaur (2011). Delivery of Sesamol Loaded Solid Lipid Nanoparticles to

Brain for Menopause Related Emotional and Cognitive Central Nervous System

Derangements. Rejuvenation Research, 14(6): 597-604.

Page 43: University Institute of Pharmaceutical Sciences

57. Vandita Kakkar, Indu Pal Kaur (2011), Evaluating potential of curcumin loaded

solid lipid nanoparticles in Aluminium induced behavioural, biochemical and

histopathological alterations in mice brain. Food and Chemical Toxicology,

49(11):2906-13.

58. Chabra S, Ranjan M, Bhandari R, Kaur T, Aggrawal M, Puri V, Mahajan N, Kaur

IP, Puri S and Sobti RC (2011), Solid Lipid Nanoparticles Regulate Functional

Assortment of Mouse Mesenchymal Stem Cells. Journal of Stem cells and

Regenerative medicine. 7(2), 75-79.

59. Praveen Rishi, Sushma Bharrhan, Gurdeep Singh, Indu Pal Kaur (2011), Effect of

Lactobacillus plantarum and l-arginine against endotoxin-induced liver injury in a

rat model. Life Sciences. 89(23-24), 847-853.

60. Indu Pal Kaur and Manoj Kumar Verma (2011), Exploring scope of solid lipid

nanoparticles for intranasal administration of streptomycin. International Jounal of

Pharmacy.,1(2), 110-117.

61. Neelima Dhingra, Tilak Raj Bhardwaj, Neeraj Mehta, Tapas Mukhopadhyay,

Ashok Kumar, and Manoj Kumar, “Synthesis, Antiproliferative Activity, Acute

Toxicity and Assessment of the Antiandrogenic Activities of New Androstane

Derivatives” Arch. Pharm. Res. 34 (2011), 1055-1063.

62. Honey Goel, V R Sinha, Suresh Thareja, Saurabh Aggarwal and Manoj Kumar

“Assessment of biological half life using in silico QSPkR approach: a self

organizing molecular field analysis (SOMFA) on a series of antimicrobial

quinolone drugs” Int. J. Pharm. 415(2011) 158-6.

63. Neeraj Kumar, Shishu, Varun Rishi Kapoor. Facile synthesis of novel salts of a

triazole antifungal agent with enhanced solubility. Journal of Heterocyclic

Chemistry( in press)

64. Aggarwal N. and Shishu A review of recent investigations on medicinal herbs

possessing anti-diabetic properties. Journal Nutritional Disorders & Therapy Vol.

1, Issue 1, Page 1-10, 2011.

65. Shishu, Kamalpreet and Aggarwal N. Gastro-retentive floating beads of curcumin

β-cyclodextrin complex to treat stomach tumors. Alternative Medicine Studies

Vol. 1:Ed. 12, Page 49-53, 2011

66. Shishu, Kamalpreet and Manjul Maheshwari. Development of novel

microemulsion based oral formulations of 5-fluorouracil with enhanced

bioavailability. Drug Development and Industrial Pharmacy, 1-7, 2011

67. Aggarwal N., Shishu, Mehta S. D. Preparation and evaluation of dermal delivery

system of griseofulvin containing vitamin E-TPGS as penetration enhancer. Nidhi

Aggarwal, Shishu and Swami Dass Mehta. Volume 13, Number 1, 67-74, AAPS

Pharm. Sci. Tech.2011

Page 44: University Institute of Pharmaceutical Sciences

68. Harikesh Kalonia, Puneet Kumar and Anil Kumar. Comparative neuroprotective

profile of statins in quinolinic acid induced neurotoxicity in rats. Behavioral Brain

Res 2011,216(1),220-228

69. Harikesh Kalonia, Puneet Kumar and Anil Kumar. Protective effect of montelukast

against quinolinic acid / malonic acid induced neurotoxicity: possible behavioral,

biochemical, mitochondrial and TNF-Alpha level alterations in rats. Neuroscience

2010,171 (1),284-99

70. Vaibhav Gaur and Anil Kumar. Neuroprotective potentials of candesartan,

atorvastatin and their combination against stroke induced motor dysfunction.

Inflammopharmacology 2010,19,205-214.

71. Anil Kumar, Ruchika Garg and Atish Prakash. Protective effect of Curcumin

(Curcuma longa) against D-galactose induced senescence in mice. Asian Journal

of Natural Product Research 2011, 13(11), 42-55.

72. Harikesh Kalonia, Puneet Kumar and Anil Kumar. Attenuation of proinflammatory

cytokines and apoptotic process by verapamil and diltiazem against quinolinic acid

induced Huntington like alterations in rats. Brain Research 2011,1372,115-26

73. Harikesh Kalonia, Puneet Kumar and Anil Kumar. Licofelone attenuates quinolinic

acid induced Huntington like symptoms: Possible behavioral, biochemical and

cellular alterations. Progress in Neuro-Psychopharmacology & Biological

Psychiatry 2011, 35,607-615.

74. Harikesh Kalonia, Puneet Kumar and Anil Kumar. Suppressing inflammatory

cascade by cyclo-oxygenase inhibitors attenuates quinolinic acid induced

Huntington's like alterations in rats. Life Science 2011, 88(17-18):784-91

75. Anil Kumar, Ruchika Garg, Vaibhav Gaur and Puneet Kumar Nitric oxide

modulation in protective role of antidepressants against chronic fatigue syndrome-

in mice. Indian Journal of Pharmacology 2011,35(2),607-15.

76. Anil Kumar, Deeksha Pahwa and Atish Prakash. Galantamine potentiates the

protective effect of rofecoxib and caffeic acid against intrahippocampal Kainic

acid–induced cognitive dysfunction in rat. Brain Res Bulletin 2011,85,158-168.

77. Anil Kumar, Seema Meena, Harikesh Kalonia, Amit Gupta & Puneet Kumar.

Effect of nitric oxide in protective effect of melatonin against chronic constriction

sciatic nerve injury induced neuropathic pain in rats. Indian Journal of

Experimental Biology, 2011, 49,664-671.

78. Vaibhav Gaur and Anil Kumar. Effect of non selective and selective COX-2

inhibitors on memory dysfunction, glutathione system and tumor necrosis factor-α

level in rats after cerebral ischemia reperfusion injury. Drug and Chemical

Toxicology 2011, 1-7.

Page 45: University Institute of Pharmaceutical Sciences

79. Vaibhav Gaur, Aditi Aggarwal and Anil Kumar. Possible nitric oxide mechanism

in the protective effect of hesperidin against ischemic reperfusion cerebral injury.

Indian Journal of Experimental Biology 2011, 49,609-618.

80. Anil Kumar, Deeksha Pahwa and Atish Prakash. Galantamine potentiates the

protective effect of rofecoxib and caffeic acid against intrahippocampal Kainic

acid–induced cognitive dysfunction in rat. Brain Res Bulletin 2011, 85,158-168.

81. Anil Kumar, Atish Prakash, Samrita Dogra Effect of carvedilol against aluminum

induced toxicity: Possible behavioral and biochemical alterations in rats"

Pharmacological Report 2011, 63(4) 915-923.

82. Puneet Kumar, Harikesh Kalonia, Anil Kumar. Role of LOX/COX pathways in 3-

nitropropionic acid-induced HD like symptoms in rats: Protective role of

Licofelone. British Journal of Pharmacology 2011, 164,644-654.

83. Anil Kumar, Ruchika Garg, Vaibhav Gaur and Puneet Kumar Nitric oxide

modulation in protective role of antidepressants against chronic fatigue syndrome-

in mice. Indian Journal of Pharmacology 2011, 35(2),607-15.

84. Harikesh Kalonia, Puneet Kumar and Anil Kumar. Suppressing inflammatory

cascade by cyclo-oxygenase inhibitors attenuates quinolinic acid induced

Huntington's like alterations in rats. Life Science 2011, 88(17-18):784-91

85. Amit Gupta, Anil Kumar and Kulkarni SK. Targeting oxidative stress,

mitochondrial dysfunction and neuroinflammatory signaling by selective

cyclooxygenase (COX)-2 inhibitors mitigates MPTP-induced neurotoxicity in mice

Progress in Neuro-Psychopharmacology & Biological Psychiatry 2011, Feb

issue[PMID 21291942]

86. Ranju Bansal, Priyanka Jain, Carmen Calle, Rosalia Carron, Karen Pemberton,

Alan L. Harvey „Synthesis of a new series of 4-aryl-1,4-dihydropyridines with

calcium channel blocking and vasodilatory activity‟ Medicinal Chemistry Research

2011, DOI: 10.1007/s00044-011-9600-x

87. Ranju Bansal, Sheetal Guleria, Sridhar Thota, R.W.Hartmann and Christina

Zimmer „Synthesis and biological evaluation of 16E-arylidenosteroids as cytotoxic

and anti-aromatase agents‟ Chem. Pharm. Bull. 2011, 59(3),327-331

88. Ranju Bansal, Sheetal Guleria, Louise C. Young and Alan L. Harvey

„Synthesis of quaternary ammonium salts of 16E-[4-(2-alkylaminoethoxy)-3-

methoxybenzylidene]androstene derivatives as skeletal muscle relaxants‟ Steroids

2011, 76, 254–260.

89. Ranju Bansal, Gulshan Kumar, Deepika Gandhi, Louise C. Young and

Alan L. Harvey „Synthesis of a new series of imdazolyl substituted 8-

phenylxanthines as adenosine receptor ligands‟ Chemistry & Biodiversity 2011,

8(7), 1290-1300.

Page 46: University Institute of Pharmaceutical Sciences

90. Ranju Bansal, Navjot Singh and Rakesh Yadav „Microwave-assisted organic

synthesis‟ The Pharmacos, 35, 2008, 17-24.

91. Ranju Bansal, Ashish Dhir and Rakesh Yadav „Sixty years of pharmaceutical

education at Panjab university: the glorious saga of post-partition era‟ The

Pharmacos, 35, 2008, 9-16.

92. Piplani, P.; Rani, A.; Saihgal, R.; Sharma, M. Synthesis and pharmacological

evaluation of some quinoline derivatives as potential cognition enhancers.

ChemInform 2011, 42(44), 147.

93. Piplani, P.; Danta, C.C.; Opportunity for the discovery of new drug molecules for

future cancer chemotherapy based on novel targets. The Pharmacos 2011.

(accepted)

94. Piplani, P.; Rani,A.; Saihgal, R.; Sharma, M. Synthesis and pharmacological

evaluation of some quinoline derivatives as potential cognition enhancers.

Arzneim-Forsch. /Drug Res. 2011, 373-378.

95. Piplani, P.; Malik, R.; Kaur, B.; Kaplish. A. Synthesis and pharmacological

evaluation of some new naphthol derived aryloxy derivatives as cognition

enhancers. Medicinal Chemistry Research 2011, 1-9.

96. Nikam, A.P.; Ghule, A.E.; Piplani, P.; Bansal, J.; Bodhankar, S.L. Cardioprotective

and antiarrythmic activity of oxalate salt of 1-(isopropylamino)-3-(5-

((isopropylamino) methyl)-2-methoxyphenoxy) propan-2-ol (PP-24): A newly

synthesized aryloxypropanolamine derivative Biomedicine and Aging Pathology

2011, 1(2), 84-89.

97. Gurumoorthy, A.; Gopalsamy, V.; k.R.; Piplani, P.; Malik R. N-[4-(2-

Morpholinoethoxy) phenyl]acetamide monohydrate. Acta. Cryst. E 2011, o262-

o262.

98. Malik, J., Karan, M. and Vasisht, K. (2011). Nootropic, anxiolyitc and CNS-

depressant studies on different plant sources of shankhpushpi. Pharmaceutical

Biology, 1-9.

99. Arora, P., Nanda, A. and Karan, M. (2011). Plants used in management of

dandruff. The Indian Pharmacist (March 2011), 28-32.

100. Arora, P., Nanda, A. and Karan, M. (2011). Shampoos based on synthetic

ingredients vis-à-vis shampoos based on herbal ingredients-A review. International

Journal of Pharmaceutical Sciences Review and Research 7, 41-46.

101. Bali Alka „Molecular Field Based Three Dimensional Similarity Studies on

Quinoline Based CNS Active Agents, ISRN Pharmaceutics, 2011, 2011, 186943.

102. Alka Bali and Umesh Sen „Imidazole based angiotensin receptor antagonists: A 2D

QSAR study‟, Pharmacos, 2011, 38, 19-25.

Page 47: University Institute of Pharmaceutical Sciences

103. Alka Bali and Prateek Gaur „A Novel Method for Spectrophotometric

Determination of Pregabalin in Pure Form and in Capsules‟ Chemistry Central

Journal, 2011, 5, 59.

104. Alka Bali, Sabrinjit Kaur and Chandrasekaran Balakumar „Alkoxyphenyl

methanesulfonamides: Synthesis, anti-inflammatory effect, and docking studies‟

Medicinal Chemistry Research, 2011, In Press (DOI 10.1007/s00044-011-9819-6).

2012

1. Bhatia A., Singh B., Raza K., Wadhwa S. and Katare O.P., Novel phospholipid-

based topical formulations of tamoxifen: Evaluation for antipsoriatic activity using

mouse-tail model, Pharmaceutical Development and Technology (Informa Health

Care, USA), Accepted for Publication, 2012, Manuscript ID LPDT-2012-0258.R1

2. Raza K., Katare O P., Setia A., Bhatia A and Singh B., Improved Therapeutic

Performance of Dithranol against Psoriasis employing Systematically Optimized

Nano-Emulsomes. Journal of Microencapsulation. 2012. ID: 717115

DOI:10.3109/02652048.2012.717115.

3. Bandyopadyay S., Katare O.P. and Bhupinder Singh., Optimized Self Nano-

Emulsifying Systems of Ezetimibe with Enhanced Bioavailability Potential using

Long Chain and Medium Chain Triglycerides, Colloids and Surfaces B:

Biointerfaces (Elsevier, USA), 2012, 100, 50-61.

4. Bhatia A., Singh B., Raza K., Shukla A., Amarji B., and Katare O.P., Tamoxifen-

Loaded Novel Liposomal Formulations: Evaluation of Anti-cancer Activity on

DMBA-TPA Induced Mouse Skin Carcinogenesis, Journal of Drug Targeting,

Journal of Drug Targeting, (Informa Health Care, USA), 2012, 544-50.

5. Shukla A., Singh B and Katare O.P., Oral Mucosal Immunization using Novel

Nanovesicles, Proceedings of International Conference on “Frontiers in

Nanoscience, Nanotechnology and their Applications” NanoSciTech 2012,

Chandigarh, Session: Harnessing Nanotechnology for Biomedical Applications,

2012, 16-18, 410-418.

6. Raza K., Katare O.P.. Setia A., Bhatia A and Singh B., "Improved Therapeutic

Performance of Dithranol against Psoriasis employing Systematically Optimized

Nano-Emulsomes", Journal of Microencapsulation, (Informa Health Care, USA),

Accepted for Publication, 2012, Manuscript # TMNC-2012-0035.

7. Bamiro OA, Odeku OA, Sinha VR, Kumar R. Terminalia gum as a directly

compressible excipient for controlled drug delivery. AAPS PharmSciTech. 2012,

13(1):16-23.

8. Kumar RV, Sinha VR. A novel synergistic galactomannan-based unit dosage form

for sustained release of acarbose. AAPS PharmSciTech. 2012 (1):262-75.

Page 48: University Institute of Pharmaceutical Sciences

9. R.V. Kumar and V.R Sinha. Utility of an oxidation reaction for the

spectrophotometric determination of acarbose in controlled release tablets in

simulated gastrointestinal media. Acta Poloniae Pharmaceutica-Drug Research.

Accepted for publication in Issue 69, 2012.

10. Kumar RV, Sinha VR. A novel synergistic galactomannan-based unit dosage form

for sustained release of acarbose. AAPS PharmSciTech. 2012 (1):262-75.

11. Bamiro OA, Odeku OA, Sinha VR, Kumar R. Terminalia gum as a directly

compressible excipient for controlled drug delivery. AAPS PharmSciTech. 2012,

13(1):16-23.

12. Kumar RV, Sinha VR. A novel synergistic galactomannan-based unit dosage form

for sustained release of acarbose. AAPS PharmSciTech. 2012 (1):262-75.

13. Bamiro OA, Odeku OA, Sinha VR, Kumar R. Terminalia gum as a directly

compressible excipient for controlled drug delivery. AAPS PharmSciTech. 2012,

13(1):16-23.

14. S Thareja, M Kumar, VR Sinha., Self-organizing molecular field analysis of

NSAIDs: assessment of pharmacokinetic and physicochemical properties using

3D-QSPkR approach.- European journal of medicinal chemistry, 2012.

15. In silico predicative studies for cytotoxic potential of NSAIDs using self-

organizing molecular field analysis. Goel, H., Thareja, S., Malla, P., Kumar, M.,

Sinha, V.R. International Journal of Toxicology 31 (4) , pp. 390-396, 2012.

Honey, Thareja S, Kumar M, Sinha V. R. Eur J Med Chem. 2012 Jul;53:76-82.

16. Quantitative structural activity relationship studies for in silico prediction of in

vitro cytotoxicity of NSAIDs in colon cancer cell lines. Goel, H., Thareja, S.,

Malla, P., Kumar, M., Sinha, V.R. Letters in Drug Design and Discovery 9 (8) ,

pp. 755-763, 2012.

17. Nanoemulsions as self-emulsified drug delivery carriers for enhanced permeability

of the poorly water-soluble selective β1-adrenoreceptor blocker Talinolol. Ghai,

D., Sinha, V.R. Nanomedicine: Nanotechnology, Biology, and Medicine 8 (5), pp.

618-626, 2012.

18. R.V. Kumar and V.R Sinha. Utility of an oxidation reaction for the

spectrophotometric determination of acarbose in controlled release tablets in

simulated gastrointestinal media. Acta Poloniae Pharmaceutica-Drug Research.

Accepted for publication in Issue 69, 2012.

19. Critical aspects in rationale design of fluorouracil-based adjuvant therapies for the

management of colon cancer. Sinha, V.R., Honey. Critical Reviews in Therapeutic

Drug Carrier Systems 29 (1), pp. 89-148, 2012.

20. S. Bandyopadyay, O. P. Katare and Bhupinder Singh, Optimized Self Nano-

Emulsifying Systems of Ezetimibe with Enhanced Bioavailability Potential using

Page 49: University Institute of Pharmaceutical Sciences

Long Chain and Medium Chain Triglycerides, Colloids and Surfaces B:

Biointerfaces, 2012, 100, 50-61.

21. R. Kapil and Bhupinder Singh, Optimized Novel Drug Delivery Systems for the

Treatment of Alzheimer‟s Disease: A QbD-based Developmental Approach,

AAPS QbD and Product Performance Focus Group Newsletter, American

Association of Pharmaceutical Sciences (AAPS), USA, Issue 4, December 2012,

4, 3-6.

22. Bhupinder Singh, B. Garg, S.C. Chaturvedi, S. Arora, R. Mandsaurwale, R. Kapil,

and B. Singh, Formulation Development of Gastroretentive Tablets of Lamivudine

using Floating-Bioadhesive Potential of Optimized Polymer Blends, Journal of

Pharmacy and Pharmacology, 2012, 64(5), 654-69.

23. R. Kapil, S. Dhawan, B. Singh, B. Garg and Bhupinder Singh, Systematic

Formulation Development of Once-a-day Gastroretentive Controlled Release

Tablets of Rivastigmine using Optimized Polymer Blends, Journal of Drug

Delivery Science and Technology, 2012, 22(6), 511-521.

24. Bhupinder Singh, R. Kapil, S. Beg, Carbon Nano Tubes (CNTs) and their

Application in Drug Delivery Systems, Book Chapter No. 1, in “Fundamentals of

Pharmaceutical Nanoscience,” Woei Ping Cheng (Editor), Springer Publishers,

Hatfield, United Kingdom, In press, 2012.

25. Renu Chadha, Poonam Arora, Anupam saini and Dharamvir Singh Jain. An insight

into thermodynamic relationship between polymorphic forms of efavirenz. Journal

of Pharmacy and Pharmaceutical Sciences. 15(2), 2012, 234 – 251.

26. Renu Chadha, Sushma Gupta & Natasha Pathak. Artesunate loaded

Chitosan/lecithin nanoparticles: preparation, characterization and in vivo studies.

Drug Development and Industrial Pharmacy.2012

('DOI:10.3109/03639045.2012.658812).

27. Renu Chadha, Poonam Arora, Anupam Saini and Dharamvir Singh Jain.

Polymorphic Forms of Lamivudine: Characterization, Estimation of Transition

Temperature, and Stability Studies by Thermodynamic and Spectroscopic Studies.

ISRN Thermodynamics. 2012 (2012), Article ID 671027, 8 pages.

28. Renu Chadha, Sushma Gupta, Geeta Shukla, D.V.S. Jain, Raghuvir R S

Pissurlenkar and Evans C Coutinho. Characterization, thermodynamic parameters,

molecular modeling and in vivo studies of inclusion complexes of pyrimethamine

with native β-cyclodextrin and its derivatives. International Journal of Pharmacy

and Pharmaceutical Sciences. 2012, 4(4), 102.

29. Renu Chadha, Astha Kuhad, Poonam Arora and Shyam Kishor. Characterisation

and

evaluation of pharmaceutical solvates of Atorvastatin calcium by thermoanalytical

and spectroscopic studies. Chemistry Central Journal. 2012; 6: 114.

Page 50: University Institute of Pharmaceutical Sciences

30. Renu Chadha, Anupam Saini, Dharamvir S. Jain, and P. Venugopalan. Preparation

and Solid-State Characterization of Three Novel Multicomponent Solid Forms of

Oxcarbazepine: Improvement in Solubility through Saccharin Cocrystal. Crystal

growth & Design. 2012, 12 (8), pp 4211–4224.

31. Renu Chadha, Swati Bhandari, Darpan Kataria, Sushma Gupta and Dharamvir

Singh Jain. Exploring the potential of lecithin/ chitosan nanoparticles in

enhancement antihypertensive activity of hydrochlorothiazide. Journal of

Microencapsulation. 29(8) 2012, 805-812.

32. Renu Chadha, Poonam Arora, Anupam saini and Dharamvir Singh Jain. An insight

into thermodynamic relationship between polymorphic forms of efavirenz. Journal

of Pharmacy and Pharmaceutical Sciences. 15(2), 2012, 234 – 251.

33. Maninder Karan, Kunal Chadha, Renu Chadha and Anupam Saini. Cocrystal of

caffeine with propionic acid: Preliminary characterization and stability evaluation.

Journal of Pharmacy Research. 2012, 5(4), 2022-2026.

34. Maninder Karan, Renu Chadha, Kunal Chadha and Poonam Arora. Identification,

characterization and evaluation of crystal forms of Quinine sulphate.

Pharmacology & Pharmacy. 2012, 3, 129-138.

35. Renu Chadha, Sushma Gupta & Natasha Pathak. Artesunate loaded

Chitosan/lecithin nanoparticles: preparation, characterization and in vivo studies.

Drug Development and Industrial Pharmacy.2012

('DOI:10.3109/03639045.2012.658812).

36. Renu Chadha, Poonam Arora, Anupam Saini, Somnath and DVS Jain. Cocrystals

of Efavirenz with selected conformers: Preparation and characterization.

International Journal of Pharmacy and Pharmaceutical Sciences. Vol.4(2), 244-

250, 2012.

37. Karan, M., Kunal, C., Chadha, R. and (2012). Identification, characterization and

evaluation of crystal forms of quinine sulphate. Pharmacology and Pharmacy.

Accepted.

38. Prakash A, Medhi B, Chopra K. Granulocyte colony stimulating factor (GCSF)

improves memory and neurobehavior in an amyloid-β induced experimental model

of Alzheimer's disease. Pharmacol Biochem Behav (2013)110C:46-57.

39. Tiwari V, Chopra K. Protective effect of curcumin against chronic alcohol-induced

cognitive deficits and neuroinflammation in the adult rat brain. Neuroscience

(2013)244:147-58.

40. Kakkar V, Muppu SK, Chopra K, Kaur IP. Curcumin loaded solid lipid

nanoparticles: An efficient formulation approach for cerebral ischemic reperfusion

injury in rats. Eur J Pharm Biopharm (2013).

Page 51: University Institute of Pharmaceutical Sciences

41. Tiwari V, Chopra K. Resveratrol abrogates alcohol-induced cognitive deficits by

attenuating oxidative-nitrosative stress and inflammatory cascade in the adult rat

brain. Neurochem Int (2013) 62(6):861-9.

42. Kaur A, Jindal S, Kaur IP, Chopra K. Effect of sesamol on the pathophysiological

changes induced by surgical menopause in rodents. Climacteric 2012;15:1-12.

43. Tiwari V, Chopra K. Attenuation of oxidative stress, neuroinflammation, and

apoptosis by curcumin prevents cognitive deficits in rats postnatally exposed to

ethanol. Psychopharmacology (2012)224(4):519-35.

44. Tiwari V, Kuhad A, Chopra K. Neuroprotective effect of vitamin E isoforms

against chronic alcohol-induced peripheral neurotoxicity: possible involvement of

oxidative-nitrodative stress. Phytother Res (2012) 26(11):1738-45.

45. Tiwari V, Arora V, Chopra K. Attenuation of NF-κβ mediated apoptotic signaling

by tocotrienol ameliorates cognitive deficits in rats postnatally exposed to ethanol.

Neurochem Int (2012) 61(3):310-20.

46. Bharrhan S, Chopra K, Arora SK, Toor JS, Rishi P. Down-regulation of NF-κB

signalling by polyphenolic compounds prevents endotoxin-induced liver injury in

a rat model. Innate Immun. 2012 Feb;18(1):70-9. (IF- 3.283)

47. Singh PK, Chopra K, Kuhad A, Kaur IP. Role of Lactobacillus acidophilus loaded

floating beads in chronic fatigue syndrome: behavioral and biochemical evidences.

Neurogastroenterol Motil. 2012 (in press)

48. Pramod Kumar Singh, Indu Pal Kaur (2012), Synbiotic (probiotic and ginger

extract) loaded floating beads: a novel therapeutic option in an experimental

paradigm of gastric ulcer. Journal of Pharmacy and Pharmacology. 64(2), 207–

217.

49. Pramod Kumar singh, Parneet Kaur Deol and Indu Pal Kaur (2012). Entrapment

of Lactobacillus acidophilus in to alginate beads for the effective treatment of cold

restraint stress induced gastric ulcer. Food and Function. 3(1), 83-90.

50. Manoj Kumar Verma, Mandeep Singh, Vandita Kakkar, Indu Pal Kaur (accepted

for Publication), Applicability of a colorimetric method for evaluating

streptomycin sulphate loaded solid lipid nanoparticles. International jounal of

pharmacy and Pharmaceutical sciences (IJPPS).

51. Manoj Kumar Verma, Mandeep Singh, Vandita Kakkar, Indu Pal Kaur,

Applicability of a colorimetric method for evaluating streptomycin sulphate loaded

solid lipid nanoparticles. International Jounal of Pharmacy and Pharmaceutical

Sciences (IJPPS). 4(5), 50-53, 2012

52. Shilpa Kakkar, Indu Pal Kaur. A Novel Nanovesicular Carrier System To Deliver

Drugs Topically. Pharmaceutical Development and Technology, 18:673-85, 2013

Page 52: University Institute of Pharmaceutical Sciences

53. Vandita kakkar and Indu Pal Kaur. Preparation, characterization and scale-up of

sesamol loaded solid lipid nanoparticles, Nanotechnology Development, 2:e8,

2012

54. Vandita K, Shashi B, Santosh KG, Kaur, IP. Enhanced Apoptotic Effect of

Curcumin Loaded Solid Lipid Nanoparticles. Molecualr Pharmaceutics. Nov 6.

(Epub ahead of print), 2012

55. Bhandari, Rohit and Kaur, Indu Pal. A method to prepare solid lipid nanoparticles

with improved entrapment efficiency of hydrophilic drugs. Current nanoscience, 9,

DOI 10.2174/1573413711309020008, 2013.

56. Nidhi Aggarwal and Shishu Goindi. Preparation and in vivo evaluation of solid

lipid nanoparticles of griseofulvin for dermal use. Journal of Biomedical

Nanotechnology, Vol. 9, Page 1-13, 2012 (Publisher – American Scientific

Publishers; Impact Factor: 4.216).

57. Nidhi Aggarwal and Shishu Goindi. Preparation and evaluation of antifungal

efficacy of griseofulvin loaded deformable membrane vesicles in optimized guinea

pig model of Microsporum canis- Dermatophytosis. International Journal of

Pharmaceutics, Vol. 437, Page 277–287, 2012 (Publisher – Elsevier; Impact

Factor: 3.350).

58. Nidhi Aggarwal, Shishu Goindi and Swami Dass Mehta. Preparation and

evaluation of dermal delivery system of griseofulvin containing vitamin E-TPGS

as penetration enhancer. AAPS PharmSciTech., Vol. 13, Page 67–74, 2012

(Publisher – Springer; Impact Factor: 1.432).

59. Neeraj Kumar, Shishu, Varn Rishi Kapoor. Facile syntheses of novel salts of a

triazole antifungal agent with enhanced solubility. J Heterocycl Chem. (2012) DOI

10.1002/jhet.1120. (Publisher- wiley interscience; Impact Factor: 1.22)

60. Neeraj Kumar, Shishu, Gulshan Bansal, Sandeep Kumar, Asim Kumar Jana.

Ditosylate salt of itraconazole and dissolution enhancement using cyclodextrins.

AAPS PharmSciTech. (2012) Volume 13, 863-874. (Publisher – Springer; Impact

Factor: 1.432).

61. ANIL KUMAR and Preetinder Kaur and Puneet Rinwa. Evaluation of

morphological, phytochemical and physicochemical properties of Indian

Polyherbal formulation, chyawanprash for quality evaluation. Asian Journal of

Pharmaceutical Education and Research, 2012, 1(2), 121-140.

62. Puneet Rinwa and ANIL KUMAR. Piperine potentiates the protective effects of

curcumin against chronic unpredictable stress-induced cognitive impairment and

oxidative damage in mice. Brain Research, 2012, 1488, 38-50.

63. ANIL KUMAR, Preetinder Kaur, Puneet Rinwa. Comparative study of various

marketed brands of Indian chywanprash for their anti-anxiety and antioxidant

potential. Int J Pharmaceu Res Bio-Sci, 2012, 1(4), 296-310.

Page 53: University Institute of Pharmaceutical Sciences

64. ANIL KUMAR, Aditi Vashist, Puneet Kumar, Harikesh Kalonia, Jitendriya

Mishra. Protective effect of HMG CoA reductase inhibitors against running wheel

activity induced fatigue, anxiety like behaviour, oxidative stress and mitochondrial

dysfunction in mice. Pharmacological Report 2012;64(6):1326-36.

65. ANIL KUMAR, Aditi Vashist, Puneet Kumar, Harikesh Kalonia, Jitendriya

Mishra. Potential role of licofelone, minocycline and their combination against

chronic fatigue stress (CFS) induced behavioral, biochemical and mitochondrial

alterations in mice. Pharmacological Report 2012 Sep;64(5):1105-15.

66. Anil Kumar, Neha Sharma; Amit Gupta; Harikesh Kalonia; Jitendriya Mishra.

Neuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase

inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson-like

symptoms. Brain Research 2012,47, 13-22.

67. ANIL KUMAR, Gurleen Kaur, Harikesh Kalonia and Puneet Rinwa. Melatonin

potentiates the protective effect of Buspirone against Sleep Deprivation induced

Anxiety like Behavior: Possible Serotonergic Mechanism. International Journal of

Research and Development in Pharmacy & Life Sciences, 2012, Vol 2, (1), 225-

234.

68. Puneet Kumar, Harikesh Kalonia, ANIL KUMAR Possible GABAergic

mechanism in the neuroprotective effect of gabapentin and lamotrigine against 3-

nitropropionic acid induced neurotoxicity. EJP, 2012, 674,265-274.

69. Harikesh Kalonia, Jitendriya Mishra, Anil Kumar, Targeting Neuro-Inflammatory

Cytokines and Oxidative Stress by Minocycline Attenuates Quinolinic-Acid-

Induced Huntington's Disease-Like Symptoms in Rats, Neurotoxicity Research,

2012, DOI 10.1007/s12640-012-9315-x (Article in press).

70. Ranju Bansal, Anika Guleria, P. C. Acharya, FT-IR Method Development and

Validation for Quantitative Estimation of Zidovudine in Bulk and Tablet Dosage

Form, Drug Research, 2013, 63, 1 DOI: DrugRes/ 2012-10-0173/ 11.2.2013

71. Ranju Bansal, Dinesh Kumar, Deepika Sharma, Carmen Calle, and Rosalia

Carron, Synthesis and Pharmacological Evaluation of 6-Arylpyridazinones as

Potent Vasorelaxants, Drug Development Research, 2013, DOI:

10.1002/ddr.21079

72. Ranju Bansal, Gourav Narang, Carmen Calle, Rosallia Carron, K. Pemberton,

Alan L. Harvey. Synthesis of 4-(carbonyloxyphenyl)-1,4-dihydropyridines as

Potential Antihypertensive Agents. Drug Development Research 2013, 74, 50.

73. Ranju Bansal, Sheetal Guleria, Sridhar Thota, R. W. Hartmann, C. Zimmer.

Synthesis of Imidazole-Derived Steroidal Hybrids as Potent Aromatase Inhibitors.

Medicinal Chemistry Research 2012, 22, 692-698.

74. Ranju Bansal, Sridhar Thota, N. Karkra, Maninder Minu, C. Zimmer, R.W.

Hartmann. Synthesis and Aromatase Inhibitory Activity of Some New 16E-

Arylidenosteroids. Bioorganic Chemistry, 2012, 45, 36-40.

Page 54: University Institute of Pharmaceutical Sciences

75. Ranju Bansal, Puneet Chauhan, R. Sharma. Synthesis and anticonvulsant activity

of O-Alkylated Derivatives of 1-(2-Naphthyl)-2-(Imidazol-1-Yl)Ethanone Oxime.

Arzneimittel-Forschung/Drug Research 2012, 62, 420-424.

76. A. G. Anitha, R. Hema, Ranju Bansal, Sridhar Thota, S. R. Begum. 16α,17α-

Epoxy-17β-(1H-imidazol-1-yl)androst-4-en-3-one monohydrate. Acta

Crystalographica 2012. E68, o2345.

77. Ranju Bansal, Pratap Chandra Acharya „Synthesis and antileukemic activity of

16E- [4-(2-carboxy)ethoxybenzylidene]-androstene amides‟ Steroids 2012 DOI:

10.1016/j.steroids.2012.01.020

78. Ranju Bansal , Sheetal Guleria, Sridhar Thota, Subhash L. Bodhankar, Moreshwar

R. Patwardhan, Christina Zimmer, Rolf W. Hartmann, Alan L. Harvey „Design,

synthesis and evaluation of novel 16-imidazolyl substituted steroidal derivatives

possessing potent diversified pharmacological properties‟ Steroids 2012.

79. Arora, P., Nanda, A. and Karan, M. (2012). A glance on dandruff. Research

Journal of Topical and Cosmetic Sciences; 3 (1). Accepted.

80. Karan, M., Chadha, K., Chadha, R. and Saini, A. (2012). Cocrystal of caffeine with

propionic acid: Preliminary characterization and stability evaluation. Journal of

Pharmacy Research. Accepted.

81. Alka Bali, Ruchika Ohri, Pran Kishore Deb „Synthesis, evaluation and docking

studies on 3-alkoxy-4-methanesulfonamidoacetophenone derivatives as non

ulcerogenic anti-inflammatory agents‟, European Journal of Medicinal Chemistry,

2012, 49, 397-405.

82. Alka Bali, Abhishek Bhalla, Suman Bala and Rajesh Kumar „Synthesis and

computational studies on aryloxypropyl piperazine derivatives as potential atypical

antipsychotic agents‟, Letters in Drug Design and Discovery, 2012, 9(2), 218-224.

83. Kumar B, Arora V, Kuhad A, Chopra K. Vaccinium myrtillus ameliorates

unpredictable chronic mild stress induced depression: possible involvement of

nitric oxide pathway. Phytother Res. 2012;26(4):488-97.

84. Tiwari V, Kuhad A, Chopra K. Neuroprotective effect of vitamin E isoforms

against chronic alcohol-induced peripheral neurotoxicity: possible involvement of

oxidative-nitrodative stress. Phytother Res. 2012;26(11):1738-45.

85. Singh PK, Chopra K, Kuhad A, Kaur IP. Role of Lactobacillus acidophilus loaded

floating beads in chronic fatigue syndrome: behavioral and biochemical evidences.

Neurogastroenterol Motil. 2012;24(4):366-e170.

86. Neelima Dhingra, T.R. Bhardwaj, K.L.Bedi and Manoj Kumar, 17-Hydroximino

Steroids with enhanced cytotoxicity against liver and neuroblastmna cancer cells”,

Biomedicine: 2012; 32(2):169 – 174

Page 55: University Institute of Pharmaceutical Sciences

87. Kritika Mittal, Jai Malik, Vinod Gauttam “Development of HPTLC Method for

Quantitative Estimation of Geraniol in Volatile Oil of Pelargonium Graveolens”

International Journal of Research in Ayurveda and Pharmacy (2012) 2:24-30.

88. Manoj Kumar Verma , Mandeep Singh, Vandita kakkar Indu Pal Kaur*

Applicability of a colorimetric method for evaluating streptomycin sulphate loaded

solid lipid nanoparticles .(2012) International journal of Pharmacy and

Pharmaceutical Sciences (accepted)

89. Vandita Kakkar and Indu Pal Kaur. Preparation and characterization of sesamol

loaded solid lipid nanoparticles. (2012) Nanotechnology Development,

doi:10.4081/nd.2012.e8

Enhanced Anticancer Potential of Encapsulated Solid Lipid Nanoparticles of TPD:

A Novel Triterpenediol from Boswellia serrata

90. Shashi Bhushan,*,† Vandita Kakkar,‡ Harish Chandra Pal,§ Santosh Kumar

Guru,† Ajay Kumar,† D. M. Mondhe,† P. R. Sharma,† Subhash Chandra Taneja,†

Indu Pal Kaur,‡ Jaswant Singh,† and A. K. Saxena†

91. Joshi T, Sah SP, Singh A. (2012). Antistress activity of ethanolic extract of

Asparagus racemosus Willd roots in mice. Indian Journal of Experimental

Biology, 50(6):419-24.

92. Savita Pandey, Sangeeta P. Sah, Anita Singh (2012). Nephroprotective potential of

Urtica parviflora Roxb. against paracetamol induced nephrotoxicity in rats.

2(4):316-322.

2013

1. Bhatia A., Singh B., Raza K., Wadhwa S. and Katare O.P., Tamoxifen-loaded

Lecithin Organogel (LO) for Topical Application: Development, Optimization and

Characterization. International Journal of Pharmaceutics, 2013,

doi:10.1016/j.ijpharm.2013.01.029.

2. Raza K., Singh B., Singal P., Wadhwa S. and Katare O.P.., Systematically

optimized biocompatible isotretinoin-loaded solid lipid nanoparticles (SLNs) for

topical treatment of acne. Colloids and Surfaces B: Biointerfaces, 105C, 67-74,

2013.

3. Raza K., Singh B., Singla N., Negi P., Singal P. and Katare O. P., Nano-Lipoidal

Carriers of Isotretinoin with Anti-aging Potential: Formulation, Characterization

and Biochemical Evaluation, Journal of Drug Targeting (Informa Health Care,

USA), Accepted for Publication, 2013, doi:10.3109/1061186X.2012.761224.

4. Bhatia A., Singh B., Raza K., Wadhwa S. and Katare O.P., Tamoxifen-loaded

Lecithin Organogel (LO) for Topical Application: Development, Optimization and

Page 56: University Institute of Pharmaceutical Sciences

Characterization. International Journal of Pharmaceutics, 2013,

doi:10.1016/j.ijpharm.2013.01.029.

5. "Stability Indicating HPTLC method for the determination of Pregabalin in Bulk

and Pharmaceutical dosage forms" . Jaswant, Kumar R V, Sinha, V R. Accepted

in Indian Journal of Analytical chemistry, 2013

6. K. Raza, O.P. Katare, A. Setia, A. Bhatia and Bhupinder Singh, Improved

Therapeutic Performance of Dithranol against Psoriasis employing Systematically

Optimized Nano-Emulsomes, Journal of Microencapsulation, 2013, 30(3), 225-36.

7. K Raza, Bhupinder Singh, N. Singla, P. Negi, P. Singal and O.P. Katare, Nano-

Lipoidal Carriers of Isotretinoin with Anti-aging Potential: Formulation,

Characterization and Biochemical Evaluation, Journal of Drug Targeting, 2013,

21(5), 435-442.

8. K. Raza, Bhupinder Singh, P. Singal, S. Wadhwa and O. P. Katare, Systematically

Optimized Biocompatible Isotretinoin-Loaded Solid Lipid Nanoparticles (SLNs)

for Topical Treatment of Acne, Colloids and Surfaces B: Biointerfaces, 2013, 105,

67-74.

9. Y Paul, Parina, A Singla, Bhupinder Singh, In Silico Quantitative Structure

Pharmacokinetic Relationship Modeling on Antidiabetic Drugs: Half-Life,

International Journal of Chemical Sciences, 2013, 11(1), 177-185.

10. A. Bhatia, Bhupinder Singh, S. Wadhwa, K. Raza and O.P. Katare, Novel

phospholipid-based topical formulations of tamoxifen: Evaluation for antipsoriatic

activity using mouse-tail model, Pharmaceutical Development and Technology,

Posted online on January 2013, DOI:10.3109/10837450.2013.763260.

11. A. Bhatia, Bhupinder Singh, K. Raza, S. Wadhwa and O.P. Katare, Tamoxifen-

loaded Lecithin Organogel (LO) for Topical Application: Development,

Optimization and Characterization. International Journal of Pharmaceutics. 2013,

444 (1-2), 47-59.

12. K. Raza, Bhupinder Singh, S. Singla, S. Wadhwa, B. Garg, S. Chibber and O. P.

Katare, Nanocolloidal Carriers of Isotretinoin: Antimicrobial Activity against

Propionibacterium acnes and Dermatokinetic Modeling. Molecular Pharmaceutics.

2013, 10(5), 1958-1963.

13. Renu Chadha, Anupam Saini, Sadhika Khullar, Dharamvir Singh Jain, Sanjay K

Mandal and T N Guru Row. Crystal Structures and Physicochemical Properties of

Four New Lamotrigine Multicomponent Forms. Crystal Growth & Design. 13 (2),

858-870, 2013.

14. Renu Chadha, Dharamvir Singh Jain, Poonam Arora, Rekha Chhikara and Swati

Bhandari. Characterization, quantification and stability of differently prepared

amorphous forms of some oral hypoglycaemic agents. Pharmaceutical

Development and Technology. 2013, 18(2), 504-514.

Page 57: University Institute of Pharmaceutical Sciences

15. Rohit Bhandari, Indu Pal Kaur. Pharmacokinetics, tissue distribution and relative

bioavailability of isoniazid-solid lipid nanoparticles. International Journal of

Pharmaceutics. 441:202-212, 2013

16. Harinder Singh, Rohit Bhandari, Indu Pal Kaur. Encapsulation of Rifampicin in a

Solid Lipid Nanoparticulate System to limit its Degradation and Interaction with

Isoniazid at Acidic pH. International Journal of Pharmaceutics 446:106-11, 2013

17. Vandita Kakkar, Anil K Mishra, Krishna Chuttani, Indu Pal Kaur. Proof of

Concept Studies to Confirm the Delivery of Curcumin Loaded Solid Lipid

Nanoparticles (C-Slns) to Brain. International Journal of Pharmaceutics,

doi.org/10.1016/j.ijpharm.2013.03.046, 2013

18. Vandita Kakkar, Sravan Kumar Muppu, Kanwaljit Chopra, Indu Pal Kaur.

Curcumin loaded solid lipid nanoparticles: An efficient formulation approach for

cerebral ischemic reperfusion injury in rats. European Journal of Pharmaceutics

and Biopharmaceutics. doi: 10.1016/j.ejpb.2013.02.005, 2013

19. Bhushan S, Kakkar V, Pal HC, Guru SK, Kumar A, Mondhe DM, Sharma PR,

Taneja SC, Kaur IP, Singh J, Saxena AK. Enhanced Anticancer Potential of

Encapsulated Solid Lipid Nanoparticles of TPD: A Novel Triterpenediol from

Boswellia serrata. Molecular Pharmaceutics, 10(1):225-35, 2013.

20. Nidhi Aggarwal, Shishu Goindi and Ranjit Khurana. Formulation, characterization

and evaluation of an optimized microemulsion formulation of griseofulvin for

topical application. Colloids and Surfaces B: Biointerfaces, Vol. 105, Page 158–

166, 2013 (Publisher – Elsevier; Impact Factor: 3.456).

21. Neeraj Kumar, Shishu, Gulshan Bansal, Sandeep Kumar, Asim Kumar Jana.

Preparation and cyclodextrin assisted dissolution rate enhancement of

itraconazolium dinitrate salt. Drug Devel. Ind. Pharm. (2013) Volume 39, 342-345.

22. Varun Rishi Kapoor, Shishu. A novel validation hptlc method for the quantitative

determination of clofazimine, Int J Pharm Bio Sci (2013) Apr; 4(2): (P) 819 – 828.

(Impact Factor: 0.47).

23. Neeraj Kumar , Shishu Goindi, Sandeep Kumar Asim Kumar Jana The Effect of

N-Alkyl Substituents on the Usability of Imidazolium Cation-Based Ionic Liquids

in Microemulsion Systems: A Technical Note, AAPS PharmSciTech. (2013) DOI:

10.1208/s12249-013-9939-z, (Publisher – Springer; Impact Factor: 1.432).

24. Puneet Rinwa, Sukant Garg, Anil Kumar. Suppression of neuroinflammatory and

apoptotic signaling cascade by curcumin alone and in combination with piperine in

rat model of olfactory bulbectomy induced depression. PLOS, 2013, 8(4), e61052,

1-11.

25. Anil Kumar, Neha Sharma, Jitendriya Mishra and Harikesh Kalonia. Synergistical

neuroprotection of rofecoxib and statins against malonic acid induced Huntington's

disease like symptoms and related cognitive dysfunction in rats. Eur J Pharmacol

2013,709,1-12.

Page 58: University Institute of Pharmaceutical Sciences

26. Anil Kumar, Gurleen Kaur, Harikesh Kalonia and Puneet Rinwa. Sesamol exhibits

synergism with buspirone against immobilization stress induced anxiety like

behavior and oxidative stress. Indian J Pharmacology 2013, 45(1), 49-53.

27. Kakkar Vandita, Bhushan Shashi., Kumar Santosh Guru ., Kaur Indu Pal ( 2013)

Enhanced apoptotic effect of curcumin loaded solid lipid nanoparticles (C-SLNS),

Molecular Pharmaceutics

28. Proof of concept studies to confirm the delivery of curcumin loaded solid lipid

nanoparticles (2013)

29. Vandita Kakkar, Anil Kumar Mishra , Krishna Chuttani, and Indu Pal Kaur:

Curcumin loaded solid lipid nanoparticles: an efficient formulation approach for

cerebral ischemic reperfusion injury in rats (In Press)

30. Jai Malik, Munish Kumar, Rahul Deshmukh “Ameliorating effect of lyophilized

extract of Butea frondosa (leaves) on scopolamine induced amnesia in rats‟‟

Pharmaceutical Biology (2013) 51:233-239.

31. Aarti Khulbe, Savita Pandey, Sangeeta Pilkhwal Sah. Antidepressant-like action of

the hydromethanolic flower extract of Tagetes erecta L. in mice and its possible

mechanism of action, Indian Journal of Pharmacology. Article in press.

*The list may contains multiple in single publication

23. Details of patents and income generated PatentsGranted

1. Katare O. P., Kumar B and Agarwal R. A Novel Inter and Intra Multilamellar Vesicular Composition, Australian Patent No. 2006225991 dated 06 May 2010.

2. Sinha V.R. A process of preparing a directly compressible delayed release matrix formulations of aceclofenac and product thereof” by Govt. of India, Patent No. 238193/ 25.1.2010

3. RanjuBansal, SheetalGuleria, GauravNarang and Rolf W Hartmann, “Novel series of

imidazolyl substituted steroidal and indan-1-one derivatives” China Patent no.

200680036698.X dated 12.08.2010

4. RanjuBansal, SheetalGuleria, GauravNarang and Rolf W Hartmann, “Novel series of

imidazolyl substituted steroidal and indan-1-one derivatives” European Patent no.

06795447.9-1211 PCT/IB2006002471

5. RanjuBansal, SheetalGuleria, GauravNarang and Rolf W Hartmann, “Novel series of

imidazolyl substituted steroidal and indan-1-one derivatives” US Patent no. IPC8 Class:

AA61K3158FI USPC Class: 514176

6. O. P. Katare, R. Kumar, Bhupinder Singh, S. Dogra, and I. Kaur, “A multi-compartmental

liposomal system for topical drug delivery”. Indian Patent, The Patent Office Journal, Editor. 2009: Kolkata (India). p. 6210(filed in September 2005, Application No. 2514/DEL/2005).

Page 59: University Institute of Pharmaceutical Sciences

7. O. P. Katare, R. Kumar, Bhupinder Singh, S. Dogra, and I. Kaur, “Cyclosporinorganogel systems for topical delivery, method of preparation and pharmaceutical compositions, which contains them”, Indian Patent, The Patent Office Journal, 2009: Kolkata (India). p. 6211 (filed in September 2005, Application No. 2515/DEL/2005).

8. Bhupinder Singh, R. Kumar, G. Bakshi, B. Jain, and O. P. Katare, “Topical pharmaceutical

compositions of finasteride for dermatological applications”. Indian Patent, filed in September 2007, Application No. 1903/DEL/2007

9. 8207222,T.R.Bhardwaj, Manoj Kumar, Neeraj Mehta, NeelimaDhingraa, Nitric oxide releasing derivatives of paracetamol

10. US PATENT 8435975: Novel Steroidal Esters of 17-oximino-5-androsten-3-ol. (Granted

in May 2013) to Dr. NeelimaDhingra

11. RanjuBansal, SheetalGuleria, GauravNarang and Rolf W Hartmann, “Novel series of

imidazolyl substituted steroidal and indan-1-one derivatives” China Patent no.

200680036698.X dated 12.08.2010

Filed

1. A Novel Inter and Intra Multilamellar Vesicular Composition, Australian Patent Number 2006225991 (06th May, 2010) (Prof O. P. Katare)

2. A Novel Inter and Intra Multilamellar Vesicular Composition, Chinese Patent Granted (March, 2010) (Prof O. P. Katare)

3. Rao A.R., New Thienopyridines as Pharmacologically active Agents through DST (TIFAC) [Provisional patent application], PCT Request No. PCT/IN/2010/000004 Dated 04/01/2010.

4. Rao A.R., Novel SustitutedQuinazolines as Antibacterial and Cytotoxic agents, Appl. No. 400/Del/2009, dated 03/03/2009.

5. Indu Pal Kaur, GautamBakshi, Pramod Kumar Singh. Probiotic Containing Triforked

Pharmaceutical Compositions with DCGI (3052/DEL/2010, dated 21/12/2010)

6. Karan M, Vasisht K and Verma M. Novel polyherbal composition for prevention and treatment of inflammation and arthritis. Indian patent application no. 1651/DEL/2012.

7. Vasisht K, Karan M and Dhobi M. Novel compounds as memory enhancers. Indian patent application no. 1650/DEL/2012.

8. Shukla A., Bhupinder Singh., Katare O.P and Vyas S.P. Surface-modified bile-salt stabilized non-ionic surfactant nano-vesicles for oral delivery of bioactives. Indian patent application no. 1564/DEL/2012

Page 60: University Institute of Pharmaceutical Sciences

9. Sinha V.R. and GhaiDamanjit Novel nanoemulsion/self-nanoemulsifying drug delivery system for enhanced oral bioavailability of hydrophobic selective β1-adrenoreceptor blocker”. Indian patent application no 1436/DEL/2012

10. Sinha V.R. and GhaiDamanjit Novel Nanoemulsion/self nanoemulsifying drug delivery system for enhanced oral bioavailability of muscle relaxant. Indian patent application no 3903/DEL/2012

11. Sinha V.R. and KaurRamanpreet Validated HPTLC and stability indicating HPLC method for prasugrel hydrochloride. Indian patent application no 2852/DEL/2012

12. Vasisht, K., Karan, M. and Dhobi, M. Novel compounds as memory enhancers. PCT application no. PCT/IN2013/000345. Dated 03.06.2013)

24. Areas of consultancy and income generated

DETAIL OF VARIOUS PROJECTS CONSULTANCY

FOR THE SESSION 2009-2010

Sr.No Name of the

Researcher

Description Sponsoring Agency Amount

1 Prof O.P.

Katare, UIPS

1) Development of some

Novel Formulations of

Isotretinoin, Etodolac,

Methotrexate

2) Development of Novel

Formulation –Acylovir and

EMLa

M/S IPCA

Laboratories Ltd.

1200000

420000

2 1. Prof

B.S.Bhoop,

UIPS

2. Prof Bimla

Nehru

Screening and Formulation

development of Novel

Phytochemical Drugs for

Various CNS Disorders

Advance

Physiotherapies Pvt.

400000

3 Prof A.R.Rao

UIPS

Transfer of technology M/s Sanative

Therapeutics Pvt.

Ltd.

400000

Page 61: University Institute of Pharmaceutical Sciences

2010-2011

S.No Name of the

Researcher

Description Sponsoring

Agency

Amount

1 DrKanwaljit Chopra,

UIPS

Anti diabetic activity of

Fenugreek Extract

M/S Chemical

Resources,

Panchkula,

210100

2 Prof A.R. Rao, UIPS Aromatase inhibitors

and adenosine kinase

inhibitors

M/S Sanative

Therapeutics Pvt.

Ltd

138650

3 DrIndu Pal Kaur

,UIPS

Genotoxicity studies on

impurities of Active

Pharmaceutical

Ingredients

M/s

JubiliantOrganosys

Ltd., Noida

327034

13 Prof O.P. Katare,

UIPS

Development and scale

up of liposomal

preparation”

M/S Lifecare

Innovation,

Gurgaon

377880

2011-2012

Sr.No Name of

Institution

Description Sponsoring Agency Amou

nt

1 Prof O.P. Katare,

UIPS

Royalty M/S Lifecare

Innovation Pvt.Ltd,

Gurgaon

38427

2 Prof. Karan

Vashisht, UIPS

Analysis of plant

samples

M/S Chemical

Resources

19742

4

3 DrIndu Pal Kaur

,UIPS

Gentoxicity studies on

impurities of Active

Pharmaceutical

Ingredients

M/s

JubiliantOrganosys

Ltd., Noida 38500

4 Prof V.R. Sinha,

UIPS

Development of

formulation and NDDS

M/S Cachet

Pharmaceuticals

Pvt.Ltd,Baddi

15000

0

5 Prof. Kanwaljit

Chopra, UIPS

Evaluation of

Goniflex® in Arthritis

& Diabetes

M/S Dozo

Laboratories Ltd. 35000

0

Page 62: University Institute of Pharmaceutical Sciences

2012-2013

Sr.No Name of the

Researcher

Description Sponsoring

Agency

Amount

1 Dr. Indu Pal Kaur,UIPS. To develop a formula

for a medical paste”

M/S Medical

System,

Chandigarh

144383

2 Dr. Kanwaljit Chopra Evaluation of

Goneflex in Arthritis

&Diabetes

Dr. DOZO

Laboratories

503016

25. Faculty selected nationally / internationally to visit other laboratories / institutions /

industries in India and abroad Professor V.R. Sinha

Professor O.P. Katare

Professor B.S. Bhoop

Professor Manoj Kumar

Professor Anil Kumar

Professor RanjuBansal

Professor PoonamPiplani

Dr.AnuragKuhad

26. Faculty serving in

a) National committees: Professor Karan Vasisht& Professor B.S. Bhoop

b) International committees: Professor B.S. Bhoop

c) Editorial Boards : All Professors of UIPS

d) d) any other (please specify)

27. Faculty recharging strategies (UGC, ASC, Refresher / orientation programs, workshops,

training programs and similar programs).

Dr.AnuragKuhad

Dr.NeelimaDhingra

Dr.Ashwani Kumar

Dr. Jai Malik

Dr.Vandita

Dr.AmitaSarwal

Dr.SangeetaPilkhwalSah

28. Student projects

• percentage of students who have done in-house projects including inter-departmental projects: 10%

• percentage of students doing projects in collaboration with other universities / industry / institute:5%

Page 63: University Institute of Pharmaceutical Sciences

29. Awards / recognitions received at the national and international level by

• Faculty : All Faculty Members

Awards &Honours2009-2013

Professor Karan Vasisht

1. Discovered one new skeleton from natural source and four new molecules from a

natural source in the year 2012-13.

2. Appointed as a Coordinator for UGC Networking Resource Centre at University

Institute of Pharmaceutical Sciences, Panjab University, Chandigarhin the year

2011.

Professor O.P. Katare

1. Received Best Patent Award - Prof. S. P. THYAGARAJAN - Prof. S.

RAJARAJAN Endowment Award 2012, by IABMS Society at 33rd

Annual

Conference of Indian Association of Biomedical Scientists, 22nd

Nov 2012.

2. Award of Honour for Scientific Innovations, by Panjab University in association

with Panjab State Council for Science and Technology on IPR Day, 26th

April

2013

3. Chaired Scientific Session on “Pharm. D.” at 62nd

Indian

PharmaceuticalCongress, Manipal, December 17-19, 2010.

4. Received Dr. R. K. Upadhyaya National Teacher Excellence Award by IES

group of Institutions, Bhopal, Distinguished Alumnus Award by Panjab

University Alumni Association, Panjab University‟ Illustrious Alumni Award

(Dr. H. S. GourVishwaVidyalaya, Sagar) .

5. Two time Felicitation by Panjab University Syndicate for being appointed as an

International Expert and for Technology Award.

SPECIAL ACHIEVEMENTS

1. LIPOTARTM: Novel Lipid-based Topical Drug Delivery Product of Coal Tar

(LIPOTARTM) has been successfully developed in 2010 and the product has

been transferredto M/s. Lifecare Innovations Pvt. Ltd., Gurgaon, Haryana, India.

This product/invention is duly tested on human subjects at PGIMER,

Chandigarh.

Professor V.R. Sinha

1. Honorary Director, Central Placement Cell, Panjab University, Chandigarh.

3rd

Dec.2008 to 3rd

Feb. 2009.

2. Programme Coordinator MBA (Pharmaceutical Management), University

Institute of Pharmaceutical Sciences (UIAMS), Panjab University, Chandigarh.

Page 64: University Institute of Pharmaceutical Sciences

3. Member of Evaluation Committee of National Board of Accreditation (NBA) for

Pharmacy College, New Delhi, Member of Board of Studies, Dept. of

Pharmaceutical Sciences, Punjabi University Patiala, Dept. of Pharmaceutics, IT,

BHU, Banaras, PTU, Punjab and member of Selection Committee of Faculty

position, NIPER,

Mohali

4. Award of Honour for scientific Innovation by CIIP, Panjab University

Chandigarh (April 2013)

Professor B.S. Bhoop

1. Awarded exalted status ofDEAN OF ALUMNI AFFAIRS, Panjab University

w.e.f. February 2008 to August 2008; September 2008 to June 2009; July 2009 to

June 2010; July 2010 onwards. (Ranked Sixth in Hierarchy of Panjab University

Officials)

2. Declared as PHARMA PERSONALITY OF THE YEAR 2008-09: Leading

Educator of Pharma World by Pharma Buzz, Ind Swift Communications Ltd.,

July 2009.

3. Awarded “BEST CITIZENS OF INDIA AWARD” in recognition to exceptional

caliber in Pharmaceutical Sciences and outstanding performance in various

humanitarian activities, International Publishing House, New Delhi, January

2009.

4. Appointed asCOORDINATOR, FIRST AUTUMN SCHOOL for Training the

Chosen Mid-Level Faculty from Indian Pharmacy Institutions on, “Newer

Paradigms in Pharmaceutics and Biopharmaceutics”, Sponsored by UGC

Networking Resource Center, UIPS, Panjab University, Chandigarh, October 25-

30, 2010.

5. Appointed as Coordinator, OCET (Pharmaceutical) Examinations for Ph. D.

Entrance in Pharmaceutical Sciences, Panjab University, Chandigarh, 2010.

6. Appointed as Coordinator, Ph. D. Entrance in Pharmaceutical Sciences, Punjab

Technical University, Jalandhar, 2010.

7. Awarded “India Excellence Inscribed Medal”, American Biographical Institute

Inc.,USA, May 2010.

8. Awarded “International Peace Prize”, United Cultural Convention, USA, Jan.

2010.

9. ScienceDirect, the largest online collections of published scientific research in

the world, declared one of the Research Articles, published in “European Journal

of Pharmaceutics and Biopharmaceutics” in 2007 with Impact Factor of 3.928, as

SECOND amongst “TOP 25 HOTTEST ARTICLES” under “Pharmacology,

Toxicology and Pharmaceutical Sciences”.

Page 65: University Institute of Pharmaceutical Sciences

10. Guided A1 course under UGC Networking School on Drug Delivery

Optimization, Bioenhanced Drug Delivery and Nanoparticulate systems

(Gurinder Singh, Al Ameen College of Pharmacy, Bangalore)

11. Biographic profile included in Marquis Who‟s Who in Medicine and Health

Care, USA, 6th Edition, June 2006 onwards.

12. Biographic profile included in Marquis Who‟s Who in Asia, USA, 1st Edition,

August 2007 onwards.

13. Biographic profile included in Asia/Pacific Who‟s Who by Rifacimento

International, Volume X, May 2010.

14. Adjudged as Personality of the Month by Pharma Buzz, Ind Swift

Communications Ltd., February 2009.

15. Group Leader, Centre with Potential for Excellence in a Particular Area

(CPEPA) on “Nanomaterials, Nanoparticles and Nanocomposites”, for UGC

Proposal and Presentation on behalf of Panjab University, Chandigarh, 2011.

16. Chosen as Organizing Secretary of Science Day &3rd Chandigarh Science

Congress (CHASCON) Celebrations and Convener, Souvenir Committee, Panjab

University Chandigarh, 26-28 February 2009.

17. Appointed as Sectional President, Pharmaceutical & Medical Sciences,

5th

Chandigarh Science Congress (CHASCON), Panjab University Chandigarh,

26-28 February 2011.

18. Received PHARMA QbD EXCELLENCE AWARD” in recognition to

unparalleled contributions in the domain of QbD-based product development

using Formulation by Design (FbD), by Convention on Pharmaceutical

Ingredients (CPhI), Ahmedabad, 25 September 2012.

19. QbD and PRODUCT PERFORMANCE AWARD” by American Association of

Pharmaceutical Scientists (AAPS) in recognition to one of our research works in

the domain of “Drug Delivery Development using Quality by Design (QbD)”,

Chicago, USA, October 2012

UNIVERSITY SYNDICATE FELICITATIONSON ACCOMPLISHMENTS:

Syndicate, the highest temporal body of Panjab University felicitated me for:

20. Research Article declared as SECOND amongst “TOP 25 HOTTEST

ARTICLES” by ScienceDirect, June 2010.

21. Industry-Institute MoU signed with Avance Pharmaceuticals Ltd,February 2010.

22. “BEST PAPER” AWARDS bagged by the Research work presented at 17

National/International Conferences

Page 66: University Institute of Pharmaceutical Sciences

23. Silver Jubilee 25th

IPGA Conference on Challenges and Opportunities for

Pharmacy Graduates, I.S.F. College of Pharmacy, Moga, Punjab, 7-8 Nov. 2009.

24. 30thAnnual Conference of Indian Association of Biomedical Scientists

(IABMS), Defence Institute of High Altitude Research (DIEHAR), Jointly

organized by DRDO, DBT, DST and AICTE, Chandigarh, Both for Oral &

Poster presentations, 20 November 2009.

25. 9thAnnual Conference of Society of Pharmacovigilance: Quality and Safety of

Drugs, Sirsa, Haryana, 22-24 November 2009.

26. 13thPunjab Science Congress on Climate Change, Chandigarh, 7-9 March 2010.

27. 35thAnnual Conference of Environmental Mutagen Society of India

(EMSI), and an International Symposium on 12-14 March, 2010.

28. Int. Conference on Polymer Science and Engineering (PSE): Emerging

Dimensions (PSE-2010), Asian Polymer Association (APA), Panjab University,

Chandigarh, 26-27 November, 2010.

29. UGC Sponsored National Symposium on Molecular Pathogenesis of

Neurodegenerative Diseases, Panjab University, Chandigarh, 22 February 2011.

30. 5th Chandigarh Science Congress (CHASCON 2011), Chandigarh, 26-28

February 2011.

31.

CHIEF GUEST, IMPORTANT NATIONAL/ REGIONAL FORUMS

32. Foundation Day function, Alliance Institute of Advanced Pharmaceutical &

Health Sciences, in collaboration with University of Pacific, Stockton, USA, and

Jawaharlal Nehru Technological University, Hyderabad, 2 March 2010.

33. IPA National Pharmacy Week Function, Akal Pharmacy College, Mastuana,

Sangrur, Punjab, 27 November 2009.

34. National Seminar on “Pharmacokinetic and Pharmacodynamic Modeling:

Concepts and Applications”, Valedictory function,Smriti College of

Pharmaceutical Education (SCOPE), Indore (MP), 1-2 August 2009.

GUEST OF HONOR, KEY NATIONAL/ REGIONAL FORUMS

35. National Pharma Fest 2010: Safe Usage of Drugs, Department of Pharmaceutical

Sciences and Drug Research, Punjabi University, Patiala, Punjab, 7 October

2010.

36. Guest of Honor, Vimarsh-2010: First International Student Academic

Convention on “Higher Education in the Era of Globalisation: Students‟

Page 67: University Institute of Pharmaceutical Sciences

Perspective”, A Convention for Students and Experts in Academia, Business and

Government, Panjab University, Chandigarh, 23 February 2010, Adjudged Best

Posters.

Professor Indu Pal Kaur

1. Organising Secretary of XXXVth Annual Conference of Environmental Mutagen

Society of India (EMSI) & International Symposium on “Mutagens and Genetic

Diversity for Health and Agriculture” held at Panjab University, Chandigarh,

India from March 12-14, 2010.

Research work well recognised by best paper awards presented at various

National/International conferences

2. Won the “Dr P. D. Sethi Annual Award for Best Paper in Pharmaceutical

Analysis” 2010 for a research paper titled „Pharmacokinetic Applicability of a

Validated LC/MS/MS Method for Orally AdminsteredCurcumin Loaded Solid

Lipid Nanoparticles‟.

3. A research paper titled, “Development of Antioxidant Molecules as Anticancer

Agents: A Journey from Identifying the Biological Activity to Developing an

Effective Delivery System” presented at XXXVth Annual Conference of

Environmental Mutagen Society of India (EMSI) &International Symposium on

“Mutagens and Genetic Diversity for Health and Agriculture” held at Panjab

University, Chandigarh, India from March 12-14, 2010, received best oral

presentation award

4. A research paper titled, “Sesamol Loaded Floating Beads: A Therapeutic Option

for Treatment of Gastric Cancer” presented at XXXVth Annual Conference of

Environmental Mutagen Society of India (EMSI) &International Symposium on

“Mutagens and Genetic Diversity for Health and Agriculture” held at Panjab

University, Chandigarh, India from March 12-14, 2010, received best paper

Award.

5. Young Investigator award to the student co-author based on the abstract of the

research work entitled, “Role of A Novel Carrier System of

PolyphenolicLignanSesamol in Menopause Related Biochemical And Behavioral

Paradigms” submitted for the 4th International Conference on Polyphenols and

Health (ICPH2009) held at Yorkshire, UK from 7-10 December, 2009.

6. A research paper titled “Development of a Topical Nanoelastic Vesicular System

Targeting the Posterior Eye and to the Deeper Skin Layers” presented at National

Symposium on Animal Remodeling: From Laboratory to Clinic held at

PGIMER, Chandigarh on 3rd

October, 2009, received a Best Paper Award.

7. A research paper titled “Evaluation of variation of mean frequency of

menopausal symptoms with age, education and working/non-working status in

north-Indian sub population using menopause rating scale (MRS)” presented at

Page 68: University Institute of Pharmaceutical Sciences

59th

Indian Pharmaceutical conference held at Varanasi from 12-14 December,

2007, received a Best Paper Award.

8. A research paper titled “Use of Entrapped Probiotic Bacteria for the Treatment of

Gatsric Ulcers” presented at an International Conference on Emerging Trends in

Free Radical and Antioxidant Research, SFRR, 8-11 January, 2007 at Lonavala,

India, received a Best Paper Award.

Professor Shishu

1. LEADING SCIENTISTS of the WORLD-2013 by the International Biographical

Centre, Cambridge England IBC.

2. Received award of Honour by Centre for Industry Institute Partnership

Programme (CIIPP), Panjab University on IPR day on Friday, 26th

April, 2013

and SECOND BEST POSTER: held at Chitkara College of Pharmacy, Rajpura

on 15-16 March 2013

3. First Runner Up: Shishu and Aggarwal N. Formulation and evaluation of a

vesicular topical delivery system of griseofulvin, Poster presentation at

Biotechnica Chandigarh-2010, Biotechnology-its Blue, Green, Red and White

Faces, Panjab University, 16-18th

, November 2010.

4. First Prize Winner: Shishu, Anupama, and Dhatt B. Development of novel carrier

based transdermal delivery system of cyclophosphamide, Poster presentation at

International Symposium on Cancer Research and Translational Initiatives and

Workshop on Flowcytometry, Panjab University, Chandigarh, 14-16th October,

2010.

5. First Prize Winner: Shishu, Maheshwari M., Kumar N., Aggarwal N. and Kapoor

V.R. Bioavailability assessment of Curcumin, Turmeric and Biocurcumax™ in

traditional vehicles using non-everted rat intestinal sac model, Poster

presentation at Manthan 2010, First International Symposium on Current

Advances in Novel & Parenteral Drug Development organized by Venus

Medicine Research Centre (VMRC) January 14th

16th

, 2010.

6. Invited talk: “Dietary phytochemicals as inhibitors of cooked food induced

mutagenesis” at First World Congress on Cancer (WCC-2009) held at Kottayam

Kerala, Jan., 12th

-14th

, 2009.

7. Chaired Scientific Session, “First World Congress on Cancer: WCC-2009”,

Kottayam, Kerela, 12-14th January, 2009.

8. Invited talk: “Microemulsions: drug carriers for delivery of water insoluble

drugs” at International Conference on Innovative Technologies (ICIT-09):

Research and Development in Science, Technology and Management, PDM

College of Engineering, in collaboration with IEEE-IMS/ EMBS (Delhi),

Bahadurgarh, on June 18th-19th, 2009.

Page 69: University Institute of Pharmaceutical Sciences

9. Selected as one of the International Biographical Centre Cambridge England

IBC‟s LEADING SCIENTISTS of the WORLD-2008.

10. Selected as one of the International Biographical Centre Cambridge England

IBC‟s TOP 100 SCIENTISTS -2008.

11. Best poster award: in Pharmaceutical Technology for poster “Formulation

development and evaluation of taste masked ofloxacin rapid disintegrating

tablets and oral suspension.” Presented paper 12th APTI Convention-2007,

Panjab University, Chandigarh.

Professor Anil Kumar

1. Received Bharat ShikshaRatan Award (2013) by Global Society for health and

Educational Growth, Delhi

2. Dr. Anil Kumar was awarded APTI Young Pharmacy teacher

3. BOYSCAST Fellow (Postdoctoral fellowship) 2010 of the Department of

Science and Technology, New Delhi for advanced research/ undergoing training

in specialized training in the Chosen areas of science and technology in

Philadelphia College of Osteopathic Medicine- School of Pharmacy, 625 Old

Peachtree Road, NW Suwanee GA 30024, USA

4. Biographical profile appeared in Marquis‟s Who's Who in Medicine and

Healthcare 2009-2010 as world's foremost achievers.

5. Prestigious Eli Lilly Young Investigator Fellow award, 7th International

Conference on Bipolar disorders held in Pittsburgh, Pennsylvania, USA from 6-

9th

June 2007

6. AICTE Career Award 2007 for Young Teachers by All India Council for

Technical Education (AICTE), New Delhi.

7. Attended ISN/APSN/IBRO, IBRO school of neuroscience School of Pharmacy,

Fudan University held in Shanghai, P.R. of China from 16-21 June 2008

8. Selected for Advanced School of Neurochemistry held in South Korea from 19th

to

23rd

August 2009.

9. Travel Grant from organizers for attending SFN-IBRO Workshop and IBRO

World Congress on Neuroscience, "Neurodegenerative Diseases: Different

Phenotypes, Shared Mechanism of Pathogenesis", to be held in Melbourne,

Australia from July 10-12, 2007.

Page 70: University Institute of Pharmaceutical Sciences

Professor RanjuBansal

1. Honored for contribution in field of IPR on world Intellectual Property Day by

IPR cell of Panjab University on Friday, 26th

April, 2013.

Professor Maninder Karan

2. Organizing Secretary of Biotechnica Chandigarh-2010 organized by the

department under the aegis of Panjab University and DBT.

• Doctoral / post doctoral fellows: Ph.D. scholars

• Students:

Awards &Honours2009-2013

1. Saurabh Srivastava- Foreign Travel Grant” from “Council of Scientific and

Industrial Research” CSIR, New Delhi, INDIA in 2009, for presenting the research

work in “AAPS Annual Meeting and Exposition” held at Los Angeles, CA, USA.

(November 8-12, 2009).

2. Honey - Awarded young scientist foreign travel grant from Department of Science

and Technology, Ministry of Science and Technology (DST), New Delhi in 2009 for

for presenting the research work in “AAPS Annual Meeting and Exposition” held at

Los Angeles, CA, USA. (November 8-12, 2009).

3. Honey - Awarded 2nd

best oral presentation award at the National conference on

„Innovation in Drug Discovery & Research held at Panjabi University, Patiala

(March 3-5, 2009).

4. R. Kapil, S. Dhawan, Shantanu and Bhupinder Singh, Novel Buccoadhesive Films

of Rivastigmine for Once-a-day Application: Development, Optimization and

Evaluation, 13th

Punjab Science Congress, Punjab Science Academy of Sciences, 7-

9 February 2009, Panjab University, Chandigarh, Abstract E-P09, THE

PRESENTATION BAGGED “BEST PAPER” AWARD. 5. J. Singh, Y. Paul and Bhupinder Singh, Chronopharmacokinetic Studies: A Tool to

Optimize Dosage Regimen and Reduce Adverse Effects, 9th

Annual Conference of

Society of Pharmacovigilance: Quality and Safety of Drugs, Rajendra Institute of

Technology & Sciences, Sirsa, Haryana, 22-24 November 2009, Abstract No.

O11. THE PRESENTATION BAGGED “BEST PAPER” AWARD.

6. BhupinderSingh, Babita, M. Thappa, A. Kaur and BaljinderSingh, Gastroretentive

Drug Delivery Systems of Trimetazidine Hydrochloride with Improved

Bioavailability and Patient Compliance, 30th

Annual Conference of Indian

Association of Biomedical Scientists, Defence Institute of High Altitude Research,

Chandigarh, India, 18-20 November 2009, Abstract No. OP 10. PRESENTATION

BAGGED “BEST PODIUM PAPER” AWARD. 7. R. Kapil, S. Dhawan and Bhupinder Singh, Treating Alzheimer‟s Disease with

Quercetin: Development and Evaluation of Solid Lipid Nanoparticles, 30th

Annual

Conference of Indian Association of Biomedical Scientists, Defence Institute of

High Altitude Research, Chandigarh, India, 18-20 November 2009, Abstract No. PP

48. PRESENTATION BAGGED “BEST POSTER PAPER” AWARD.

8. A. Kaur, Babita, B. Singh, R. Kapil and Bhupinder Singh, Development of

Gastroretentive Drug Delivery Systems of Trimetazidine Hydrochloride:

Optimization of Drug Release, Floating and Bioadhesive Characteristics, Silver

Jubilee 25th

IPGA Conference, 7-8 November 2009, I.S.F. College of Pharmacy,

Page 71: University Institute of Pharmaceutical Sciences

Moga, Punjab, Abstract C43. THE PRESENTATION BAGGED “BEST PAPER”

AWARD.

9. National Symposium on Animal Remodeling: From Laboratory to Clinic held

at PGIMER, Chandigarh on 3rd

October, 2009 Harinder Singh, ShilpaKakkar,

Indu Pal Kaur, Development of Topical Nanoelastic Vesicular System Targeting

the Posterior Eye and to the Deeper Skin Layers.*Received Best Paper Award for

the same.

10. 4th International Conference on Polyphenols and Health (ICPH2009) held at

Yorkshire, UK from 7-10 December, 2009 VanditaKakkar*, Indu Pal Kaur, Role

of a Novel Carrier System of PolyphenolicLignanSesamol in Menopause Related

Biochemical and Behavioral Paradigms. *Young Investigator award has been

announced for the student co-author based on the abstract of the research work

entitled.

11. Shishu, Nidhi Aggarwal. First Runner up Award in Poster Presentation

“Formulation and evaluation of a vesicular topical delivery system of griseofulvin”

Biotechnology- Its blue, green, red and white faces. BIOTECHNICA, 2010.

12. Shishu, Anupama, Dhatt B. Best Poster Award “Development of novel carrier based

transdermal delivery system of cyclophosphamide” International Symposium on

Cancer Research and Translational Initiatives and Workshop on Flowcytometry,

2010.

13. Shishu, Manjul Maheshwari, Neeraj Kumar, Nidhi Aggarwal, Varun Rishi Kapoor.

Best Poster Award“Bioavailability assessment of Curcumin, Turmeric and

BiocurcumaxTM

in traditional vehicles using non-everted rat intestinal sac model”

First International Symposium on Current Advances in Novel and Parenteral Drug

Development (MANTHAN-2010).

14. Ruchita V Kumar- Received Foreign Travel Grant for Young Scientists from

Department of Science and Technology, Ministry of Science and Technology (DST),

Government of India in 2010 for attending CRS 2010 held in Oregon, USA.

15. XXXVth

Annual Conference of Environmental Mutagen Society of India

(EMSI) & International Symposium on “Mutagens and Genetic Diversity for

Health and Agriculture” held at Panjab University, Chandigarh, India from

March 12-14, 2010. VanditaKakkar*, Indu Pal Kaur, Development of Antioxidant

Molecules as Anticancer Agents: A Journey from Identifying the Biological Activity

to Developing an Effective Delivery System.*Best Oral Presentation Award for

the same.

16. Bienneial International Conference On Drug Discovery From Natural Products

And Traditional Medicines (DDNPTM-2010) held from 20 November to 24

November, 2010 at National Institute of Pharmaceutical Education and Research

(NIPER), SAS Nagar, Mohali, Punjab.Kakkar Vandita*, Singh Sukhjit , Singla

Dinesh, Kaur Indu Pal “Developing Solid Lipid Nanoparticles of Curcumin to

Enhance Its Oral Bioavailability” *Best Poster Award for the same.

17. XXXVth

Annual Conference of Environmental Mutagen Society of India

(EMSI) & International Symposium on “Mutagens and Genetic Diversity for

Health and Agriculture” held at Panjab University, Chandigarh, India from

March 12-14, 2010. Pramod Kumar Singh*, GeethaThiraviam, Indu Pal Kaur,

Sesamol Loaded Floating Beads: A Therapeutic Option for Treatment of Gastric

Cancer.*Best Paper Award for the same.

18. R Kapil, S Dhawan, Shantanu and Bhupinder Singh, Pharmacological and

Biochemical Studies on Brain Targeting of Quercetin through Novel Nanoparticulate

Page 72: University Institute of Pharmaceutical Sciences

Formulation Strategies, 35th

Annual Conference of Environmental Mutagen

Society of India (EMSI) &International Symposium on “Mutagens and Genetic

Diversity for Health and Agriculture”, 12–14 March 2010, Panjab University,

Chandigarh, Abstract No. AP-15, THE PRESENTATION BAGGED “BEST

PAPER” AWARD.

19. Shishu, Prabhleen Kaur, Neeraj. Best Poster Award “A novel ionic liquid-in-oil

microemulsion system for topical delivery of an antiviral agent” Annual National

Convention, 2011.

20. Nidhi Aggarwal, Shishu, Ankita Guleria. Best Poster Award “Bioavailability

enhancement and dermal targeting of Griseofulvin using nanoparticulate carrier

system” Vision 2020: India-The Pharma Power House. International Pharmaceutical

Congress, (IPC- 2011).

21. A. Shukla,Bhupinder Singhand O. P. Katare, Novel Nanosomal formulation as

potential oral vaccine delivery system: Development, characterization and

evaluation, DST-sponsored Indo-Taiwan Workshop 2011 on “Drug Development

for Cancer and Infectious Diseases: From Basic to Industry, at ISF College of

Pharmacy, Moga, Punjab, December 14-15, 2011. THE PRESENTATION

BAGGED “BEST PAPER” AWARD.

22. Anand Kamal Sachdeva received special travel grant to attend 8th

IBRO world

conference (12th

-18 th July 2011) Florence Italy.

23. Anand Kamal Sachdeva received best poster presentation award for presenting

paper during 8th

IBRO world conference (12th

-18th

July 2011) Florence Italy.

24. Vipin Arora recieved Received IBRO International Travel Award to attend 31st

Annual Meeting of the Australian Neuroscience Society held at Auckland (New

Zealand) (March 31st - 3rd

Feburary, 2011).

25. International Meeting On Emerging Diseases Held At Vienna, Austria,

February 4-7, 2011. Bhandari Rohit* and Kaur Indu Pal; Tuberculous Meningitis:

Novel ways to evadeantimicrobial resistance. *Received a DST young scientist

travel award for the same.

26. R Kapil, S Dhawan and Bhupinder Singh, Solid Lipid Nanoparticles for Brain

Targeting of Quercetin, 5th

Chandigarh Science Congress (CHASCON–2011),

Chandigarh, 26-28 February 2011, Abstract No. 17. THE PRESENTATION

BAGGED “BEST PAPER” AWARD.

27. R Kapil, S Dhawan and Bhupinder Singh, Treating Alzheimer‟s Disease with Solid

Lipid Nanoparticles of Quercetin, UGC Sponsored National Symposium on

Molecular Pathogenesis of Neurodegenerative Diseases, Panjab University,

Chandigarh, 22 February, 2011, Abstract No. 1. THE PRESENTATION

BAGGED “BEST PAPER” AWARD.

28. VipinArorarecieved “Young Investigator Scientist Award” by International Brain

Research Organization for one month training programme (June 13 to July 13, 2011)

University of Cagliari.

Page 73: University Institute of Pharmaceutical Sciences

29. VinodTiwarirecieved “Young Investigator Scientist Award” by International

Brain Research Organization for one month training programme (June 13 to July 13,

2011) Paris.

30. Prerna, A. Singla, Y. Paul and Bhupinder Singh. In Silico Quantitative Structure

Pharmacokinetic Relationship Modeling on Antidiabetic Drugs: Half-Life. AICTE

sponsored National Seminar on Recent Developments from Drug Discovery to Drug

Delivery. Lord Shiva College of Pharmacy, Sirsa, Haryana. April 28-29, 2012.

Abstract No. NATSEM P-58. THEPRESENTATION BAGGED “BEST PAPER”

AWARD.

31. R. Kapil, S. Dhawan and Bhupinder Singh, Buccoadhesive Films of Rivastigmine

for Once-a-Day Application: Development, Optimization and Evaluation, 6th

Chandigarh Science Congress (CHASCON–2012), Chandigarh, February 26-28,

2012. Abstract Phar 5. THEPRESENTATION BAGGED “BEST PAPER”

AWARD.

32. Shishu, Manleen Kaur Narula. First Runner up Award in Poster Presentation

“Development and evaluation of microemulsionof tenoxicam for topical delivery”

Synergy: Together Towards Tomorrow. Chandigarh Science Congress,

(CHASCON-2012).

33. International Conference NanoSciTech-2012 on “Frontiers in Nanoscience,

Nanotechnology and Applications” during February 16-18, 2012 at the Panjab

University, Chandigarh. Manoj Kumar Verma*, Indu Pal Kaur, Preparation and

Characterization of Vitamin A and D3 Loaded Solid Lipid Nanoparticles for

Prophylaxis of Tuberculosis.*Best paper award for the same

34. International Conference NanoSciTech-2012 on “Frontiers in Nanoscience,

Nanotechnology and Applications” during February 16-18, 2012 at the Panjab

University, Chandigarh. ShilpaKakkar*, Keshav Jindal,Indu Pal Kaur, Co-Solvent

Based Sterlisable Vesicular Systems for Ocular Delivery of Acetazolamide.*Best

paper award for the same.

35. VipinArora received travel Grant from Department of Biotechnology, INDIA to

attend 28th CINP World Congress of Neuropsychopharmacology, Stockholm,

Sweden, from June 3-7, 2012

36. Vipin Arora recieved The International Association for the Study of Pain (IASP)

Financial Aid for attending 14th World Congress on Pain, held from August 27,

2012 - August 31, 2012, in Milan, Italy

37. Rakesh Kumar - Awarded Asia-Arvo national travel grant to attend Asia-Arvo

2013 in New Delhi (October 28-31, 2013).

38. RK Khurana, CB Tripathi, Bhupinder SinghBagged Best Paper

Award“Development of Systematically Optimized Self-Nanoemulsifying Drug

Delivery Systems of Artemether with Enhanced Bioavailability Potential”at the One

Day National Seminar of TEQIP at Chandigarh in November 11, 2013.

39. S Beg, V Chaudhary, S Singh, O.P. Katare, Bhupinder SinghBagged Best Paper

Award “Development & Validation of RP-HPLC Method for Estimation of

Nevirapine employing Analytical Quality by Design (AQbD)” at the 65th

IPC at New

Delhi, December 12-16, 2013.

Page 74: University Institute of Pharmaceutical Sciences

40. S. Beg, G. Sharma, O.P. Katare, Bhupinder Singh, QbD-Enabled Development of

Self-Nanoemulsifying Drug Delivery Systems of Olmesartan with enhanced

bioavailability potential. Select Bio QbD in Pharma Development, Hotel Ramada,

Powai, February 24-25, Mumbai. Poster No. 110. THE PRESENTATION BAGGED

“BEST PAPER”AWARD.

41. S. Beg, R. Kapil, S. Dhawan, Bhupinder Singh, Pharmacokinetic Evaluation and

Establishment of IVIVC: Case Study on Buccoadhesive and Mucoadhesive Systems

of Rivastigmine. International Conference on “ADME & Toxicology 2013”, Hotel

Radisson Blu Plaza, New Delhi, PP-204. THE PRESENTATION BAGGED “BEST

PAPER”AWARD.

42. A. Shukla, Bhupinder Singh and O. P. Katare, Optimized Oral delivery of

Diphtheria-Toxoid using Nano-bilosomes induces Significant Systemic and Mucosal

Immune Response, BioAsia 2013-Hyderabad, International Convention Center,

Hyderabad, India, January 28-30, 2013. THE PRESENTATION BAGGED “BEST

PAPER” AWARD.

43. S. Beg, V. Chaudhary, S. Singh, Bhupinder Singh, Development & Validation of A

Rp-Hplc Method for Estimation of Nevirapine employing Analytical Quality by

Design (AQbD). 65th

Indian Pharmaceutical Congress, New Delhi. Poster No. F-

17. THE PRESENTATION BAGGED BEST PAPER AWARD.

44. R.K. Khurana, C.B. Tripathi, Bhupinder Singh, Development of Systematically

Optimized Self-Nanoemulsifying Drug Delivery Systems of Artemether with

Enhanced Bioavailability Potential. One Day National Seminar of TEQIP, UICET,

Panjab University, Chandigarh, November 11, 2013. “THE PRESENTATION

BAGGED BEST PAPER AWARD”.

45. Vipin Arora received First prize in Oral Presentation during Chandigarh Science

Conference 1st to 3

rd March 2013

46. Seema Bansal received second prize Oral Presentation during Chandigarh

Science Conference 1st to 3

rd March 2013

47. Anand Kamal Sachdeva received special travel grant to attend Alzheimer,s

Association Internatinal Conference (July 12-18 2013).

48. VIIth

Chandigarh Science Congress on Contemporary Issues & Interdisciplinary

Science & Technology for Societal Needs, March 1-3, 2013 at Panjab University,

Chandigarh. Harinder Singh*, Indu Pal Kaur, Single Dose Oral Pharmacokinetic

and Toxicity Studies of Rifampicin Loaded Solid Lipid Nanoparticles * Best paper

award for the same.

49. Shishu, Ankita Guleria, Amanpreet Kaur.Best Poster Award “Development and

evaluation of solid lipid nanoparticles of N-6-furfuryl adenine as an anti-ageing

agent”International Conference on Advances in Pharmacological and Pharmaceutical

approaches to Drug Discovery and Clinical Development (APPADDCD-2013).

Page 75: University Institute of Pharmaceutical Sciences

30. Seminars/ Conferences/Workshops organized and the source of funding (national /

international) with details of outstanding participants, if any.

UGC NETWORKING RESOURCE CENTRE (2009 – 2013)

FUNDING AGENCY: University Grants Commission (UGC )

Course

Modul

e

Date

Theme of

the Training

Course

Total

Particip

ants

Participants’ Name

B-2

Janu

ary

11 to

16,

2010

Emerging

Areas in

Pharmaceut

ical Sciences

20

1. Jayendra Maurya, Lecturer, TS

Pharmacy College, Ghaziabad, Uttar

Pradesh

2. Nitin Agarwal, Noida Institute of Engg.

& Technology, Greater Noida, Uttar

Pradesh

3. Yash Paul, Principal, Lord Shiva

College of Pharmacy, Sirsa, Haryana

4. Jagtar.S.Chohan, Assistant Professor

(Reader), Lord Shiva College of

Pharmacy, Sirsa, Haryana

5. Gurpreet Kaur, Lecturer (Selection

Grade), Punjabi University, Patiala,

Punjab

6. Sarvesh Sharma, Senior Lecturer,

LNCT, Bhopal, Madhya Pradesh

7. Dr. Banappa S Unger, S.S. Lecturer,

KLE University, Vidyanagar, Hubli,

Karnataka

8. Jayamanti Pandit, Lecturer,

Technocarts Institute of Technology,

Bhopal, Madhya Pradesh

9. Ramninder Kaur, Lecturer,

G.H.G.Khalsa College of Pharmacy

Gurusar,Sadhar, Ludhiana, Punjab

10. Pratibha, Lecturer, M.M. College of

Pharmacy, Mullana, Ambala, Haryana

11. Ratendra Kumar, Lecturer, Faculty of

Pharmaceutical Sciences, Jodhpur

National University, Jodhpur,

Rajasthan

12. Komalpreet Kaur, Lecturer, G.H.G.

Khalsa College of Pharmacy

Gurusar,Sadhar, Ludhiana, Punjab

13. Janhvi Dureja, Assistant Professor,

Doaba College of Pharmacy, Kharar,

Punjab

14. Vijay Singh Rana, Assistant Professor,

DIT-Faculty of Pharmacy, Dehradun,

Page 76: University Institute of Pharmaceutical Sciences

Course

Modul

e

Date

Theme of

the Training

Course

Total

Particip

ants

Participants’ Name

Uttarakhand

15. Sonia Pahuja, Assistant Professor,

Swami Vivekanand College of

Pharmacy, Punjab

16. Richa Shri, Lecturer (Selection Grade),

Dept of Pharm Sc & Drug Research,

Punjabi University, Patiala, Punjab

17. G.Rajendra Prasad, Lecturer, Vaagdevi

College of Pharmacy, Warangal,

Andhra Pradesh

18. A. Praneeth Kumar, Lecturer, Vaagdevi

College of Pharmacy, Warangal,

Andhra Pradesh

19. Rekha Rao, Lecturer, M.M. College of

Pharmacy, Mullana, Ambala, Haryana

20. Kanupriya, Senior Lecturer, Rayat and

Bahra Institute of Pharmacy, Distt.

Kharar, Sahauran, Punjab

A-2

Mar

ch

29 to

Apri

l 3,

2010

Excellence

in

Pharmaceut

ical

Research:

Methodologi

es and

Techniques

15

1. Suresh Kumar, Lecturer, Punjabi

University, Patiala, Punjab

2. Nilesh R. Kanzariya, Lecturer, S.K.

Patel College of Pharmaceutical Edu &

Research Ganpat University, Gujarat

3. Rahul Taneja, Lecturer, Guru Gobind

Singh College of Pharmacy, Yamuna

Nagar, Haryana

4. Dali Shukla, Senior Research Fellow,

Department of Pharmaceutics, IT BHU,

Varanasi, Uttar Pradesh

5. Nmuruganantham, Research Scholar,

JSS College of Pharmacy, Ooty, Tamil

Nadu

6. S.H.Seyed Mohamed Buhary, Assistant

Professor, Sankaralingam

Bhuvaneswari College, Sivakasi, Tamil

Nadu

7. Sheveta Babu, Lecturer, Maharaja

Surajmal Institute of Pharmacy,

Janakpuri, New Delhi

8. Mahavir H Ghante, Lecturer, J L

Chaturvedi College of Pharmacy,

Nagpur, Maharashtra

9. Patil Sandeep Balvant, Lecturer,

Appasaheb Birnale College of

Pharmacy, Sanglai Maharashtra

10. Sandeep Arora, Lecturer, Lachoo

Memorial College of Science and

Page 77: University Institute of Pharmaceutical Sciences

Course

Modul

e

Date

Theme of

the Training

Course

Total

Particip

ants

Participants’ Name

Technology, Jodhpur, Rajasthan

11. Channamma, Lecturer, HKES College

of Pharmacy, Gulbarga, Karnataka

12. Subhash Dwivedi, Lecturer, KNIMT,

Sultanpur, Uttar Pradesh

13. Patel Leena N, Assistant Professor,

Ramanbhai Patel College Of

Pharmacy, Changa, Gujarat

14. Anju Goyal, Assistant Professor,

Chitkara College of Pharmacy, Rajpura,

Punjab

15. Rajni Bala, Assistant Professor,

Chitkara College of Pharmacy, Rajpura,

Punjab

B-1

May

31 to

June

12,

2010

Emerging

Trends in

Drug

Discovery

and

Developmen

t

20

1. Mr. G. Sivakumar, Assistant Professor,

Shri Vishnu College of Pharmacy,

Andhra Pradesh

2. Mr. Patel KalpeshKumar Narottambhai,

Lecturer, Nootan Pharmacy College,

Gujarat

3. Mr. Patel Nileshkumar K., Lecturer, S.

K Patel College & Pharmaceutical

Education & Research, Gujarat

4. Mr. Thakor Rashmin S,

Lecturer,Nootan Pharmacy College,

Gujarat

5. Mr. Rajput Ganeshsinh C., Lecturer,

Nootan Pharmacy College, Gujarat

6. Ms. Ruchita, Lecturer, Hindu College

of Pharmacy, Sonepat, Haryana

7. Mr. Anant V. Bhandarkar, Assistant

Professor, K.L.E. University's College

of Pharmacy, Karnataka

8. Mr. Vinay Pandit, Lecturer, Al Ameen

College of Pharmacy, Bangalore,

Karnataka

9. Ms. Ruchi Malik, Associate Dean, B.

R. Nahata College of Pharmacy,

Madhya Pradesh

10. Mr. Prateek Kumar Jain, Associate

Professor, ADINA Institute of

Pharmaceutical Sciences, Madhya

Pradesh

11. Mr. Dadke Aniruddha V., Assistant

Professor, STES's Sinhgad College of

Pharmacy, Maharashtra

12. Mr. Sonawane Lalit Vijay, Lecturer, R.

Page 78: University Institute of Pharmaceutical Sciences

Course

Modul

e

Date

Theme of

the Training

Course

Total

Particip

ants

Participants’ Name

C. Patel Institute of Pharmaceutical

Education & Research, Shirpur,

Maharashtra

13. Mr. Anjan Kumar Mahapatra, Lecturer,

School of Pharmaceutical Education,

Dept of Pharmacy, Berhampur, Orissa

14. Mr. Thakur Gurjeet Singh, Lecturer,

Chitkara College of Pharmacy, Punjab

15. Mr. Ashish Kumar Rehni, Senior

Lecturer, Chitkara College of

Pharmacy, Punjab

16. Ms. Sumitra Nain, Research Associate,

Banasthali Vidyapith, Rajasthan

17. Mr. Gulshan Chhabra, Lecturer, Rajiv

Academy for Pharmacy, Mathura, Uttar

Pradesh

18. Mr. Suneel, Lecturer, Roorkee College

of Pharmacy, Uttarakhand

19. Ms. Ashwini Karanth S, Lecturer, PES

College of Pharmacy, Karnataka

20. Mr. Girish Kumar Gupta, Lecturer,

M.M. College of Pharmacy, Haryana

B-2

Octo

ber

25 to

30,

2010

Newer

Paradigms

in

Pharmaceut

ics &

Biopharmac

eutics

20

1. Dr Sanjay Bajaj, Principal, Swami

Vivekanand College of Pharmacy,

Punjab

2. Dr Rachna Kumria, Professor, M.M.

College of Pharmacy, Haryana

3. Dr A. Srinatha, Assistant Professor,

National College of Pharmacy,

Karnataka

4. Dr Mohammed Gulzar Ahmed,

Professor, Sri Adichunchanagiri

College of Pharmacy, Karnataka

5. Dr Girish Narsinhbhai Patel, Assistant

Professor, S. K. Patel College of

Pharmaceutical Education & Research,

Gujarat

6. Kamal Singh Rathore, Reader, B.N.

Girls College of Pharmacy, Rajasthan

7. D. Nagasamy Venkatesh, Assistant

Professor, JSS College of Pharmacy,

Tamil Nadu

8. Saahil Arora, Assistant Professor, I.S.F.

College of Pharmacy, Punjab

9. Vandana Kharb, Senior Lecturer,

ASBAJSM College of Pharmacy,

Punjab

Page 79: University Institute of Pharmaceutical Sciences

Course

Modul

e

Date

Theme of

the Training

Course

Total

Particip

ants

Participants’ Name

10. Anish Chandy, Lecturer, Chauksey

Engineering College, School of

Pharmacy, Chattisgarh

11. Sourabh Jain, Lecturer, L.M. College of

Science & Technology, Rajasthan

12. Sanjay Bansal, Senior Lecturer, Mehr

Chand Polytechnic College, Punjab

13. Inderbir Singh, Assistant Professor,

Chitkara College of Pharmacy, Punjab

14. D. J. Kalavathy, Lecturer,

Visveswarapura Institute of

Pharmaceutical Sciences, Karnataka

15. Sonia Pandey, Lecturer, Maliba

Pharmacy College, Gujarat

16. Kuldeep Malodia, Senior Lecturer,

Lord Shiva College of Pharmacy,

Haryana

17. Geoffrey Gnana Jeba J., Lecturer,

Sankaralingam Bhuvaneswari College

of Pharmacy, Tamil Nadu

18. Dr G. Praveen Kumar, Professor, Talla

Padmavathi College of Pharmacy,

Andhra Pradesh

19. Payal Bhupendrabhat Shah, Assistant

Professor, Ramanbhai Patel College of

Pharmacy, Gujarat

20. Vaibhav Kumar Singh, Assistant

Professor, Kanpur Institute of

Technology & Pharmacy, Uttar Pradesh

A-2

Janu

ary

24 to

29,

2011

Current

Trends in

Pharmaceut

ical Analysis

and

Medicinal

Chemistry

15

1. Ritesh N. Sharma, Lecturer, S. K. Patel

College of Pharmaceutical Education &

Research, Gujarat

2. Renu S. Chauhan, Assistant Professor,

Maliba Pharmacy College, Gujarat

3. Sweemitkumar Jiwane, Lecturer,

School of Pharmaceutical Sciences,

Jiwaji University, Madhya Pradesh

4. Chandra Shekhar Singh, Lecturer,

Radharaman College of Pharmacy,

Madhya Pradesh

5. Vijay Kumar Singh, Lecturer,

Bundelkhand University, Uttar Pradesh

6. Rakesh Chawla, Lecturer, S. D. College

of Pharmacy, Punjab

7. Hari Hara Theja Dugga, Assistant

Professor, Raghuvendra Institute of

Pharmaceutical Education & Research,

Page 80: University Institute of Pharmaceutical Sciences

Course

Modul

e

Date

Theme of

the Training

Course

Total

Particip

ants

Participants’ Name

Andhra Pradesh

8. G. Sai Rajesh, Assistant Professor, G.

Pulla Reddy College of Pharmacy,

Andhra Pradesh

9. Rupinder Kaur Bhamber, Senior

Lecturer, Ram-eesh Institute of

Vocational & Technical Education,

Uttar Pradesh

10. Shaikh Mazar Hussain, Senior Lecturer,

Womens' Polytechnic (Govt.), Orissa

11. Gagandeep Chaudhary, Assistant

Professor, Rayat & Bahra Institute of

Pharmacy, Punjab

12. Amardeep Kaur, Assistant Professor,

GHG Khalsa College of Pharmacy,

Punjab

13. Ahmed Nawaz Khan, Associate

Lecturer, Jaypee University of

Information Technology, Himachal

Pradesh

14. Amanpreet Kaur, Lecturer, GHG

Khalsa College of Pharmacy, Punjab

15. Kuldeep Singh, Senior Lecturer, Jaypee

University of Information Technology,

Himachal Pradesh

B-1

May

23 to

June

4,

2011

Chromatogr

aphic

techniques

for

pharmaceuti

cal research

19

1. Sucheta, Assistant Professor, Hindu

College of Pharmacy, Haryana

2. Amita Verma, Associate Professor &

Head, Christian School of Pharmacy,

Uttar Pradesh

3. Ashutosh Pareek, Assistant Professor,

Banasthali University, Rajasthan

4. Poornima M. Malagi, Lecturer,

Vivekananda College of Pharmacy,

Karnataka

5. Sandeep Kumar T., Assistant Professor,

Care College of Pharmacy, Andhra

Pradesh

6. Ravindra Kumar Gupta, Lecturer, B. R.

Nahata College of Pharmacy, Madhya

Pradesh

7. Patel Alpesh Dineshbhai, Assistant

Professor, Shri B.M. Shah College of

Pharmaceutical Education & Research,

Gujarat

8. Pallavi Bassi, Lecturer, Baddi

University of Emerging Sciences &

Page 81: University Institute of Pharmaceutical Sciences

Course

Modul

e

Date

Theme of

the Training

Course

Total

Particip

ants

Participants’ Name

Technology, Himachal Pradesh

9. Sachin Kumar, Lecturer, DIPSAR,

New Delhi

10. Rukaiyya S. Khan, Research Scholar,

BITS-Pilani, Hyderabad, Andhra

Pradesh

11. Dhruv Dev, Assistant Professor,

Shivalik College of Pharmacy, Punjab

12. Yogita Bansal, Assistant Professor,

Punjabi University, Punjab

13. Mahendra C. Gunde, Lecturer, Kamla

Nehru College of Pharmacy,

Maharashtra

14. Vineeta Tiwari, Lecturer, Rayat-Bahra

Institute of Pharmacy, Punjab

15. Rakesh Kumar, Assistant Professor,

Chitkara College of Pharmacy, Punjab

16. Biswatrish Sarkar, Assistant Professor,

Birla Institute of Technology, Mesra,

Jharkhand

17. Lopamudra Adhikari, Lecturer, School

of Pharmaceutical Sciences, S 'O' A

University, Orissa

18. Madhulika Pradhan, Lecturer, Rungta

College of Pharmaceutical Sciences &

Research, Chhattisgarh

19. Nepram Swarnalata, Senior Lecturer,

Government Polytechnic, Imphal,

Manipur

A-2

Sept

emb

er 19

to

24,

2011

Hands-on-

Exposure to

Neurophar

macological

& Molecular

Biological

Tools

15

1. Ritesh Jivrajbhai Rangani, Assistant

Professor, Baroda College of

Pharmacy, Gujarat

2. Deshbandhu R. Pachauri, Assistant

Professor, JSPM's Rajarshi Shahu

College of Pharmacy & Research,

Maharashtra

3. Pithadia Anand Bharatkumar, Lecturer,

Parul Institute of Pharmacy, Gujarat

4. Kunal Jain, Research Scholar, J.S.S.

College of Pharmacy, Tamil Nadu

5. Dilip Dodda, Assistant Professor,

Kakatiya University, Andhra Pradesh

6. Nilay D. Solanki, Assistant Professor,

Ramanbhai Patel College of Pharmacy,

Gujarat

7. Shvetank Bhatt, Lecturer, BITS –

Pilani, Rajasthan

Page 82: University Institute of Pharmaceutical Sciences

Course

Modul

e

Date

Theme of

the Training

Course

Total

Particip

ants

Participants’ Name

8. Savita Pandey, Assistant Professor,

Devsthali Vidyapeeth College of

Pharmacy, Uttarakhand

9. Alpesh Kumar Nagar, Lecturer, SJM

College of Pharmacy, Karnataka

10. Shalini Pathak, Lecturer, Institute of

Pharmacy, Bundelkhand University,

Uttar Pradesh

11. Dr Sumeet Gupta, Associate Professor,

M. M. College of Pharmacy, Haryana

12. Sriti Kayal, Lecturer, Kanak Manjari

Institute of Pharmaceutical Research,

Orissa

13. Manas Kumar Das, Assistant Professor/

Lecturer, Dept of Pharmacy, IEC

Group, Uttar Pradesh

14. R. Jayaraman, Assistant Professor,

KMCH College of Pharmacy, Tamil

Nadu

15. Nimmy Chacko, Senior Lecturer, Nitte

Gulabi Shetty Memorial Institute of

Pharmaceutical Sciences (NGSMIPS),

Karnataka

B-2

Mar

ch

26 to

31,

2012

Pharmacogn

osy –

Shaping the

Drug

Discovery in

New

Millennium

14

1. Dr Showkat R. Mir, Assistant

Professor, Hamdard University, New

Delhi

2. Prakash Chandra Gupta, Lecturer,

C.S.J.M. University, Kanpur, Uttar

Pradesh

3. Rajesh Garg, Associate Professor, B.R.

Nahata College of Pharmacy, Madhya

Pradesh

4. Supriya Agnihotri, Lecturer, DIPSAR,

New Delhi

5. Dr Hardikkumar Prahladbhai Patel,

Assistant Professor, S. K. Patel College

of Pharmaceutical Edu. & Research,

Gujarat

6. Kshitij Chauhan, Lecturer, PGT - SFC

Cell, IPGT&R, GAU, Gujarat

7. Dr S. Hemalatha, Associate Professor,

Dept of Pharmaceutics, Instt. of

Technology, Banaras Hindu University,

Uttar Pradesh

8. Mr Vyas Niraj Yashvantrai, Assistant

Professor, Ramanbhai Patel College of

Pharmacy, Gujarat

Page 83: University Institute of Pharmaceutical Sciences

Course

Modul

e

Date

Theme of

the Training

Course

Total

Particip

ants

Participants’ Name

9. Ms Kanankumari Gamanlal Gamit,

Assistant Professor, Ramanbhai Patel

College of Pharmacy, Gujarat

10. Mr Bhavikkumar H. Satani, Assistant

Professor, Maliba Pharmacy College,

Gujarat

11. Ms Jaspreet Kaur Sidana, Lecturer, M.

M. College of Pharmacy, Haryana

12. Ms Pooja Arora, Assistant Professor,

Swami Devi Dyal Institute of

Pharmacy, Haryana

13. Kundan Singh Bora, Assistant

Professor, L. R. Institute of Pharmacy,

Himachal Pradesh

14. Mr Dinesh Kumar, Assistant Professor,

Kurukshetra University, Haryana

B-2

Octo

ber 8

to

13,

2012

Nanotechnol

ogy in Drug

Delivery:

Promises

and

Concerns

20

1. Arun Kumar Das, Assistant Professor,

CM College of Pharmacy, Andhra

Pradesh

2. Pamula Reddy Bhavanam, Associate

Professor, Shri Vishnu College of

Pharmacy, Andhra Pradesh

3. B J Patgiri, Associate Professor,

Gujarat Ayurved University, Gujarat

4. Dhaivat Chandrakant Parikh, Assistant

Professor, Nirma University, Gujarat

5. Hemal T. Tandel, Assistant Professor,

The M. S. University of Baroda,

Gujarat

6. Hetal Paresh Thakkar, Assistant

Professor, The M. S. University of

Baroda, Gujarat

7. Sukhbir Lal, Assistant Professor,

Kurukshetra University, Haryana

8. Twinkle Singla, Assistant Professor,

Swami Devi Dyal Institute of

Pharmacy, Haryana

9. Anjana Adhyapak, Assistant Professor,

KLE University's College of Pharmacy,

Karnataka

10. P Tripura Sundari, Assistant Professor,

SPP SPTM SVKMs NMIMS,

Maharashtra

11. Surendra S. Agrawal, Assistant

Professor, SPP SPTM SVKMs

NMIMS, Maharashtra

12. Harmanpreet Singh, Assistant

Page 84: University Institute of Pharmaceutical Sciences

Course

Modul

e

Date

Theme of

the Training

Course

Total

Particip

ants

Participants’ Name

Professor, Lovely Professional

University, Punjab

13. Jaspreet Kour Ramana, Assistant

Professor, Chandigarh College of

Pharmacy, Punjab

14. Jasvir Kaur, Assistant Professor,

G.H.G. Khalsa College of Pharmacy,

Punjab

15. Shiv Parkash Goel, Principal &

Professor, Sachdeva College of

Pharmacy, Punjab

16. Archana Khosa Kakkar, Lecturer, Birla

Institute of Technology and Sciences,

Rajasthan

17. Jitendra Singh Rajawat, Lecturer, B. N.

College of Pharmacy, Rajasthan

18. Rahul Kumar Garg, Assistant

Professor, Geetanjali Institute of

Pharmacy, Rajasthan

19. Karuna Nidhi Rai, Assistant Professor,

I.T.M. GIDA, Uttar Pradesh

20. Arun Kumar Singh, Assistant

Professor, Devasthali Vidyapeeth

College of Pharmacy, Uttarakhand

B-1

Janu

ary

28 to

Febr

uary

9,

2013

Computer

Aided Drug

Design:

Hands-on

Workshop

20

1. Bharathkumar Inturi, Assistant

Professor, Mohammadiya Institute of

Pharmacy, Andhra Pradesh

2. Santhosh Kumar S., Research Scholar,

BITS Pilani, Andhra Pradesh

3. Ashish Mohanrao Kanhed, Ph.D.

Scholar, M. S. University of Baroda,

Gujarat

4. Chauhan Navneet Singh, Assistant

Professor, B. S. Patel Pharmacy

College, Gujarat

5. Ankit Jain, Assistant Professor,

Rajendra Institute of Technology &

Sciences, Haryana

6. Deepak Kumar Jindal, Ph.D. Research

Scholar, Guru Jambeshwar University

of Science & Technology, Haryana

7. Amol Baban Khade, Research Scholar

(QIP), Manipal College of

Pharmaceutical Sciences, Karnataka

8. Girish A. Hampannavar, Assistant

Professor, K.L.E. University's College

of Pharmacy, Karnataka

Page 85: University Institute of Pharmaceutical Sciences

Course

Modul

e

Date

Theme of

the Training

Course

Total

Particip

ants

Participants’ Name

9. Shashidhar S. Kerur, Assistant

Professor, K.L.E. University's College

of Pharmacy, Karnataka

10. Sanal Dev, Assistant Professor, Al-

Shifa College of Pharmacy, Kerala

11. Sujit Ghanshyam Bhansali, Ph.D.

Student, Poona College of Pharmacy,

Maharashtra

12. Dr Suresh Kumar, CSIR-Research

Associate, Jamia Hamdard, New Delhi

13. Jagdish Kumar Arun, Ph.D. Research

Fellow UGC, SRF, Jamia Hamdard,

New Delhi

14. Biswa Mohan Sahoo, Lecturer, Roland

Institute of Pharmaceutical Sciences,

Odisha

15. Tripti Sharma, Assistant Professor,

School of Pharmaceutical Sciences,

SoA University, Odisha

16. Neeraj Kumar, Assistant Professor,

Geetanjali Institute of Pharmacy,

Rajasthan

17. Avinash Chandra Tripathi, Assistant

Professor, BBDNIIT, Lucknow, Uttar

Pradesh

18. Savita Upadhyay, Assistant Professor,

BBDNIIT, Lucknow, Uttar Pradesh

19. Abhishek Tiwari, Assistant Professor,

Devasthali Vidyapeeth College of

Pharmacy, Uttarakhand

20. Arun Kumar Mahato, Assistant

Professor, Sardar Bhagwan Singh PG

Institute of Biomedical Sciences &

Research, Uttarakhand

A-2

Mar

ch

11 to

16,

2013

Innovations

in Pharma

Research:

Stepping

Stones

15

1. Arpita A. Patel, Ph.D. Scholar, The M.

S. University of Baroda, Gujarat

2. Desai Jagruti L., Ph.D. Scholar, The M.

S. University of Baroda, Gujarat

3. Dr Modi Meghal V., Assistant

Professor, B. S. Patel College of

Pharmacy, Gujarat

4. Shailesh V. Jain, Ph.D. Scholar,

Institute of Pharmacy, Nirma

University, Gujarat

5. Dr Parminder Nain, Associate

Professor, M. M. College of Pharmacy,

Haryana

Page 86: University Institute of Pharmaceutical Sciences

Course

Modul

e

Date

Theme of

the Training

Course

Total

Particip

ants

Participants’ Name

6. Ashwini Mallikarjun Rayaji, Research

Scholar, KLE University's College of

Pharmacy, Karnataka

7. Neelakanth M. Jeedi, Lecturer, KLE

University's College of Pharmacy,

Karnataka

8. Shrishail K. Nimbal, Assistant

Professor, KLE University's College of

Pharmacy, Karnataka

9. Dr Alok Kumar Shukla, Assistant

Professor, Radharaman College of

Pharmacy, Madhya Pradesh

10. Dr Fakhruddin Ahmed, Assistant

Professor, School of Studies in

Pharmaceutical Sciences, Jiwaji

University, Madhya Pradesh

11. Kawade Rajendra Madhukar, Ph.D.

Scholar, SSBE's Nanded Pharmacy

College, Maharashtra

12. Ashwani Singh Rawat, Ph.D. Scholar,

DIPSAR, New Delhi

13. Dr Vinay Kumar, Assistant Professor,

Krishna Institute of Engineering &

Technology, New Delhi

14. Preeti Kush, Assistant Professor,

Chandigarh College of Pharmacy,

Punjab

15. Sachin Goyal, Lecturer, Pacific College

of Pharmacy, Rajasthan

B-2

Aug

ust 5

to

10,

2013

Learning

Methodologi

es in

Pharmaceut

ical

Chemistry:

Medicinal

and

Analytical

Aspects

15

1. Bodiwala Kunjan B., Assistant

Professor, Maliba Pharmacy College,

Gujarat

2. Shirishkumar Rameshbhai Patel,

Assistant Professor, Hemchandracharya

North Gujarat University, Gujarat

3. Umangkumar H. Shah, Assistant

Professor, Ramanbhai Patel College of

Pharmacy, Gujarat

4. Dr Dinesh Mehta, Associate Professor,

M. M. College of Pharmacy, Haryana

5. Dr Sukhbir Lal, Assistant Professor,

Kurukshetra University, Haryana

6. Dr Rohit Dutt, Associate Professor,

Guru Gobind Singh College of

Pharmacy, Haryana

7. Dr Anurekha Jain, Professor & Head,

B. R. Nahata College of Pharmacy,

Page 87: University Institute of Pharmaceutical Sciences

Course

Modul

e

Date

Theme of

the Training

Course

Total

Particip

ants

Participants’ Name

Madhya Pradesh

8. Rita Mourya, Assistant Professor, VNS

Faculty of Pharmacy, Madhya Pradesh

9. Gajeli Ganesh Balappa, Lecturer, DSTS

Mandal's College of Pharmacy,

Maharashtra

10. Ankur Gera, Assistant Professor,

Chitkara College of Pharmacy, Punjab

11. Ritchu Babbar, Assistant Professor,

Chitkara College of Pharmacy, Punjab

12. Mahaveer Singh, Lecturer, BITS Pilani,

Rajasthan

13. Abhay Bhardwaj, Assistant Professor,

K.I.E.T School of Pharmacy, Uttar

Pradesh

14. Minakshi Pandey, Assistant Professor,

RKGIT College of Pharmacy, Uttar

Pradesh

15. Anil Waldia, Assistant Professor,

Devsthali Vidyapeeth College of

Pharmacy, Uttarakhand

A-2

Nove

mbe

r 18

to

23,

2013

Challenges

and

Opportuniti

es in Drug

Discovery

15

1. Rajasekhar Reddy Alavala, JRF,

Vaagdevi College of Pharmacy, Andhra

Pradesh

2. Srujana M, Associate Professor,

Chaitanya College of Pharmacy,

Andhra Pradesh

3. Mohammed Asief, Assistant Professor,

Mohammadiya Institute of Pharmacy,

Andhra Pradesh

4. Mayank Kumar Sharma, Ph.D.

Research Scholar, M.S. University of

Baroda, Gujarat

5. Rajneesh Kaur, Research Scholar,

Jaypee University of Information

Technology, Himachal Pradesh

6. Rohit Bhatia, Assistant Professor,

Laureate Institute of Pharmacy,

Himachal Pradesh

7. Chethan G. H., Research Scholar,

Manipal College of Pharmaceutical

Sciences, Karnataka

8. Basavaraj M. Dinnimath, Assistant

Professor, KLEU's College of

Pharmacy, Karnataka

9. P. C. Lalawpuii, Assistant Professor,

Regional Institute of Paramedical &

Page 88: University Institute of Pharmaceutical Sciences

Course

Modul

e

Date

Theme of

the Training

Course

Total

Particip

ants

Participants’ Name

Nursing Sciences, Mizoram

10. Omprakash Goshain, Project Fellow,

Jamia Hamdard, New Delhi

11. Swati Sudan, Assistant Professor,

Chandigarh College of Pharmacy,

Chandigarh

12. Rina Das, Assistant Professor,

Maharishi Markandeshwar College of

Pharmacy, Haryana

13. Mohit Mangla, Assistant Professor,

PCTE Institute of Pharmacy, Punjab

14. Sanjay Kumar Kushwaha, Associate

Professor, Geetanjali Institute of

Pharmacy, Rajasthan

15. Md. Rahmat Ali, Ph.D. Research

Scholar, Jamia Hamdard, New Delhi

31. Code of ethics for research followed by the departments: Yes

32. Student profile programme-wise:

Name of the Applications Selected Pass percentage

Programme received Male Female Male Female

(refer to question no. 4)

B. Pharm

Received by

the Joint

Admission 14 32 10 21

M. Pharm 160 4 18 4 18

33. Diversity of Students

Name of the

Programme (refer to question

no. 4)

% of

students

from the same

university

% of students

from other

universities within the

State

% of students

from

universities outside the

State

% of

students

from other

countries

M. Pharm. (22) 9 - 13 -

Page 89: University Institute of Pharmaceutical Sciences

34. How many students have cleared Civil Services and Defense Services examinations,

NET, SET, GATE and other competitive examinations? Give details category-wise.

PCS: 1

GPAT

2009-2010: 41

2010-2011: 41

2011-2012: 27

2012-2013: 24

35. Student progression

Student progression Percentage against enrolled

UG to PG 80%

PG to M.Phil. NA

PG to Ph.D. 70%

Ph.D. to Post-Doctoral 40%

Campus selection

Other than campus recruitment 100%

Entrepreneurs

5%

36. Diversity of Staff

Percentage of faculty who are graduates

of the same university About 80%

from other universities within the State -

from universities from other States About 20%

from universities outside the country -

Page 90: University Institute of Pharmaceutical Sciences

37. Number of faculty who were awarded M.Phil., Ph.D., D.Sc. and D.Litt. during the

assessment period : 3

38. Present details of departmental infrastructural facilities with regard to

a) Library Yes

b) Internet facilities for staff and students: Yeswi-fi campus

c) Total number of class rooms: 5

d) Class rooms with ICT facility: 4

e) Students‟ laboratories : 13

f) Research laboratories : 17

39. List of doctoral, post-doctoral students and Research Associates

a) from the host institution/university 17

b) from other institutions/universities 37

40. Number of post graduate students getting financial assistance from the university.: 10

41.

42. Was any need assessment exercise undertaken before the development of new

programme (s)? If so, highlight the methodology. Yes

43. Does the department obtain feedback from

a. faculty on curriculum as well as teaching-learning-evaluation? If yes, how does the

department utilize the feedback? Yes; we update the curriculum on yearly basis as per

feed back of faculty. We also try to improve teaching-learning module by enhancing

students participation in seminars and group discussion.

b. students on staff, curriculum and teaching-learning-evaluation and how does the

department utilize the feedback? Yes; we critically analyse the feedback of students &

incorporated their valid suggestions.

c. alumni and employers on the programmes offered and how does the department utilize

the feedback? Yes; we constantly revise our curriculum & expose the students to current

requirement of industries as per alumni & employer suggestions.

44. List the distinguished alumni of the department (maximum 10)

Dr. K.N. Gaind

Dr. C.K. Atal

Dr.Harkishan Singh

Dr. B. D. Miglani

Dr. S.S. Handa

Dr. S.K. Kulkarni

Dr. P.D. Sethi

Dr. V.K. Gambar

Page 91: University Institute of Pharmaceutical Sciences

Dr. Ashok Rampal

Dr. K.C. Jindal

Dr. K.K. Bhutani

Dr. Rajeev Malik

Dr. S.L. Nasa

Dr. T.K. Mittal

45. Give details of student enrichment programmes (special lectures / workshops / seminar)

involving external experts.

NRC Lectures, Invited Lectures

46. List the teaching methods adopted by the faculty for different programmes.

Black Board Teaching & Advanced IT Teaching Tools like LCD, TV, LCD

Projector, Interactive Panel, Interactive Board, OHP

47. How does the department ensure that programme objectives are constantly met and

learning outcomes are monitored?

On the basis of students and faculty performance:

Studentsperformance in:

GPAT/GATE

CAT – NIPER

GRE

TOFFLE

Jobs in MNCs/Government

Faculty performance:

Patents

Publications

Research Grant

National Collaborations

International Collaborations

Industrial Collaborations

Nationals & Internationals Recognitions

48. Highlight the participation of students and faculty in extension activities.

Faculty Participation:

Organizing National International conferences, workshops etc.

Sports meets

Cultural events

Alumni Meet

Page 92: University Institute of Pharmaceutical Sciences

Student Participation:

Annual function

Freshers

Farewell

Sports ,meet

Cultural activities

48. Give details of “beyond syllabus scholarly activities” of the department.

Networking Resource Centre, workshops, conferences, extension/invited lectures,

Participation inPharmacovigilanceprogram of India& Prescription monitoring

49. State whether the programme/ department is accredited/ graded by other agencies? If

yes, give details. No

50. Briefly highlight the contributions of the department in generating new knowledge, basic

or applied.

Development of New Drug Delivery system

Development of new carrier system specifically Nano

Chemical & Physical Modifications of existing drugs with enhanced therapeutic

value with less side effects

Synthesis of new series of chemical moieties for plethora of diseases

Isolation & characterization of phytoconstituents

Development of new animal models

Pharmacological evaluation of synthetic & herbal molecules

Patient Pharmacist communication skills

Discussion of clinical case studies

51. Detail five major Strengths, Weaknesses, Opportunities and Challenges (SWOC) of the

department.

Strengths:Faculty/Infrastructure/Good Laboratories

Weaknesses:More faculty & space required

Opportunities: Provide good opportunities & training for research in the

area of Drug Discovery and Drug Development

Challenges: Strengthening of especially new M. Pharm. courses

Placement

Collaborations with Industries & Institute.

52. Future plans of the department.

General of trained human resource Improvement of teaching – learning methodology Establish state-of-art research facility International & National Research collaborations Establish Industry – oriented research facility